Ionis Pharmaceuticals Inc. (IONS) NASDAQ
$43.35 (1.31) (-2.93%)
Market Cap: $6.32B
As of 03/28/24 04:00 PM EDT. Market closed.
Ionis Pharmaceuticals Inc. (IONS)
NASDAQ
$43.35
(1.31) (-2.93%)
Market Cap: $6.32B
As of 03/28/24 04:00 PM EDT. Market closed.
ionis pharmaceuticals, inc., located in the north san diego county city of carlsbad, was founded in 1989 to create advanced, novel medicines to treat complex and challenging diseases. we are the pioneer in the discovery and development of antisense drugs with more than 1300 patents. ionis is a challenging, motivating and rewarding environment designed to foster innovation and scientific ... read more
ionis pharmaceuticals, inc., located in the north san diego county city of carlsbad, was founded in 1989 to create advanced, novel medicines to treat complex and challenging diseases. we are the pioneer in the discovery and development of antisense drugs with more than 1300 patents. ionis is a challenging, motivating and rewarding environment designed to foster innovation and scientific excellence. our founding goals have changed little in over 27 years and our success is a direct result of our outstanding employees. we are interested in bringing together individuals with different skill sets into this creative environment to be part of a productive team. join us and experience our unique culture while you develop and expand your career. for more information about ionis and to apply for an open position, please visit our website: www.ionispharma.com. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Swayze Eric | Officer Level 14 | Feb 29, 2024 | Option Exercise | $34.42 | 605 | 20,827 | 34,929 | Mar 04, 2024, 07:13 PM |
Monia Brett P | CEO Level 15 | Feb 29, 2024 | Option Exercise | $34.42 | 538 | 18,521 | 174,289 | Mar 04, 2024, 07:13 PM |
Geary Richard S | Officer Level 14 | Feb 29, 2024 | Option Exercise | $34.42 | 604 | 20,793 | 87,938 | Mar 04, 2024, 07:13 PM |
Birchler Brian | Vice President Level 14 | Feb 29, 2024 | Option Exercise | $34.42 | 604 | 20,793 | 45,186 | Mar 04, 2024, 07:13 PM |
BENNETT C FRANK | Officer Level 14 | Feb 29, 2024 | Option Exercise | $34.42 | 383 | 13,185 | 79,462 | Mar 04, 2024, 07:13 PM |
Monia Brett P | Chief Executive Officer | Feb 16, 2024 | Sale | $44.49 | 387 | 17,219 | 173,751 | Feb 16, 2024, 07:47 PM |
Swayze Eric | EVP Research | Feb 02, 2024 | Sale | $49.56 | 1,907 | 94,513 | 34,324 | Feb 02, 2024, 07:55 PM |
Swayze Eric | EVP Research | Jan 31, 2024 | Sale | $52.00 | 10,773 | 560,196 | 32,516 | Feb 02, 2024, 07:55 PM |
Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Feb 02, 2024 | Sale | $49.59 | 2,071 | 102,701 | 49,812 | Feb 02, 2024, 07:55 PM |
O'NEIL PATRICK R. | EVP CLO & General Counsel | Feb 02, 2024 | Sale | $49.67 | 1,961 | 97,410 | 48,661 | Feb 02, 2024, 07:55 PM |
Monia Brett P | Chief Executive Officer | Feb 02, 2024 | Sale | $49.37 | 23,501 | 1,160,303 | 174,138 | Feb 02, 2024, 07:55 PM |
HOUGEN ELIZABETH L | EVP, Finance & CFO | Feb 02, 2024 | Sale | $49.54 | 2,125 | 105,272 | 92,905 | Feb 02, 2024, 07:55 PM |
Geary Richard S | EVP, Chief Development Officer | Feb 02, 2024 | Sale | $50.04 | 1,961 | 98,135 | 87,334 | Feb 02, 2024, 07:54 PM |
Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str & Oper Ofc | Feb 02, 2024 | Sale | $49.60 | 2,125 | 105,404 | 35,825 | Feb 02, 2024, 07:54 PM |
BENNETT C FRANK | EVP, Chief Scientific Officer | Feb 02, 2024 | Sale | $49.52 | 1,853 | 91,752 | 79,079 | Feb 02, 2024, 07:54 PM |
Monia Brett P | Chief Executive Officer | Jan 25, 2024 | Sale | $51.75 | 2,285 | 118,249 | 151,851 | Jan 29, 2024, 05:34 PM |
O'NEIL PATRICK R. | EVP CLO & General Counsel | Jan 25, 2024 | Sale | $51.75 | 6,450 | 333,788 | 46,802 | Jan 29, 2024, 05:34 PM |
Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str & Oper Ofc | Jan 17, 2024 | Sale | $50.42 | 5,564 | 280,520 | 33,810 | Jan 18, 2024, 06:07 PM |
O'NEIL PATRICK R. | EVP CLO & General Counsel | Jan 17, 2024 | Sale | $50.42 | 7,744 | 390,429 | 53,252 | Jan 18, 2024, 05:59 PM |
Birchler Brian | EVP, Corp and Development Ops | Jan 17, 2024 | Sale | $50.42 | 4,497 | 226,725 | 44,582 | Jan 18, 2024, 05:55 PM |
Swayze Eric | EVP Research | Jan 17, 2024 | Sale | $50.42 | 6,296 | 317,425 | 43,289 | Jan 18, 2024, 05:49 PM |
Swayze Eric | EVP Research | Jan 17, 2024 | Sale | $50.42 | 9 | 454 | 85 | Jan 18, 2024, 05:49 PM |
Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Jan 17, 2024 | Sale | $50.42 | 5,482 | 276,386 | 47,850 | Jan 18, 2024, 05:48 PM |
Monia Brett P | Chief Executive Officer | Jan 17, 2024 | Sale | $50.42 | 32,059 | 1,616,319 | 154,136 | Jan 18, 2024, 05:48 PM |
HOUGEN ELIZABETH L | EVP, Finance & CFO | Jan 17, 2024 | Sale | $50.42 | 8,683 | 437,771 | 90,890 | Jan 18, 2024, 05:48 PM |
Geary Richard S | EVP, Chief Development Officer | Jan 17, 2024 | Sale | $50.42 | 7,338 | 369,960 | 85,475 | Jan 18, 2024, 05:47 PM |
BENNETT C FRANK | EVP, Chief Scientific Officer | Jan 17, 2024 | Sale | $50.42 | 6,745 | 340,063 | 77,323 | Jan 18, 2024, 05:44 PM |
Baroldi Joseph | EVP, Chief Business Officer | Jan 17, 2024 | Sale | $50.42 | 564 | 28,435 | 1,640 | Jan 18, 2024, 05:44 PM |
Baroldi Joseph | EVP, Chief Business Officer | Jan 17, 2024 | Sale | $50.42 | 1,460 | 73,609 | 12,799 | Jan 18, 2024, 05:44 PM |
Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Jan 12, 2024 | Option Exercise | $32.60 | 8,000 | 260,800 | 46,170 | Jan 17, 2024, 08:51 PM |
Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Jan 12, 2024 | Sale | $53.50 | 8,000 | 427,999 | 38,170 | Jan 17, 2024, 08:51 PM |
Swayze Eric | EVP Research | Dec 28, 2023 | Option Exercise | $47.34 | 27,100 | 1,282,914 | 59,616 | Jan 02, 2024, 05:54 PM |
Swayze Eric | EVP Research | Dec 28, 2023 | Sale | $50.19 | 27,100 | 1,360,081 | 32,516 | Jan 02, 2024, 05:54 PM |
HOUGEN ELIZABETH L | EVP, Finance & CFO | Dec 28, 2023 | Option Exercise | $50.50 | 43,798 | 2,211,799 | 77,086 | Jan 02, 2024, 05:54 PM |
HOUGEN ELIZABETH L | EVP, Finance & CFO | Dec 28, 2023 | Option Exercise | $47.34 | 45,225 | 2,140,952 | 120,884 | Jan 02, 2024, 05:54 PM |
Birchler Brian | EVP, Corp and Development Ops | Dec 28, 2023 | Option Exercise | $50.50 | 11,029 | 556,965 | 36,999 | Jan 02, 2024, 05:54 PM |
Birchler Brian | EVP, Corp and Development Ops | Dec 28, 2023 | Option Exercise | $47.34 | 11,500 | 544,410 | 48,028 | Jan 02, 2024, 05:54 PM |
O'NEIL PATRICK R. | EVP CLO & General Counsel | Dec 26, 2023 | Option Exercise | $47.34 | 20,825 | 985,856 | 61,180 | Dec 28, 2023, 07:18 PM |
O'NEIL PATRICK R. | EVP CLO & General Counsel | Dec 26, 2023 | Sale | $51.46 | 20,825 | 1,071,717 | 40,355 | Dec 28, 2023, 07:18 PM |
PARSHALL B LYNNE | Director | Dec 28, 2023 | Option Exercise | $47.34 | 42,525 | 2,013,134 | 125,113 | Dec 28, 2023, 07:18 PM |
PARSHALL B LYNNE | Director | Dec 27, 2023 | Option Exercise | $47.34 | 50,000 | 2,367,000 | 132,588 | Dec 28, 2023, 07:18 PM |
PARSHALL B LYNNE | Director | Dec 26, 2023 | Option Exercise | $47.34 | 25,113 | 1,188,849 | 107,701 | Dec 28, 2023, 07:18 PM |
PARSHALL B LYNNE | Director | Dec 27, 2023 | Sale | $50.23 | 50,000 | 2,511,515 | 82,588 | Dec 28, 2023, 07:18 PM |
PARSHALL B LYNNE | Director | Dec 26, 2023 | Sale | $51.46 | 25,113 | 1,292,390 | 82,588 | Dec 28, 2023, 07:18 PM |
PARSHALL B LYNNE | Director | Dec 28, 2023 | Sale | $50.19 | 42,525 | 2,134,223 | 82,588 | Dec 28, 2023, 07:18 PM |
Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Dec 26, 2023 | Option Exercise | $47.34 | 25,000 | 1,183,500 | 61,052 | Dec 28, 2023, 07:18 PM |
Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Dec 26, 2023 | Sale | $51.46 | 25,000 | 1,286,575 | 36,052 | Dec 28, 2023, 07:18 PM |
BENNETT C FRANK | EVP, Chief Scientific Officer | Dec 20, 2023 | Option Exercise | $47.34 | 6,500 | 307,710 | 72,254 | Dec 22, 2023, 07:11 PM |
BENNETT C FRANK | EVP, Chief Scientific Officer | Dec 21, 2023 | Option Exercise | $47.34 | 16,113 | 762,789 | 81,867 | Dec 22, 2023, 07:11 PM |
BENNETT C FRANK | EVP, Chief Scientific Officer | Dec 20, 2023 | Sale | $49.64 | 6,500 | 322,643 | 65,754 | Dec 22, 2023, 07:11 PM |
BENNETT C FRANK | EVP, Chief Scientific Officer | Dec 21, 2023 | Sale | $49.29 | 16,113 | 794,211 | 65,754 | Dec 22, 2023, 07:11 PM |
Geary Richard S | EVP, Chief Development Officer | Dec 21, 2023 | Option Exercise | $47.34 | 4,112 | 194,662 | 77,073 | Dec 22, 2023, 07:11 PM |
Geary Richard S | EVP, Chief Development Officer | Dec 20, 2023 | Option Exercise | $47.34 | 6,500 | 307,710 | 79,461 | Dec 22, 2023, 07:11 PM |
Geary Richard S | EVP, Chief Development Officer | Dec 21, 2023 | Sale | $49.29 | 4,112 | 202,681 | 72,961 | Dec 22, 2023, 07:11 PM |
Geary Richard S | EVP, Chief Development Officer | Dec 20, 2023 | Sale | $49.64 | 6,500 | 322,643 | 72,961 | Dec 22, 2023, 07:11 PM |
Monia Brett P | Chief Executive Officer | Dec 21, 2023 | Option Exercise | $47.34 | 17,500 | 828,450 | 135,611 | Dec 22, 2023, 07:11 PM |
Monia Brett P | Chief Executive Officer | Dec 20, 2023 | Option Exercise | $47.34 | 6,500 | 307,710 | 124,611 | Dec 22, 2023, 07:11 PM |
Monia Brett P | Chief Executive Officer | Dec 21, 2023 | Sale | $49.29 | 17,500 | 862,577 | 118,111 | Dec 22, 2023, 07:11 PM |
Monia Brett P | Chief Executive Officer | Dec 20, 2023 | Sale | $49.64 | 6,500 | 322,643 | 118,111 | Dec 22, 2023, 07:11 PM |
Monia Brett P | Chief Executive Officer | Dec 14, 2023 | Option Exercise | $47.34 | 24,000 | 1,136,160 | 132,971 | Dec 18, 2023, 04:56 PM |
Monia Brett P | Chief Executive Officer | Dec 14, 2023 | Sale | $49.58 | 24,000 | 1,190,019 | 118,111 | Dec 18, 2023, 04:56 PM |
Geary Richard S | EVP, Chief Development Officer | Dec 14, 2023 | Option Exercise | $47.34 | 10,613 | 502,419 | 79,532 | Dec 18, 2023, 04:55 PM |
Geary Richard S | EVP, Chief Development Officer | Dec 14, 2023 | Sale | $49.58 | 10,613 | 526,236 | 72,961 | Dec 18, 2023, 04:55 PM |
BENNETT C FRANK | EVP, Chief Scientific Officer | Dec 14, 2023 | Option Exercise | $47.34 | 22,612 | 1,070,452 | 79,756 | Dec 18, 2023, 04:55 PM |
BENNETT C FRANK | EVP, Chief Scientific Officer | Dec 14, 2023 | Sale | $49.58 | 22,612 | 1,121,195 | 65,754 | Dec 18, 2023, 04:55 PM |
KLEIN JOSEPH III | Director | Nov 15, 2023 | Sale | $50.00 | 2,000 | 100,000 | 16,346 | Nov 17, 2023, 04:58 PM |
Swayze Eric | EVP Research | Oct 17, 2023 | Sale | $47.95 | 52 | 2,493 | 73 | Oct 18, 2023, 06:40 PM |
Monia Brett P | Chief Executive Officer | Oct 12, 2023 | Sale | $46.00 | 3,770 | 173,420 | 118,111 | Oct 16, 2023, 04:35 PM |
BENNETT C FRANK | EVP, Chief Scientific Officer | Sep 28, 2023 | Sale | $46.50 | 4,460 | 207,390 | 65,754 | Sep 29, 2023, 05:20 PM |
PARSHALL B LYNNE | Director | Sep 26, 2023 | Sale | $45.13 | 10,000 | 451,268 | 82,588 | Sep 28, 2023, 06:03 PM |
KLEIN JOSEPH III | Director | Sep 26, 2023 | Sale | $45.13 | 2,000 | 90,254 | 18,346 | Sep 28, 2023, 06:03 PM |
BENNETT C FRANK | Officer Level 14 | Aug 31, 2023 | Option Exercise | $30.56 | 180 | 5,500 | 70,214 | Sep 05, 2023, 04:59 PM |
Geary Richard S | Officer Level 14 | Aug 31, 2023 | Option Exercise | $30.56 | 1 | 31 | 72,961 | Sep 05, 2023, 04:59 PM |
Monia Brett P | CEO Level 15 | Aug 31, 2023 | Option Exercise | $30.56 | 157 | 4,798 | 121,881 | Sep 05, 2023, 04:59 PM |
Diaz Allene M. | Director | Aug 01, 2023 | Sale | $41.05 | 657 | 26,970 | 12,676 | Aug 03, 2023, 05:20 PM |
KLEIN JOSEPH III | Director | Jul 18, 2023 | Sale | $42.00 | 3,555 | 149,310 | 20,346 | Jul 19, 2023, 06:05 PM |
Monia Brett P | Chief Executive Officer | Jul 07, 2023 | Sale | $42.25 | 18,650 | 787,953 | 121,724 | Jul 11, 2023, 05:07 PM |
BERTHELSEN SPENCER R | Director | Jun 20, 2023 | Option Exercise | $28.47 | 11,250 | 320,287 | 140,147 | Jun 22, 2023, 05:17 PM |
O'NEIL PATRICK R. | EVP CLO & General Counsel | May 24, 2023 | Sale | $41.70 | 1,527 | 63,676 | 40,355 | May 24, 2023, 08:25 PM |
Monia Brett P | Chief Executive Officer | May 22, 2023 | Sale | $40.14 | 4,931 | 197,907 | 143,004 | May 24, 2023, 08:25 PM |
Birchler Brian | EVP, Corp and Development Ops | Apr 18, 2023 | Sale | $36.50 | 672 | 24,530 | 36,528 | Apr 19, 2023, 08:18 PM |
Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str & Oper Ofc | Apr 18, 2023 | Sale | $36.50 | 2,582 | 94,250 | 24,312 | Apr 19, 2023, 08:18 PM |
Baroldi Joseph | EVP, Chief Business Officer | Apr 18, 2023 | Sale | $36.50 | 3,880 | 141,631 | 10,571 | Apr 19, 2023, 08:18 PM |
Swayze Eric | EVP Research | Feb 28, 2023 | Option Exercise | $30.51 | 575 | 17,546 | 32,516 | Mar 02, 2023, 05:19 PM |
O'NEIL PATRICK R. | EVP CLO & General Counsel | Feb 28, 2023 | Option Exercise | $30.51 | 301 | 9,185 | 41,882 | Mar 02, 2023, 05:19 PM |
Geary Richard S | EVP, Chief Development Officer | Feb 28, 2023 | Option Exercise | $30.51 | 575 | 17,546 | 72,960 | Mar 02, 2023, 05:18 PM |
HOUGEN ELIZABETH L | EVP, Finance & CFO | Feb 28, 2023 | Option Exercise | $30.51 | 163 | 4,974 | 75,659 | Mar 02, 2023, 05:18 PM |
BENNETT C FRANK | EVP, Chief Scientific Officer | Feb 28, 2023 | Option Exercise | $30.51 | 383 | 11,687 | 70,034 | Mar 02, 2023, 05:18 PM |
Swayze Eric | EVP Research | Feb 06, 2023 | Sale | $40.79 | 1,815 | 74,031 | 31,941 | Feb 07, 2023, 05:37 PM |
Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Feb 06, 2023 | Sale | $40.67 | 1,413 | 57,464 | 24,946 | Feb 07, 2023, 05:37 PM |
O'NEIL PATRICK R. | EVP CLO & General Counsel | Feb 06, 2023 | Sale | $40.86 | 1,920 | 78,460 | 41,581 | Feb 07, 2023, 05:37 PM |
Monia Brett P | Chief Executive Officer | Feb 06, 2023 | Sale | $40.69 | 24,651 | 1,003,153 | 145,305 | Feb 07, 2023, 05:36 PM |
HOUGEN ELIZABETH L | EVP, Finance & CFO | Feb 06, 2023 | Sale | $40.59 | 2,079 | 84,392 | 75,496 | Feb 07, 2023, 05:36 PM |
Geary Richard S | EVP, Chief Development Officer | Feb 06, 2023 | Sale | $40.66 | 1,920 | 78,070 | 72,385 | Feb 07, 2023, 05:36 PM |
Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str & Oper Ofc | Feb 06, 2023 | Sale | $40.66 | 1,451 | 58,997 | 21,227 | Feb 07, 2023, 05:36 PM |
BENNETT C FRANK | EVP, Chief Scientific Officer | Feb 06, 2023 | Sale | $40.57 | 1,813 | 73,560 | 69,651 | Feb 07, 2023, 05:36 PM |
O'NEIL PATRICK R. | EVP CLO & General Counsel | Jan 31, 2023 | Sale | $39.71 | 4,500 | 178,700 | 39,679 | Feb 02, 2023, 01:48 PM |
O'NEIL PATRICK R. | EVP CLO & General Counsel | Jan 30, 2023 | Sale | $39.42 | 4,500 | 177,372 | 44,179 | Feb 02, 2023, 01:48 PM |
Swayze Eric | EVP Research | Jan 18, 2023 | Sale | $39.74 | 5,631 | 223,800 | 30,041 | Jan 19, 2023, 08:22 PM |
Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Jan 18, 2023 | Sale | $39.57 | 4,752 | 188,052 | 22,326 | Jan 19, 2023, 08:22 PM |
O'NEIL PATRICK R. | EVP CLO & General Counsel | Jan 18, 2023 | Sale | $39.49 | 7,836 | 309,480 | 48,679 | Jan 19, 2023, 08:21 PM |
Monia Brett P | Chief Executive Officer | Jan 18, 2023 | Sale | $39.49 | 25,066 | 989,947 | 120,863 | Jan 19, 2023, 08:21 PM |
HOUGEN ELIZABETH L | EVP, Finance & CFO | Jan 18, 2023 | Sale | $39.70 | 8,280 | 328,721 | 73,435 | Jan 19, 2023, 08:19 PM |
Geary Richard S | EVP, Chief Development Officer | Jan 18, 2023 | Sale | $39.57 | 7,873 | 311,525 | 70,483 | Jan 19, 2023, 08:19 PM |
Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str & Oper Ofc | Jan 18, 2023 | Sale | $39.55 | 3,748 | 148,223 | 18,538 | Jan 19, 2023, 08:19 PM |
BENNETT C FRANK | EVP, Chief Scientific Officer | Jan 18, 2023 | Sale | $38.89 | 6,978 | 271,356 | 67,855 | Jan 19, 2023, 08:19 PM |
Baroldi Joseph | EVP, Chief Business Officer | Jan 18, 2023 | Sale | $39.79 | 375 | 14,920 | 851 | Jan 19, 2023, 08:19 PM |
KLEIN JOSEPH III | Director | Jan 17, 2023 | Sale | $40.00 | 2,000 | 80,000 | 16,791 | Jan 18, 2023, 08:19 PM |
Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Oct 17, 2022 | Option Exercise | $46.52 | 144 | 6,699 | 14,032 | Oct 18, 2022, 07:10 PM |
Swayze Eric | EVP Research | Sep 08, 2022 | Sale | $44.55 | 460 | 20,493 | 19,892 | Sep 12, 2022, 07:09 PM |
O'NEIL PATRICK R. | EVP CLO & General Counsel | Aug 31, 2022 | Option Exercise | $28.97 | 108 | 3,129 | 34,644 | Sep 01, 2022, 07:03 PM |
HOUGEN ELIZABETH L | EVP, Finance & CFO | Aug 31, 2022 | Option Exercise | $28.97 | 202 | 5,852 | 58,561 | Sep 01, 2022, 07:03 PM |
BENNETT C FRANK | EVP, Chief Scientific Officer | Aug 31, 2022 | Option Exercise | $28.97 | 183 | 5,301 | 55,416 | Sep 01, 2022, 07:03 PM |
Swayze Eric | EVP Research | Aug 05, 2022 | Sale | $45.20 | 1 | 45 | 20,352 | Aug 09, 2022, 07:02 PM |
KLEIN JOSEPH III | Director | Jul 15, 2022 | Sale | $38.24 | 1,333 | 50,977 | 19,435 | Jul 19, 2022, 07:20 PM |
MUTO FREDERICK T | Director | Jul 01, 2022 | Option Exercise | $12.94 | 11,250 | 145,575 | 51,599 | Jul 06, 2022, 05:25 PM |
BERTHELSEN SPENCER R | Director | Jun 07, 2022 | Option Exercise | $12.94 | 11,250 | 145,575 | 120,899 | Jun 09, 2022, 05:53 PM |
Swayze Eric | EVP Research | Apr 21, 2022 | Sale | $44.15 | 378 | 16,689 | 20,353 | Apr 25, 2022, 08:56 PM |
Cadoret-Manier Onaiza | EVP, Chf Pdt Str & Oper Ofc | Apr 18, 2022 | Option Exercise | $41.01 | 1,960 | 80,380 | 12,089 | Apr 19, 2022, 08:23 PM |
O'NEIL PATRICK R. | EVP CLO & General Counsel | Apr 12, 2022 | Sale | $40.06 | 6,792 | 272,057 | 34,536 | Apr 14, 2022, 06:02 PM |
Monia Brett P | Chief Executive Officer | Apr 01, 2022 | Sale | $37.49 | 355 | 13,309 | 88,662 | Apr 05, 2022, 06:27 PM |
Swayze Eric | EVP Research | Feb 28, 2022 | Option Exercise | $28.37 | 621 | 17,620 | 20,731 | Mar 02, 2022, 06:43 PM |
O'NEIL PATRICK R. | EVP CLO & General Counsel | Feb 28, 2022 | Option Exercise | $28.37 | 735 | 20,854 | 41,328 | Mar 02, 2022, 06:42 PM |
Monia Brett P | Chief Executive Officer | Feb 28, 2022 | Option Exercise | $28.37 | 621 | 17,620 | 89,017 | Mar 02, 2022, 06:42 PM |
HOUGEN ELIZABETH L | EVP, Finance & CFO | Feb 28, 2022 | Option Exercise | $28.37 | 384 | 10,895 | 58,359 | Mar 02, 2022, 06:42 PM |
BENNETT C FRANK | EVP, Chief Scientific Officer | Feb 28, 2022 | Option Exercise | $28.37 | 346 | 9,817 | 55,233 | Mar 02, 2022, 06:41 PM |
Geary Richard S | EVP, Chief Development Officer | Feb 28, 2022 | Option Exercise | $28.37 | 621 | 17,620 | 56,373 | Mar 02, 2022, 06:41 PM |
Monia Brett P | Chief Executive Officer | Jan 26, 2022 | Option Exercise | $31.44 | 8,032 | 252,526 | 88,396 | Jan 28, 2022, 05:58 PM |
PARSHALL B LYNNE | Director | Jan 18, 2022 | Option Exercise | $30.12 | 1,652 | 49,758 | 77,480 | Jan 20, 2022, 08:21 PM |
Cadoret-Manier Onaiza | EVP, Chf Corp Dev and Cml Offc | Jan 18, 2022 | Option Exercise | $30.12 | 2,305 | 69,427 | 8,382 | Jan 20, 2022, 08:21 PM |
BENNETT C FRANK | EVP, Chief Scientific Officer | Jan 18, 2022 | Option Exercise | $30.12 | 6,726 | 202,587 | 54,887 | Jan 20, 2022, 08:21 PM |
O'NEIL PATRICK R. | EVP CLO & General Counsel | Jan 18, 2022 | Option Exercise | $30.12 | 7,501 | 225,930 | 40,593 | Jan 20, 2022, 08:18 PM |
HOUGEN ELIZABETH L | EVP, Finance & CFO | Jan 18, 2022 | Option Exercise | $30.12 | 7,828 | 235,779 | 57,975 | Jan 20, 2022, 08:18 PM |
Monia Brett P | Chief Executive Officer | Jan 18, 2022 | Option Exercise | $30.12 | 19,714 | 593,786 | 80,230 | Jan 20, 2022, 08:17 PM |
Geary Richard S | EVP, Chief Development Officer | Jan 18, 2022 | Option Exercise | $30.12 | 7,605 | 229,063 | 55,752 | Jan 20, 2022, 08:16 PM |
Schneider Eugene | EVP, Chf Clinical Develop Offc | Jan 18, 2022 | Option Exercise | $30.12 | 3,815 | 114,908 | 13,760 | Jan 20, 2022, 08:16 PM |
Swayze Eric | EVP Research | Jan 18, 2022 | Option Exercise | $30.12 | 4,994 | 150,419 | 20,110 | Jan 20, 2022, 08:16 PM |
Schneider Eugene | EVP, Chf Clinical Develop Offc | Oct 15, 2021 | Option Exercise | $35.10 | 145 | 5,089 | 7,175 | Oct 19, 2021, 06:29 PM |
Geary Richard S | EVP, Chief Development Offc | Aug 31, 2021 | Option Exercise | $33.80 | 46 | 1,555 | 41,966 | Sep 02, 2021, 07:25 PM |
O'NEIL PATRICK R. | EVP Legal & General Counsel | Aug 31, 2021 | Option Exercise | $33.80 | 309 | 10,443 | 27,008 | Sep 02, 2021, 07:21 PM |
Monia Brett P | Chief Executive Officer | Aug 31, 2021 | Option Exercise | $33.80 | 355 | 11,998 | 50,469 | Sep 02, 2021, 07:21 PM |
HOUGEN ELIZABETH L | EVP, Finance & CFO | Aug 31, 2021 | Option Exercise | $33.80 | 166 | 5,610 | 43,753 | Sep 02, 2021, 07:20 PM |
Cadoret-Manier Onaiza | Chief Corp Dev and Cml Officer | Aug 31, 2021 | Option Exercise | $33.80 | 431 | 14,566 | 4,630 | Sep 02, 2021, 07:20 PM |
BENNETT C FRANK | EVP & Chief Scientific Officer | Aug 31, 2021 | Option Exercise | $33.80 | 151 | 5,103 | 42,771 | Sep 02, 2021, 07:20 PM |
KLEIN JOSEPH III | Director | Jul 15, 2021 | Sale | $35.30 | 4,334 | 152,989 | 18,126 | Jul 19, 2021, 08:14 PM |
BERTHELSEN SPENCER R | Director | Jun 23, 2021 | Option Exercise | $9.30 | 15,000 | 139,500 | 115,983 | Jun 25, 2021, 05:19 PM |
BERTHELSEN SPENCER R | Director | Jun 23, 2021 | Sale | $37.74 | 15,000 | 566,100 | 100,983 | Jun 25, 2021, 05:19 PM |
MUTO FREDERICK T | Director | Jun 15, 2021 | Option Exercise | $9.30 | 15,000 | 139,500 | 36,683 | Jun 17, 2021, 05:05 PM |
MUTO FREDERICK T | Director | Jun 15, 2021 | Sale | $36.63 | 15,000 | 549,500 | 31,683 | Jun 17, 2021, 05:05 PM |
Cadoret-Manier Onaiza | Chief Corp Dev and Cml Officer | Apr 15, 2021 | Option Exercise | $41.03 | 1,960 | 80,419 | 4,199 | Apr 19, 2021, 05:04 PM |
Swayze Eric | EVP, Research | Feb 26, 2021 | Option Exercise | $44.54 | 460 | 20,488 | 11,295 | Mar 02, 2021, 08:36 PM |
O'NEIL PATRICK R. | EVP & General Counsel | Feb 26, 2021 | Option Exercise | $44.54 | 197 | 8,774 | 26,699 | Mar 02, 2021, 08:34 PM |
HOUGEN ELIZABETH L | EVP, Finance & CFO | Feb 26, 2021 | Option Exercise | $44.54 | 116 | 5,167 | 43,587 | Mar 02, 2021, 08:32 PM |
Geary Richard S | EVP, Chief Development Offc | Feb 26, 2021 | Option Exercise | $44.54 | 414 | 18,440 | 41,920 | Mar 02, 2021, 08:28 PM |
Cadoret-Manier Onaiza | Chief Corp Dev and Cml Officer | Feb 26, 2021 | Option Exercise | $44.54 | 492 | 21,914 | 492 | Mar 02, 2021, 08:27 PM |
BENNETT C FRANK | Chief Scientific Officer | Feb 26, 2021 | Option Exercise | $44.54 | 112 | 4,988 | 42,620 | Mar 02, 2021, 08:25 PM |
Monia Brett P | Chief Executive Officer | Feb 26, 2021 | Option Exercise | $44.54 | 247 | 11,001 | 50,350 | Mar 02, 2021, 08:22 PM |
Monia Brett P | Chief Executive Officer | Mar 01, 2021 | Sale | $54.28 | 236 | 12,809 | 50,114 | Mar 02, 2021, 08:22 PM |
Monia Brett P | Chief Executive Officer | Jan 28, 2021 | Option Exercise | $60.69 | 1,306 | 79,261 | 50,103 | Feb 01, 2021, 05:47 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Jan 26, 2021 | Sale | $63.74 | 28,333 | 1,805,812 | 2,021 | Jan 28, 2021, 07:22 PM |
O'NEIL PATRICK R. | EVP & General Counsel | Jan 25, 2021 | Sale | $63.50 | 5,324 | 338,074 | 26,502 | Jan 27, 2021, 05:35 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Jan 22, 2021 | Sale | $61.67 | 40,000 | 2,467,000 | 494,391 | Jan 25, 2021, 08:24 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Jan 21, 2021 | Sale | $61.20 | 35,000 | 2,142,117 | 555,433 | Jan 25, 2021, 08:24 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Jan 15, 2021 | Option Exercise | $61.28 | 1,434 | 87,876 | 3,111 | Jan 20, 2021, 07:12 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Jan 15, 2021 | Option Exercise | $61.28 | 18,924 | 1,159,663 | 30,354 | Jan 20, 2021, 07:12 PM |
BENNETT C FRANK | Chief Scientific Officer | Jan 15, 2021 | Option Exercise | $61.28 | 5,488 | 336,305 | 42,508 | Jan 20, 2021, 07:08 PM |
Geary Richard S | EVP, Chief Development Offc | Jan 15, 2021 | Option Exercise | $61.28 | 6,398 | 392,069 | 41,506 | Jan 20, 2021, 07:06 PM |
HOUGEN ELIZABETH L | EVP, Finance & CFO | Jan 15, 2021 | Option Exercise | $61.28 | 6,175 | 378,404 | 43,471 | Jan 20, 2021, 07:04 PM |
Monia Brett P | Chief Executive Officer | Jan 15, 2021 | Option Exercise | $61.28 | 14,927 | 914,727 | 48,775 | Jan 20, 2021, 07:02 PM |
O'NEIL PATRICK R. | EVP & General Counsel | Jan 15, 2021 | Option Exercise | $61.28 | 5,856 | 358,856 | 31,826 | Jan 20, 2021, 07:00 PM |
PARSHALL B LYNNE | Director | Jan 15, 2021 | Option Exercise | $61.28 | 2,741 | 167,968 | 65,378 | Jan 20, 2021, 06:59 PM |
Schneider Eugene | EVP, Chf Clinical Develop Offc | Jan 15, 2021 | Option Exercise | $61.28 | 2,718 | 166,559 | 6,903 | Jan 20, 2021, 06:55 PM |
Swayze Eric | EVP, Research | Jan 15, 2021 | Option Exercise | $61.28 | 3,216 | 197,076 | 10,835 | Jan 20, 2021, 06:53 PM |
Geary Richard S | EVP, Chief Development Offc | Jan 13, 2021 | Sale | $59.50 | 141 | 8,390 | 30,306 | Jan 15, 2021, 05:55 PM |
Swayze Eric | EVP, Research | Jan 05, 2021 | Sale | $55.99 | 195 | 10,918 | 5,107 | Jan 06, 2021, 09:23 PM |
PARSHALL B LYNNE | Director | Dec 23, 2020 | Sale | $60.00 | 10,000 | 600,000 | 57,464 | Dec 28, 2020, 05:29 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Dec 17, 2020 | Sale | $50.50 | 1,407 | 71,054 | 174 | Dec 17, 2020, 07:42 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Dec 15, 2020 | Sale | $49.78 | 39,000 | 1,941,225 | 600,391 | Dec 17, 2020, 07:42 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Dec 07, 2020 | Sale | $51.67 | 11,000 | 568,350 | 645,391 | Dec 09, 2020, 08:14 PM |
Monia Brett P | Chief Executive Officer | Dec 04, 2020 | Option Exercise | $39.87 | 23,840 | 950,501 | 52,719 | Dec 08, 2020, 08:51 PM |
Monia Brett P | Chief Executive Officer | Dec 04, 2020 | Sale | $51.04 | 23,840 | 1,216,794 | 28,879 | Dec 08, 2020, 08:51 PM |
BENNETT C FRANK | Chief Scientific Officer | Dec 04, 2020 | Option Exercise | $39.87 | 7,947 | 316,847 | 40,423 | Dec 08, 2020, 08:49 PM |
BENNETT C FRANK | Chief Scientific Officer | Dec 04, 2020 | Sale | $51.04 | 7,947 | 405,615 | 32,476 | Dec 08, 2020, 08:49 PM |
BENNETT C FRANK | Chief Scientific Officer | Dec 02, 2020 | Option Exercise | $39.87 | 7,053 | 281,203 | 39,529 | Dec 04, 2020, 08:53 PM |
BENNETT C FRANK | Chief Scientific Officer | Dec 02, 2020 | Sale | $51.32 | 7,053 | 361,960 | 32,476 | Dec 04, 2020, 08:53 PM |
Monia Brett P | Chief Executive Officer | Dec 02, 2020 | Option Exercise | $39.87 | 21,160 | 843,649 | 50,039 | Dec 04, 2020, 08:49 PM |
Monia Brett P | Chief Executive Officer | Dec 02, 2020 | Sale | $51.32 | 21,160 | 1,085,931 | 28,879 | Dec 04, 2020, 08:49 PM |
HOUGEN ELIZABETH L | EVP, Finance & CFO | Nov 25, 2020 | Option Exercise | $39.87 | 21,680 | 864,382 | 54,175 | Nov 30, 2020, 06:49 PM |
HOUGEN ELIZABETH L | EVP, Finance & CFO | Nov 25, 2020 | Sale | $50.05 | 21,680 | 1,085,084 | 32,495 | Nov 30, 2020, 06:49 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Nov 25, 2020 | Option Exercise | $39.87 | 12,990 | 517,911 | 15,011 | Nov 30, 2020, 06:48 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Nov 25, 2020 | Sale | $50.05 | 12,990 | 650,149 | 2,021 | Nov 30, 2020, 06:48 PM |
Geary Richard S | EVP, Development | Nov 25, 2020 | Option Exercise | $39.87 | 11,920 | 475,250 | 42,367 | Nov 30, 2020, 06:46 PM |
Geary Richard S | EVP, Development | Nov 25, 2020 | Sale | $50.05 | 11,920 | 596,596 | 30,447 | Nov 30, 2020, 06:46 PM |
PARSHALL B LYNNE | Director | Nov 25, 2020 | Option Exercise | $39.87 | 3,590 | 143,133 | 71,054 | Nov 30, 2020, 06:44 PM |
PARSHALL B LYNNE | Director | Nov 25, 2020 | Sale | $50.05 | 3,590 | 179,679 | 67,464 | Nov 30, 2020, 06:44 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Nov 24, 2020 | Option Exercise | $39.87 | 2,590 | 103,263 | 4,611 | Nov 25, 2020, 07:04 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Nov 23, 2020 | Option Exercise | $39.87 | 11,600 | 462,492 | 13,621 | Nov 25, 2020, 07:04 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Nov 23, 2020 | Option Exercise | $39.87 | 500 | 19,935 | 2,081 | Nov 25, 2020, 07:04 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Nov 23, 2020 | Sale | $50.11 | 11,600 | 581,276 | 2,021 | Nov 25, 2020, 07:04 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Nov 23, 2020 | Sale | $50.00 | 500 | 25,000 | 1,581 | Nov 25, 2020, 07:04 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Nov 24, 2020 | Sale | $50.83 | 2,590 | 131,650 | 2,021 | Nov 25, 2020, 07:04 PM |
HOUGEN ELIZABETH L | EVP, Finance & CFO | Nov 24, 2020 | Option Exercise | $39.87 | 4,320 | 172,238 | 36,815 | Nov 25, 2020, 07:02 PM |
HOUGEN ELIZABETH L | EVP, Finance & CFO | Nov 23, 2020 | Option Exercise | $39.87 | 19,000 | 757,530 | 45,620 | Nov 25, 2020, 07:02 PM |
HOUGEN ELIZABETH L | EVP, Finance & CFO | Nov 24, 2020 | Sale | $50.83 | 4,320 | 219,586 | 32,495 | Nov 25, 2020, 07:02 PM |
HOUGEN ELIZABETH L | EVP, Finance & CFO | Nov 23, 2020 | Sale | $50.11 | 19,000 | 952,090 | 32,495 | Nov 25, 2020, 07:02 PM |
Geary Richard S | EVP, Development | Nov 24, 2020 | Option Exercise | $39.87 | 2,380 | 94,891 | 32,827 | Nov 25, 2020, 06:58 PM |
Geary Richard S | EVP, Development | Nov 23, 2020 | Option Exercise | $39.87 | 10,700 | 426,609 | 41,147 | Nov 25, 2020, 06:58 PM |
Geary Richard S | EVP, Development | Nov 24, 2020 | Sale | $50.83 | 2,380 | 120,975 | 30,447 | Nov 25, 2020, 06:58 PM |
Geary Richard S | EVP, Development | Nov 23, 2020 | Sale | $50.11 | 10,700 | 536,177 | 30,447 | Nov 25, 2020, 06:58 PM |
PARSHALL B LYNNE | Director | Nov 24, 2020 | Option Exercise | $39.87 | 710 | 28,308 | 68,174 | Nov 25, 2020, 06:56 PM |
PARSHALL B LYNNE | Director | Nov 23, 2020 | Option Exercise | $39.87 | 3,200 | 127,584 | 70,664 | Nov 25, 2020, 06:56 PM |
PARSHALL B LYNNE | Director | Nov 23, 2020 | Sale | $50.12 | 3,200 | 160,384 | 67,464 | Nov 25, 2020, 06:56 PM |
PARSHALL B LYNNE | Director | Nov 24, 2020 | Sale | $50.82 | 710 | 36,082 | 67,464 | Nov 25, 2020, 06:56 PM |
BENNETT C FRANK | Chief Scientific Officer | Nov 03, 2020 | Option Exercise | $39.87 | 15,000 | 598,050 | 47,476 | Nov 05, 2020, 08:26 PM |
BENNETT C FRANK | Chief Scientific Officer | Nov 03, 2020 | Sale | $46.77 | 15,000 | 701,600 | 32,476 | Nov 05, 2020, 08:26 PM |
KLEIN JOSEPH III | Director | Oct 20, 2020 | Sale | $46.86 | 2,889 | 135,386 | 13,794 | Oct 22, 2020, 05:36 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Sep 22, 2020 | Sale | $50.41 | 50,000 | 2,520,460 | 650,391 | Sep 23, 2020, 06:44 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Sep 21, 2020 | Sale | $50.18 | 2,000 | 100,360 | 1,581 | Sep 23, 2020, 06:44 PM |
WENDER JOSEPH H | Director | Sep 16, 2020 | Option Exercise | $20.70 | 22,500 | 465,862 | 88,305 | Sep 18, 2020, 05:45 PM |
HOUGEN ELIZABETH L | EVP, Finance & CFO | Aug 31, 2020 | Option Exercise | $44.46 | 121 | 5,379 | 32,495 | Sep 02, 2020, 07:12 PM |
O'NEIL PATRICK R. | EVP & General Counsel | Aug 31, 2020 | Option Exercise | $44.46 | 169 | 7,513 | 21,178 | Sep 02, 2020, 07:10 PM |
Geary Richard S | EVP, Development | Aug 31, 2020 | Option Exercise | $44.46 | 1 | 44 | 30,447 | Sep 02, 2020, 07:06 PM |
Monia Brett P | Chief Executive Officer | Aug 31, 2020 | Option Exercise | $44.46 | 236 | 10,491 | 29,193 | Sep 02, 2020, 07:01 PM |
Monia Brett P | Chief Executive Officer | Sep 01, 2020 | Sale | $53.70 | 314 | 16,862 | 28,879 | Sep 02, 2020, 07:01 PM |
BENNETT C FRANK | Chief Scientific Officer | Aug 31, 2020 | Option Exercise | $44.46 | 112 | 4,979 | 32,476 | Sep 02, 2020, 06:59 PM |
Swayze Eric | EVP, Research | Aug 31, 2020 | Option Exercise | $44.46 | 1 | 44 | 5,302 | Sep 02, 2020, 06:46 PM |
MUTO FREDERICK T | Director | Jun 30, 2020 | Option Exercise | $9.22 | 15,000 | 138,300 | 27,683 | Jul 02, 2020, 05:11 PM |
Castleman Breaux | Director | Jun 25, 2020 | Option Exercise | $26.66 | 10,000 | 266,600 | 25,183 | Jun 29, 2020, 09:47 PM |
Castleman Breaux | Director | Jun 25, 2020 | Sale | $60.00 | 10,000 | 600,000 | 15,183 | Jun 29, 2020, 09:47 PM |
BENNETT C FRANK | EVP, Chief Scientific Officer | Jun 25, 2020 | Option Exercise | $39.87 | 15,000 | 598,050 | 47,364 | Jun 29, 2020, 09:47 PM |
BENNETT C FRANK | EVP, Chief Scientific Officer | Jun 25, 2020 | Sale | $59.77 | 15,000 | 896,505 | 32,364 | Jun 29, 2020, 09:47 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Jun 25, 2020 | Sale | $60.11 | 9,914 | 595,907 | 2,021 | Jun 26, 2020, 07:47 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Jun 24, 2020 | Sale | $58.80 | 5,000 | 294,000 | 11,935 | Jun 26, 2020, 07:47 PM |
BERTHELSEN SPENCER R | Director | Jun 23, 2020 | Option Exercise | $9.22 | 15,000 | 138,300 | 111,983 | Jun 25, 2020, 07:28 PM |
BERTHELSEN SPENCER R | Director | Jun 23, 2020 | Sale | $58.76 | 15,000 | 881,400 | 96,983 | Jun 25, 2020, 07:28 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Jun 19, 2020 | Sale | $58.33 | 10,000 | 583,250 | 16,935 | Jun 19, 2020, 07:03 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Jun 17, 2020 | Sale | $58.25 | 2,000 | 116,500 | 3,581 | Jun 19, 2020, 07:03 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Jun 17, 2020 | Sale | $57.90 | 15,000 | 868,521 | 26,935 | Jun 19, 2020, 07:03 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Mar 25, 2020 | Sale | $47.00 | 1,000 | 47,000 | 5,581 | Mar 27, 2020, 07:05 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Mar 25, 2020 | Sale | $47.00 | 15,000 | 705,000 | 41,935 | Mar 27, 2020, 07:05 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Mar 17, 2020 | Sale | $44.75 | 20,000 | 895,000 | 87,356 | Mar 27, 2020, 07:01 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Mar 19, 2020 | Sale | $45.00 | 1,000 | 45,000 | 6,581 | Mar 23, 2020, 06:17 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Mar 19, 2020 | Sale | $45.17 | 15,000 | 677,546 | 61,545 | Mar 23, 2020, 06:17 PM |
CROOKE STANLEY T | Exec Chairman of the Board | Mar 17, 2020 | Sale | $44.75 | 20,390 | 912,355 | 86,966 | Mar 19, 2020, 01:55 PM |
Swayze Eric | SVP, Research | Feb 29, 2020 | Option Exercise | $43.16 | 378 | 16,316 | 5,301 | Mar 03, 2020, 07:18 PM |
O'NEIL PATRICK R. | SVP & General Counsel | Feb 29, 2020 | Option Exercise | $43.16 | 289 | 12,474 | 21,009 | Mar 03, 2020, 07:16 PM |
Monia Brett P | Chief Executive Officer | Feb 29, 2020 | Option Exercise | $43.16 | 314 | 13,553 | 28,957 | Mar 03, 2020, 07:14 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Feb 29, 2020 | Option Exercise | $43.16 | 147 | 6,345 | 32,374 | Mar 03, 2020, 07:12 PM |
Geary Richard S | SVP, Development | Feb 29, 2020 | Option Exercise | $43.16 | 378 | 16,316 | 30,446 | Mar 03, 2020, 07:11 PM |
BENNETT C FRANK | Chief Scientific Officer | Feb 29, 2020 | Option Exercise | $43.16 | 169 | 7,295 | 32,364 | Mar 03, 2020, 07:09 PM |
O'NEIL PATRICK R. | SVP & General Counsel | Feb 10, 2020 | Sale | $59.60 | 3,882 | 231,367 | 20,720 | Feb 11, 2020, 05:40 PM |
Swayze Eric | SVP, Research | Jan 15, 2020 | Option Exercise | $62.06 | 2,367 | 146,896 | 4,923 | Jan 17, 2020, 06:47 PM |
PARSHALL B LYNNE | Director | Jan 15, 2020 | Option Exercise | $62.06 | 3,905 | 242,344 | 64,797 | Jan 17, 2020, 06:42 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jan 15, 2020 | Option Exercise | $62.06 | 4,277 | 265,431 | 24,602 | Jan 17, 2020, 06:39 PM |
Monia Brett P | Chief Executive Officer | Jan 15, 2020 | Option Exercise | $62.06 | 7,563 | 469,360 | 28,643 | Jan 17, 2020, 06:36 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Jan 15, 2020 | Option Exercise | $62.06 | 4,277 | 265,431 | 32,227 | Jan 17, 2020, 06:33 PM |
Geary Richard S | SVP, Development | Jan 15, 2020 | Option Exercise | $62.06 | 4,654 | 288,827 | 30,068 | Jan 17, 2020, 06:30 PM |
CROOKE STANLEY T | Executive Chairman of Board | Jan 15, 2020 | Option Exercise | $62.06 | 1,268 | 78,692 | 7,581 | Jan 17, 2020, 06:28 PM |
CROOKE STANLEY T | Executive Chairman of Board | Jan 15, 2020 | Option Exercise | $62.06 | 17,342 | 1,076,245 | 91,935 | Jan 17, 2020, 06:28 PM |
BENNETT C FRANK | Chief Scientific Officer | Jan 15, 2020 | Option Exercise | $62.06 | 4,162 | 258,294 | 32,195 | Jan 17, 2020, 06:11 PM |
Monia Brett P | Chief Executive Officer | Jan 02, 2020 | Sale | $60.25 | 173 | 10,423 | 16,285 | Jan 03, 2020, 07:04 PM |
KLEIN JOSEPH III | Director | Dec 23, 2019 | Option Exercise | $35.53 | 1,000 | 35,530 | 13,683 | Dec 23, 2019, 07:28 PM |
KLEIN JOSEPH III | Director | Dec 23, 2019 | Sale | $61.87 | 1,000 | 61,874 | 12,683 | Dec 23, 2019, 07:28 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Dec 20, 2019 | Option Exercise | $61.52 | 6,229 | 383,208 | 24,460 | Dec 20, 2019, 07:23 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Dec 20, 2019 | Option Exercise | $10.82 | 10,634 | 115,060 | 27,251 | Dec 20, 2019, 07:23 PM |
KLEIN JOSEPH III | Director | Dec 16, 2019 | Option Exercise | $35.53 | 1,000 | 35,530 | 13,683 | Dec 18, 2019, 05:07 PM |
KLEIN JOSEPH III | Director | Dec 16, 2019 | Sale | $65.45 | 1,000 | 65,447 | 12,683 | Dec 18, 2019, 05:07 PM |
KLEIN JOSEPH III | Director | Dec 09, 2019 | Option Exercise | $35.53 | 1,000 | 35,530 | 13,683 | Dec 10, 2019, 06:54 PM |
KLEIN JOSEPH III | Director | Dec 09, 2019 | Sale | $63.74 | 1,000 | 63,745 | 12,683 | Dec 10, 2019, 06:54 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Dec 04, 2019 | Option Exercise | $10.82 | 4,566 | 49,404 | 24,117 | Dec 05, 2019, 05:31 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Dec 04, 2019 | Sale | $65.00 | 4,566 | 296,790 | 20,055 | Dec 05, 2019, 05:31 PM |
Geary Richard S | SVP, Development | Dec 04, 2019 | Option Exercise | $14.69 | 10,000 | 146,900 | 31,583 | Dec 05, 2019, 05:26 PM |
Geary Richard S | SVP, Development | Dec 04, 2019 | Sale | $65.00 | 10,000 | 650,000 | 21,583 | Dec 05, 2019, 05:26 PM |
KLEIN JOSEPH III | Director | Dec 02, 2019 | Option Exercise | $35.53 | 1,000 | 35,530 | 13,683 | Dec 04, 2019, 06:26 PM |
KLEIN JOSEPH III | Director | Dec 02, 2019 | Sale | $64.08 | 1,000 | 64,083 | 12,683 | Dec 04, 2019, 06:26 PM |
Geary Richard S | SVP, Development | Dec 02, 2019 | Option Exercise | $14.69 | 5,000 | 73,450 | 26,583 | Dec 04, 2019, 06:22 PM |
Geary Richard S | SVP, Development | Dec 02, 2019 | Sale | $65.06 | 5,000 | 325,287 | 21,583 | Dec 04, 2019, 06:22 PM |
KLEIN JOSEPH III | Director | Nov 25, 2019 | Sale | $62.90 | 812 | 51,075 | 12,683 | Nov 26, 2019, 05:43 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Nov 25, 2019 | Option Exercise | $10.82 | 4,000 | 43,280 | 24,055 | Nov 26, 2019, 05:40 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Nov 25, 2019 | Sale | $62.50 | 4,000 | 250,000 | 20,055 | Nov 26, 2019, 05:40 PM |
KLEIN JOSEPH III | Director | Nov 20, 2019 | Sale | $60.00 | 2,000 | 120,000 | 13,495 | Nov 21, 2019, 06:40 PM |
Monia Brett P | COO & SVP, Translational Med | Nov 20, 2019 | Sale | $60.01 | 5,776 | 346,618 | 16,458 | Nov 21, 2019, 06:38 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Nov 19, 2019 | Option Exercise | $10.82 | 4,000 | 43,280 | 24,055 | Nov 21, 2019, 06:36 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Nov 19, 2019 | Sale | $58.80 | 4,000 | 235,200 | 20,055 | Nov 21, 2019, 06:36 PM |
CROOKE STANLEY T | Chairman and CEO | Aug 20, 2019 | Option Exercise | $39.87 | 2,000 | 79,740 | 7,532 | Aug 22, 2019, 06:41 PM |
CROOKE STANLEY T | Chairman and CEO | Aug 20, 2019 | Option Exercise | $39.87 | 10,000 | 398,700 | 79,634 | Aug 22, 2019, 06:41 PM |
CROOKE STANLEY T | Chairman and CEO | Aug 21, 2019 | Option Exercise | $39.87 | 10,000 | 398,700 | 79,634 | Aug 22, 2019, 06:41 PM |
CROOKE STANLEY T | Chairman and CEO | Aug 20, 2019 | Sale | $71.00 | 2,000 | 142,000 | 5,532 | Aug 22, 2019, 06:41 PM |
CROOKE STANLEY T | Chairman and CEO | Aug 20, 2019 | Sale | $71.00 | 10,000 | 710,000 | 69,634 | Aug 22, 2019, 06:41 PM |
CROOKE STANLEY T | Chairman and CEO | Aug 21, 2019 | Sale | $72.15 | 10,000 | 721,500 | 69,634 | Aug 22, 2019, 06:41 PM |
CROOKE STANLEY T | Chairman & CEO | Jul 18, 2019 | Option Exercise | $39.87 | 10,000 | 398,700 | 79,634 | Jul 22, 2019, 05:34 PM |
CROOKE STANLEY T | Chairman & CEO | Jul 18, 2019 | Sale | $70.25 | 10,000 | 702,506 | 69,634 | Jul 22, 2019, 05:34 PM |
McDevitt Damien | Chief Business Officer | Jul 15, 2019 | Option Exercise | $67.86 | 1,225 | 83,129 | 2,573 | Jul 17, 2019, 05:39 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Jul 01, 2019 | Option Exercise | $45.70 | 161 | 7,358 | 16,834 | Jul 02, 2019, 08:56 PM |
Monia Brett P | Chief Operating Officer | Jul 01, 2019 | Option Exercise | $45.70 | 173 | 7,907 | 22,444 | Jul 02, 2019, 08:50 PM |
Monia Brett P | Chief Operating Officer | Jul 02, 2019 | Sale | $66.40 | 210 | 13,944 | 22,234 | Jul 02, 2019, 08:50 PM |
HOUGEN ELIZABETH L | SVP Finance & CFO | Jul 01, 2019 | Option Exercise | $45.70 | 105 | 4,799 | 20,055 | Jul 02, 2019, 08:45 PM |
Geary Richard S | SVP, Development | Jul 01, 2019 | Option Exercise | $45.70 | 141 | 6,444 | 21,583 | Jul 02, 2019, 08:43 PM |
BENNETT C FRANK | SVP, Antisense Research | Jul 01, 2019 | Option Exercise | $45.70 | 118 | 5,393 | 24,646 | Jul 02, 2019, 08:39 PM |
McDevitt Damien | Chief Business Officer | Jul 01, 2019 | Option Exercise | $45.70 | 256 | 11,700 | 256 | Jul 02, 2019, 08:35 PM |
BERTHELSEN SPENCER R | Director | Jun 24, 2019 | Option Exercise | $16.32 | 15,000 | 244,800 | 103,784 | Jun 26, 2019, 06:52 PM |
BERTHELSEN SPENCER R | Director | Jun 24, 2019 | Sale | $63.67 | 15,000 | 955,113 | 94,094 | Jun 26, 2019, 06:52 PM |
MUTO FREDERICK T | Director | Jun 04, 2019 | Option Exercise | $16.32 | 15,000 | 244,800 | 24,794 | Jun 06, 2019, 06:35 PM |
MUTO FREDERICK T | Director | Jun 04, 2019 | Sale | $65.29 | 15,000 | 979,350 | 9,794 | Jun 06, 2019, 06:35 PM |
MUTO FREDERICK T | Director | May 06, 2019 | Option Exercise | $24.42 | 8,000 | 195,360 | 17,794 | May 08, 2019, 06:16 PM |
MUTO FREDERICK T | Director | May 06, 2019 | Sale | $72.75 | 8,000 | 582,002 | 9,794 | May 08, 2019, 06:16 PM |
PARSHALL B LYNNE | Director | Apr 29, 2019 | Option Exercise | $39.87 | 50,000 | 1,993,500 | 102,677 | May 01, 2019, 05:48 PM |
PARSHALL B LYNNE | Director | Apr 29, 2019 | Sale | $75.01 | 50,000 | 3,750,635 | 52,677 | May 01, 2019, 05:48 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 15, 2019 | Option Exercise | $10.82 | 1,000 | 10,820 | 6,532 | Apr 17, 2019, 07:30 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 15, 2019 | Option Exercise | $14.69 | 10,000 | 146,900 | 79,634 | Apr 17, 2019, 07:30 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 16, 2019 | Option Exercise | $31.15 | 1,000 | 31,155 | 6,232 | Apr 17, 2019, 07:30 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 16, 2019 | Option Exercise | $31.46 | 20,000 | 629,198 | 82,954 | Apr 17, 2019, 07:30 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 15, 2019 | Sale | $85.25 | 1,000 | 85,250 | 5,532 | Apr 17, 2019, 07:30 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 15, 2019 | Sale | $85.25 | 10,000 | 852,500 | 69,634 | Apr 17, 2019, 07:30 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 16, 2019 | Sale | $84.75 | 1,000 | 84,750 | 5,532 | Apr 17, 2019, 07:30 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 16, 2019 | Sale | $84.62 | 20,000 | 1,692,500 | 69,634 | Apr 17, 2019, 07:30 PM |
Geary Richard S | SVP, Development | Apr 08, 2019 | Option Exercise | $42.53 | 46,240 | 1,966,466 | 45,442 | Apr 10, 2019, 06:24 PM |
Geary Richard S | SVP, Development | Apr 08, 2019 | Sale | $84.01 | 46,240 | 3,884,753 | 21,442 | Apr 10, 2019, 06:24 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Apr 05, 2019 | Option Exercise | $61.68 | 2,252 | 138,903 | 18,925 | Apr 05, 2019, 07:29 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Apr 04, 2019 | Option Exercise | $56.76 | 36,622 | 2,078,809 | 35,165 | Apr 05, 2019, 07:29 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Apr 03, 2019 | Option Exercise | $61.68 | 7,654 | 472,099 | 27,327 | Apr 05, 2019, 07:29 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Apr 05, 2019 | Sale | $84.75 | 2,252 | 190,857 | 16,673 | Apr 05, 2019, 07:29 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Apr 04, 2019 | Sale | $83.79 | 39,622 | 3,319,929 | 19,673 | Apr 05, 2019, 07:29 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Apr 03, 2019 | Sale | $84.83 | 7,654 | 649,289 | 19,673 | Apr 05, 2019, 07:29 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Mar 18, 2019 | Option Exercise | $61.57 | 28,800 | 1,773,216 | 48,473 | Mar 20, 2019, 06:15 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Mar 18, 2019 | Sale | $78.79 | 28,800 | 2,269,187 | 19,673 | Mar 20, 2019, 06:15 PM |
WENDER JOSEPH H | Director | Mar 19, 2019 | Sale | $79.63 | 10,000 | 796,258 | 58,916 | Mar 20, 2019, 06:05 PM |
PARSHALL B LYNNE | Director | Mar 12, 2019 | Option Exercise | $39.87 | 8,334 | 332,277 | 61,011 | Mar 14, 2019, 06:24 PM |
PARSHALL B LYNNE | Director | Mar 12, 2019 | Sale | $75.00 | 8,334 | 625,050 | 52,677 | Mar 14, 2019, 06:24 PM |
PARSHALL B LYNNE | Director | Feb 27, 2019 | Option Exercise | $39.87 | 8,333 | 332,237 | 61,010 | Mar 01, 2019, 05:56 PM |
PARSHALL B LYNNE | Director | Feb 27, 2019 | Sale | $70.00 | 8,333 | 583,310 | 52,677 | Mar 01, 2019, 05:56 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Feb 27, 2019 | Option Exercise | $45.11 | 26,800 | 1,208,952 | 33,773 | Mar 01, 2019, 05:40 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Feb 27, 2019 | Sale | $68.01 | 26,800 | 1,822,580 | 19,673 | Mar 01, 2019, 05:40 PM |
CROOKE STANLEY T | Chairman and CEO | Feb 26, 2019 | Option Exercise | $39.87 | 37,000 | 1,475,190 | 106,634 | Feb 27, 2019, 07:31 PM |
CROOKE STANLEY T | Chairman and CEO | Feb 25, 2019 | Option Exercise | $39.87 | 40,000 | 1,594,800 | 109,634 | Feb 27, 2019, 07:31 PM |
CROOKE STANLEY T | Chairman and CEO | Feb 26, 2019 | Sale | $61.54 | 37,000 | 2,276,799 | 69,634 | Feb 27, 2019, 07:31 PM |
CROOKE STANLEY T | Chairman and CEO | Feb 25, 2019 | Sale | $60.07 | 40,000 | 2,402,700 | 69,634 | Feb 27, 2019, 07:31 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Feb 12, 2019 | Option Exercise | $39.87 | 275 | 10,964 | 19,948 | Feb 14, 2019, 06:01 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Feb 12, 2019 | Sale | $59.50 | 275 | 16,363 | 19,673 | Feb 14, 2019, 06:01 PM |
CROOKE STANLEY T | Chairman and CEO | Feb 13, 2019 | Option Exercise | $33.12 | 6,904 | 228,666 | 10,832 | Feb 14, 2019, 05:57 PM |
CROOKE STANLEY T | Chairman and CEO | Feb 13, 2019 | Option Exercise | $39.87 | 40,000 | 1,594,800 | 109,634 | Feb 14, 2019, 05:57 PM |
CROOKE STANLEY T | Chairman and CEO | Feb 13, 2019 | Sale | $60.10 | 40,000 | 2,404,028 | 69,634 | Feb 14, 2019, 05:57 PM |
CROOKE STANLEY T | Chairman and CEO | Feb 13, 2019 | Sale | $60.00 | 6,904 | 414,240 | 5,532 | Feb 14, 2019, 05:57 PM |
Geary Richard S | SVP, Development | Feb 13, 2019 | Sale | $60.00 | 999 | 59,940 | 21,442 | Feb 14, 2019, 05:51 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Feb 05, 2019 | Option Exercise | $39.87 | 15,600 | 621,972 | 35,273 | Feb 05, 2019, 06:05 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Feb 01, 2019 | Option Exercise | $39.87 | 4,000 | 159,480 | 23,673 | Feb 05, 2019, 06:05 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Feb 05, 2019 | Sale | $59.50 | 15,600 | 928,200 | 19,673 | Feb 05, 2019, 06:05 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Feb 01, 2019 | Sale | $58.29 | 4,000 | 233,160 | 19,673 | Feb 05, 2019, 06:05 PM |
BENNETT C FRANK | SVP, Antisense Research | Feb 01, 2019 | Option Exercise | $14.69 | 9,013 | 132,401 | 33,541 | Feb 05, 2019, 05:59 PM |
BENNETT C FRANK | SVP, Antisense Research | Feb 01, 2019 | Sale | $58.29 | 9,013 | 525,368 | 24,528 | Feb 05, 2019, 05:59 PM |
BENNETT C FRANK | SVP, Antisense Research | Jan 15, 2019 | Option Exercise | $58.26 | 2,818 | 164,177 | 24,400 | Jan 17, 2019, 07:39 PM |
Geary Richard S | SVP, Development | Jan 15, 2019 | Option Exercise | $58.26 | 2,908 | 169,420 | 22,034 | Jan 17, 2019, 07:36 PM |
HOUGEN ELIZABETH L | SVP Finance & CFO | Jan 15, 2019 | Option Exercise | $58.26 | 2,842 | 165,575 | 19,823 | Jan 17, 2019, 07:35 PM |
Monia Brett P | Chief Operating Officer | Jan 15, 2019 | Option Exercise | $58.26 | 3,572 | 208,105 | 22,275 | Jan 17, 2019, 07:34 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 15, 2019 | Option Exercise | $58.26 | 942 | 54,881 | 5,532 | Jan 17, 2019, 07:27 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 15, 2019 | Option Exercise | $58.26 | 12,686 | 739,086 | 69,634 | Jan 17, 2019, 07:27 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Jan 15, 2019 | Option Exercise | $58.26 | 2,734 | 159,283 | 19,607 | Jan 17, 2019, 07:24 PM |
PARSHALL B LYNNE | Director | Jan 15, 2019 | Option Exercise | $58.26 | 6,159 | 358,823 | 52,677 | Jan 17, 2019, 07:19 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Jan 01, 2019 | Option Exercise | $36.45 | 66 | 2,406 | 14,584 | Jan 03, 2019, 07:50 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Jan 03, 2019 | Option Exercise | $37.23 | 4,400 | 163,808 | 18,584 | Jan 03, 2019, 07:50 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Jan 03, 2019 | Sale | $54.80 | 4,400 | 241,120 | 14,584 | Jan 03, 2019, 07:50 PM |
HOUGEN ELIZABETH L | SVP Finance & CFO | Jan 01, 2019 | Option Exercise | $36.45 | 127 | 4,629 | 14,901 | Jan 03, 2019, 07:44 PM |
Monia Brett P | Chief Operating Officer | Jan 01, 2019 | Option Exercise | $36.45 | 210 | 7,654 | 16,051 | Jan 03, 2019, 07:42 PM |
Monia Brett P | Chief Operating Officer | Jan 02, 2019 | Sale | $53.50 | 214 | 11,449 | 15,837 | Jan 03, 2019, 07:42 PM |
Geary Richard S | SVP, Development | Jan 01, 2019 | Option Exercise | $36.45 | 407 | 14,834 | 17,264 | Jan 03, 2019, 07:34 PM |
BENNETT C FRANK | SVP, Antisense Research | Jan 01, 2019 | Option Exercise | $36.45 | 128 | 4,665 | 19,524 | Jan 03, 2019, 07:32 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Dec 19, 2018 | Option Exercise | $7.25 | 2,063 | 14,957 | 16,837 | Dec 20, 2018, 05:55 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Dec 18, 2018 | Option Exercise | $7.25 | 2,000 | 14,500 | 16,774 | Dec 20, 2018, 05:55 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Dec 19, 2018 | Sale | $52.05 | 2,063 | 107,379 | 14,774 | Dec 20, 2018, 05:55 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Dec 18, 2018 | Sale | $52.00 | 2,000 | 104,000 | 14,774 | Dec 20, 2018, 05:55 PM |
Monia Brett P | Chief Operating Officer | Nov 23, 2018 | Option Exercise | $14.69 | 34,000 | 499,460 | 49,841 | Nov 26, 2018, 08:01 PM |
Monia Brett P | Chief Operating Officer | Nov 23, 2018 | Sale | $55.00 | 34,000 | 1,870,058 | 15,841 | Nov 26, 2018, 08:01 PM |
BENNETT C FRANK | SVP, Antisense Research | Nov 01, 2018 | Option Exercise | $14.69 | 12,500 | 183,625 | 31,896 | Nov 01, 2018, 07:34 PM |
BENNETT C FRANK | SVP, Antisense Research | Nov 01, 2018 | Sale | $49.54 | 12,500 | 619,245 | 19,396 | Nov 01, 2018, 07:34 PM |
Monia Brett P | Chief Operating Officer | Aug 27, 2018 | Option Exercise | $7.23 | 16,493 | 119,274 | 24,834 | Aug 29, 2018, 04:49 PM |
Monia Brett P | Chief Operating Officer | Aug 27, 2018 | Sale | $54.00 | 16,493 | 890,622 | 15,841 | Aug 29, 2018, 04:49 PM |
BENNETT C FRANK | SVP, Antisense Research | Aug 08, 2018 | Option Exercise | $14.68 | 12,500 | 183,528 | 31,883 | Aug 09, 2018, 06:34 PM |
BENNETT C FRANK | SVP, Antisense Research | Aug 08, 2018 | Sale | $45.00 | 12,500 | 562,500 | 19,396 | Aug 09, 2018, 06:34 PM |
Monia Brett P | Chief Operating Officer | Jul 24, 2018 | Sale | $47.03 | 156 | 7,337 | 15,841 | Jul 25, 2018, 07:19 PM |
WENDER JOSEPH H | Director | Jul 17, 2018 | Option Exercise | $9.26 | 30,000 | 277,800 | 68,916 | Jul 19, 2018, 06:45 PM |
BENNETT C FRANK | SVP, Antisense Research | Jul 01, 2018 | Option Exercise | $35.42 | 282 | 9,988 | 19,396 | Jul 03, 2018, 03:35 PM |
Geary Richard S | SVP, Development | Jul 01, 2018 | Option Exercise | $35.42 | 177 | 6,269 | 16,857 | Jul 03, 2018, 03:33 PM |
HOUGEN ELIZABETH L | SVP Finance & CFO | Jul 01, 2018 | Option Exercise | $35.42 | 274 | 9,705 | 14,774 | Jul 03, 2018, 03:31 PM |
Monia Brett P | Chief Operating Officer | Jul 01, 2018 | Option Exercise | $35.42 | 214 | 7,580 | 15,997 | Jul 03, 2018, 03:30 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Jul 01, 2018 | Option Exercise | $35.42 | 66 | 2,338 | 14,518 | Jul 03, 2018, 03:28 PM |
BERTHELSEN SPENCER R | Director | Jun 25, 2018 | Option Exercise | $13.88 | 15,000 | 208,200 | 100,727 | Jun 25, 2018, 08:28 PM |
BERTHELSEN SPENCER R | Director | Jun 25, 2018 | Sale | $42.30 | 15,000 | 634,542 | 91,427 | Jun 25, 2018, 08:28 PM |
MUTO FREDERICK T | Director | May 31, 2018 | Option Exercise | $13.88 | 15,000 | 208,200 | 22,127 | May 31, 2018, 08:02 PM |
MUTO FREDERICK T | Director | May 31, 2018 | Sale | $46.45 | 15,000 | 696,750 | 7,127 | May 31, 2018, 08:02 PM |
BENNETT C FRANK | SVP, Antisense Research | May 11, 2018 | Option Exercise | $7.25 | 12,500 | 90,625 | 31,614 | May 11, 2018, 09:06 PM |
BENNETT C FRANK | SVP, Antisense Research | May 11, 2018 | Sale | $45.00 | 12,500 | 562,500 | 19,114 | May 11, 2018, 09:06 PM |
WENDER JOSEPH H | Director | May 11, 2018 | Option Exercise | $13.88 | 15,000 | 208,200 | 44,839 | May 11, 2018, 09:00 PM |
WENDER JOSEPH H | Director | May 11, 2018 | Sale | $45.31 | 15,000 | 679,614 | 36,249 | May 11, 2018, 09:00 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 17, 2018 | Option Exercise | $10.82 | 4,000 | 43,280 | 6,128 | Apr 19, 2018, 05:22 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 17, 2018 | Option Exercise | $14.69 | 9,962 | 146,342 | 56,714 | Apr 19, 2018, 05:22 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 17, 2018 | Sale | $44.40 | 4,000 | 177,600 | 4,128 | Apr 19, 2018, 05:22 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 17, 2018 | Sale | $44.40 | 9,962 | 442,313 | 51,733 | Apr 19, 2018, 05:22 PM |
KLEIN JOSEPH III | Director | Mar 29, 2018 | Option Exercise | $24.42 | 2,000 | 48,840 | 11,939 | Mar 30, 2018, 03:51 PM |
KLEIN JOSEPH III | Director | Mar 29, 2018 | Sale | $46.15 | 2,000 | 92,300 | 9,939 | Mar 30, 2018, 03:51 PM |
KLEIN JOSEPH III | Director | Mar 15, 2018 | Option Exercise | $24.42 | 2,000 | 48,840 | 10,839 | Mar 16, 2018, 04:19 PM |
KLEIN JOSEPH III | Director | Mar 15, 2018 | Sale | $51.13 | 2,000 | 102,258 | 9,939 | Mar 16, 2018, 04:19 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Mar 12, 2018 | Option Exercise | $10.82 | 1,000 | 10,820 | 15,452 | Mar 13, 2018, 09:14 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Mar 12, 2018 | Sale | $55.00 | 1,000 | 55,000 | 14,452 | Mar 13, 2018, 09:14 PM |
KLEIN JOSEPH III | Director | Feb 28, 2018 | Option Exercise | $35.53 | 3,000 | 106,590 | 12,039 | Mar 01, 2018, 05:52 PM |
KLEIN JOSEPH III | Director | Feb 28, 2018 | Sale | $51.91 | 3,000 | 155,727 | 9,939 | Mar 01, 2018, 05:52 PM |
KLEIN JOSEPH III | Director | Feb 15, 2018 | Option Exercise | $35.53 | 3,000 | 106,590 | 11,539 | Feb 16, 2018, 06:00 PM |
KLEIN JOSEPH III | Director | Feb 15, 2018 | Sale | $48.99 | 3,000 | 146,984 | 9,939 | Feb 16, 2018, 06:00 PM |
BENNETT C FRANK | SVP, Antisense Research | Feb 01, 2018 | Option Exercise | $7.25 | 12,500 | 90,625 | 31,614 | Feb 01, 2018, 07:58 PM |
BENNETT C FRANK | SVP, Antisense Research | Feb 01, 2018 | Sale | $52.50 | 12,500 | 656,260 | 19,114 | Feb 01, 2018, 07:58 PM |
KLEIN JOSEPH III | Director | Jan 30, 2018 | Option Exercise | $35.53 | 3,000 | 106,590 | 12,939 | Jan 31, 2018, 04:18 PM |
KLEIN JOSEPH III | Director | Jan 30, 2018 | Sale | $52.86 | 3,000 | 158,580 | 9,939 | Jan 31, 2018, 04:18 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Jan 29, 2018 | Option Exercise | $10.82 | 355 | 3,841 | 14,752 | Jan 31, 2018, 04:16 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Jan 29, 2018 | Sale | $55.00 | 355 | 19,525 | 14,452 | Jan 31, 2018, 04:16 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 29, 2018 | Option Exercise | $10.82 | 1,000 | 10,820 | 5,128 | Jan 31, 2018, 04:15 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 29, 2018 | Option Exercise | $14.69 | 10,000 | 146,900 | 61,733 | Jan 31, 2018, 04:15 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 29, 2018 | Sale | $54.12 | 10,000 | 541,200 | 51,733 | Jan 31, 2018, 04:15 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 29, 2018 | Sale | $54.12 | 1,000 | 54,120 | 4,128 | Jan 31, 2018, 04:15 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Jan 25, 2018 | Option Exercise | $10.82 | 645 | 6,979 | 15,097 | Jan 29, 2018, 04:08 PM |
O'NEIL PATRICK R. | SVP Legal & General Counsel | Jan 25, 2018 | Sale | $55.00 | 645 | 35,475 | 14,452 | Jan 29, 2018, 04:08 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Jan 16, 2018 | Sale | $51.76 | 2,724 | 140,994 | 14,500 | Jan 17, 2018, 09:46 PM |
KLEIN JOSEPH III | Director | Jan 16, 2018 | Option Exercise | $35.53 | 3,000 | 106,590 | 11,539 | Jan 17, 2018, 09:28 PM |
KLEIN JOSEPH III | Director | Jan 16, 2018 | Sale | $52.52 | 3,000 | 157,566 | 9,939 | Jan 17, 2018, 09:28 PM |
Geary Richard S | SVP, Development | Jan 16, 2018 | Sale | $51.76 | 2,723 | 140,942 | 16,680 | Jan 17, 2018, 09:26 PM |
PARSHALL B LYNNE | Director | Jan 16, 2018 | Sale | $51.76 | 5,986 | 309,835 | 38,180 | Jan 17, 2018, 09:25 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jan 16, 2018 | Sale | $51.76 | 2,697 | 139,597 | 14,452 | Jan 17, 2018, 09:25 PM |
Boyce Sarah | Chief Business Officer | Jan 16, 2018 | Sale | $51.76 | 2,196 | 113,665 | 8,931 | Jan 17, 2018, 09:23 PM |
BENNETT C FRANK | SVP, Antisense Research | Jan 16, 2018 | Sale | $51.76 | 2,696 | 139,545 | 19,114 | Jan 17, 2018, 09:22 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 15, 2018 | Sale | $51.76 | 656 | 33,955 | 4,128 | Jan 17, 2018, 09:22 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 15, 2018 | Sale | $51.76 | 15,893 | 822,622 | 51,733 | Jan 17, 2018, 09:22 PM |
Monia Brett P | COO | Jan 16, 2018 | Sale | $51.76 | 2,821 | 146,015 | 15,783 | Jan 17, 2018, 09:21 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 08, 2018 | Option Exercise | $10.82 | 1,000 | 10,820 | 4,062 | Jan 10, 2018, 06:43 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 08, 2018 | Option Exercise | $14.69 | 10,000 | 146,900 | 48,014 | Jan 10, 2018, 06:43 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 08, 2018 | Sale | $52.01 | 1,000 | 52,010 | 3,062 | Jan 10, 2018, 06:43 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 08, 2018 | Sale | $52.01 | 10,000 | 520,100 | 38,014 | Jan 10, 2018, 06:43 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 03, 2018 | Option Exercise | $9.21 | 2,000 | 18,413 | 4,158 | Jan 05, 2018, 04:41 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 03, 2018 | Option Exercise | $14.69 | 20,000 | 293,800 | 58,014 | Jan 05, 2018, 04:41 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 03, 2018 | Sale | $50.02 | 20,000 | 1,000,400 | 38,014 | Jan 05, 2018, 04:41 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 03, 2018 | Sale | $49.88 | 2,000 | 99,760 | 3,062 | Jan 05, 2018, 04:41 PM |
PARSHALL B LYNNE | COO | Jan 01, 2018 | Option Exercise | $42.76 | 86 | 3,677 | 25,827 | Jan 02, 2018, 08:51 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jan 01, 2018 | Option Exercise | $42.76 | 53 | 2,266 | 10,486 | Jan 02, 2018, 08:50 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jan 01, 2018 | Option Exercise | $42.76 | 156 | 6,670 | 11,782 | Jan 02, 2018, 08:49 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jan 02, 2018 | Sale | $50.00 | 163 | 8,150 | 11,619 | Jan 02, 2018, 08:49 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Jan 01, 2018 | Option Exercise | $42.76 | 100 | 4,276 | 10,492 | Jan 02, 2018, 08:49 PM |
Geary Richard S | SVP, Development | Jan 01, 2018 | Option Exercise | $42.76 | 320 | 13,682 | 12,671 | Jan 02, 2018, 08:48 PM |
Boyce Sarah | Chief Business Officer | Jan 01, 2018 | Option Exercise | $42.76 | 491 | 20,993 | 5,760 | Jan 02, 2018, 08:45 PM |
BENNETT C FRANK | SVP, Antisense Research | Jan 01, 2018 | Option Exercise | $42.76 | 106 | 4,532 | 15,147 | Jan 02, 2018, 08:45 PM |
KLEIN JOSEPH III | Director | Dec 29, 2017 | Option Exercise | $28.47 | 3,000 | 85,410 | 12,939 | Jan 02, 2018, 05:50 PM |
KLEIN JOSEPH III | Director | Dec 29, 2017 | Sale | $50.56 | 3,000 | 151,680 | 9,939 | Jan 02, 2018, 05:50 PM |
KLEIN JOSEPH III | Director | Dec 15, 2017 | Option Exercise | $28.47 | 3,000 | 85,410 | 12,939 | Dec 19, 2017, 08:27 PM |
KLEIN JOSEPH III | Director | Dec 15, 2017 | Sale | $51.69 | 3,000 | 155,070 | 9,939 | Dec 19, 2017, 08:27 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Dec 15, 2017 | Option Exercise | $10.29 | 5,000 | 51,450 | 15,392 | Dec 19, 2017, 08:20 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Dec 15, 2017 | Sale | $52.55 | 5,000 | 262,750 | 10,392 | Dec 19, 2017, 08:20 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Dec 04, 2017 | Option Exercise | $10.29 | 4,000 | 41,160 | 14,392 | Dec 06, 2017, 06:36 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Dec 04, 2017 | Sale | $57.00 | 4,000 | 228,000 | 10,392 | Dec 06, 2017, 06:36 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Nov 29, 2017 | Option Exercise | $10.29 | 6,000 | 61,740 | 16,392 | Dec 01, 2017, 07:12 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Nov 29, 2017 | Sale | $53.02 | 6,000 | 318,120 | 10,392 | Dec 01, 2017, 07:12 PM |
KLEIN JOSEPH III | Director | Nov 30, 2017 | Option Exercise | $28.47 | 3,000 | 85,410 | 12,939 | Dec 01, 2017, 07:04 PM |
KLEIN JOSEPH III | Director | Nov 30, 2017 | Sale | $53.55 | 3,000 | 160,650 | 9,939 | Dec 01, 2017, 07:04 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Dec 01, 2017 | Option Exercise | $10.82 | 1,000 | 10,820 | 11,433 | Dec 01, 2017, 07:03 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Dec 01, 2017 | Sale | $55.50 | 1,000 | 55,500 | 10,433 | Dec 01, 2017, 07:03 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Nov 16, 2017 | Option Exercise | $10.29 | 7,000 | 72,030 | 17,392 | Nov 17, 2017, 05:57 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Nov 16, 2017 | Sale | $54.35 | 7,000 | 380,450 | 10,392 | Nov 17, 2017, 05:57 PM |
KLEIN JOSEPH III | Director | Nov 16, 2017 | Option Exercise | $12.94 | 2,812 | 36,387 | 9,939 | Nov 17, 2017, 05:57 PM |
KLEIN JOSEPH III | Director | Nov 15, 2017 | Option Exercise | $28.47 | 2,250 | 64,057 | 9,377 | Nov 17, 2017, 05:57 PM |
KLEIN JOSEPH III | Director | Nov 15, 2017 | Sale | $53.56 | 2,250 | 120,510 | 7,127 | Nov 17, 2017, 05:57 PM |
KLEIN JOSEPH III | Director | Nov 13, 2017 | Sale | $55.39 | 3,000 | 166,170 | 7,127 | Nov 14, 2017, 06:29 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Nov 01, 2017 | Option Exercise | $10.82 | 1,000 | 10,820 | 11,433 | Nov 03, 2017, 05:20 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Nov 01, 2017 | Sale | $58.35 | 1,000 | 58,350 | 10,433 | Nov 03, 2017, 05:20 PM |
BENNETT C FRANK | SVP, Antisense Research | Oct 18, 2017 | Option Exercise | $10.29 | 12,250 | 126,052 | 27,291 | Oct 20, 2017, 05:35 PM |
BENNETT C FRANK | SVP, Antisense Research | Oct 18, 2017 | Sale | $65.00 | 12,250 | 796,250 | 15,041 | Oct 20, 2017, 05:35 PM |
PARSHALL B LYNNE | COO | Oct 18, 2017 | Option Exercise | $27.71 | 16,118 | 446,598 | 34,074 | Oct 20, 2017, 05:34 PM |
PARSHALL B LYNNE | COO | Oct 18, 2017 | Sale | $65.00 | 16,118 | 1,047,670 | 25,741 | Oct 20, 2017, 05:34 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 13, 2017 | Option Exercise | $14.69 | 15,000 | 220,350 | 53,014 | Oct 17, 2017, 05:36 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 13, 2017 | Option Exercise | $7.25 | 1,500 | 10,875 | 4,562 | Oct 17, 2017, 05:36 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 13, 2017 | Sale | $59.46 | 15,000 | 891,900 | 38,014 | Oct 17, 2017, 05:36 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 13, 2017 | Sale | $59.46 | 1,500 | 89,190 | 3,062 | Oct 17, 2017, 05:36 PM |
Geary Richard S | SVP, Development | Oct 13, 2017 | Option Exercise | $7.42 | 7,461 | 55,387 | 19,386 | Oct 17, 2017, 05:36 PM |
Geary Richard S | SVP, Development | Oct 13, 2017 | Sale | $60.00 | 8,268 | 496,080 | 12,351 | Oct 17, 2017, 05:36 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Oct 05, 2017 | Option Exercise | $10.11 | 1,000 | 10,106 | 11,233 | Oct 06, 2017, 04:41 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Oct 05, 2017 | Sale | $55.00 | 1,000 | 55,000 | 10,433 | Oct 06, 2017, 04:41 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 02, 2017 | Option Exercise | $14.69 | 15,000 | 220,350 | 43,014 | Oct 04, 2017, 07:15 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 04, 2017 | Option Exercise | $7.25 | 1,000 | 7,250 | 3,562 | Oct 04, 2017, 07:15 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 04, 2017 | Option Exercise | $14.69 | 10,000 | 146,900 | 43,014 | Oct 04, 2017, 07:15 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 02, 2017 | Option Exercise | $7.25 | 1,500 | 10,875 | 3,562 | Oct 04, 2017, 07:15 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 04, 2017 | Sale | $54.23 | 10,000 | 542,250 | 38,014 | Oct 04, 2017, 07:15 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 02, 2017 | Sale | $52.00 | 1,500 | 78,000 | 3,062 | Oct 04, 2017, 07:15 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 02, 2017 | Sale | $52.00 | 15,000 | 780,000 | 38,014 | Oct 04, 2017, 07:15 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 04, 2017 | Sale | $54.23 | 1,000 | 54,225 | 3,062 | Oct 04, 2017, 07:15 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Sep 06, 2017 | Option Exercise | $7.25 | 800 | 5,800 | 11,233 | Sep 07, 2017, 08:23 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Sep 05, 2017 | Option Exercise | $7.25 | 200 | 1,450 | 10,633 | Sep 07, 2017, 08:23 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Sep 06, 2017 | Sale | $55.00 | 800 | 44,000 | 10,433 | Sep 07, 2017, 08:23 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Sep 05, 2017 | Sale | $55.00 | 200 | 11,000 | 10,433 | Sep 07, 2017, 08:23 PM |
BENNETT C FRANK | SVP, Antisense Research | Jul 24, 2017 | Option Exercise | $10.29 | 10,000 | 102,900 | 25,041 | Jul 26, 2017, 08:03 PM |
BENNETT C FRANK | SVP, Antisense Research | Jul 24, 2017 | Sale | $59.29 | 10,000 | 592,900 | 15,041 | Jul 26, 2017, 08:03 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 20, 2017 | Option Exercise | $7.25 | 1,000 | 7,250 | 4,062 | Jul 24, 2017, 05:54 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 20, 2017 | Option Exercise | $14.69 | 10,000 | 146,900 | 48,014 | Jul 24, 2017, 05:54 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 20, 2017 | Sale | $55.35 | 1,000 | 55,350 | 3,062 | Jul 24, 2017, 05:54 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 20, 2017 | Sale | $55.35 | 10,000 | 553,500 | 38,014 | Jul 24, 2017, 05:54 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 17, 2017 | Option Exercise | $14.69 | 15,000 | 220,350 | 53,014 | Jul 18, 2017, 07:01 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 17, 2017 | Option Exercise | $7.25 | 1,500 | 10,875 | 4,562 | Jul 18, 2017, 07:01 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 17, 2017 | Sale | $52.45 | 15,000 | 786,750 | 38,014 | Jul 18, 2017, 07:01 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 17, 2017 | Sale | $52.45 | 1,500 | 78,675 | 3,062 | Jul 18, 2017, 07:01 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jul 01, 2017 | Option Exercise | $40.66 | 163 | 6,627 | 11,935 | Jul 03, 2017, 05:38 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jul 03, 2017 | Sale | $51.35 | 309 | 15,867 | 11,626 | Jul 03, 2017, 05:38 PM |
PARSHALL B LYNNE | COO | Jul 01, 2017 | Option Exercise | $40.66 | 90 | 3,659 | 25,741 | Jul 03, 2017, 05:38 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jul 01, 2017 | Option Exercise | $40.66 | 134 | 5,448 | 10,433 | Jul 03, 2017, 05:37 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Jul 01, 2017 | Option Exercise | $40.66 | 104 | 4,228 | 10,392 | Jul 03, 2017, 05:36 PM |
Geary Richard S | SVP, Development | Jul 01, 2017 | Option Exercise | $40.66 | 196 | 7,968 | 13,158 | Jul 03, 2017, 05:36 PM |
Boyce Sarah | Chief Business Officer | Jul 01, 2017 | Option Exercise | $40.66 | 17 | 691 | 5,269 | Jul 03, 2017, 05:35 PM |
BENNETT C FRANK | SVP, Antisense Research | Jul 01, 2017 | Option Exercise | $40.66 | 253 | 10,286 | 15,041 | Jul 03, 2017, 05:35 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 03, 2017 | Option Exercise | $8.01 | 15,000 | 120,193 | 51,476 | Jul 03, 2017, 05:34 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 03, 2017 | Option Exercise | $7.25 | 1,500 | 10,875 | 4,562 | Jul 03, 2017, 05:34 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 03, 2017 | Sale | $52.10 | 1,500 | 78,150 | 3,062 | Jul 03, 2017, 05:34 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 03, 2017 | Sale | $52.10 | 15,000 | 781,538 | 38,014 | Jul 03, 2017, 05:34 PM |
MUTO FREDERICK T | Director | May 31, 2017 | Option Exercise | $9.77 | 12,500 | 122,125 | 17,158 | Jun 02, 2017, 06:16 PM |
MUTO FREDERICK T | Director | May 31, 2017 | Sale | $45.22 | 12,500 | 565,250 | 4,658 | Jun 02, 2017, 06:16 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jun 01, 2017 | Option Exercise | $10.82 | 70 | 757 | 10,369 | Jun 02, 2017, 06:15 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jun 01, 2017 | Sale | $48.00 | 70 | 3,360 | 10,299 | Jun 02, 2017, 06:15 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | May 01, 2017 | Option Exercise | $10.82 | 500 | 5,410 | 10,799 | May 03, 2017, 06:01 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | May 01, 2017 | Sale | $48.75 | 650 | 31,688 | 10,299 | May 03, 2017, 06:01 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 25, 2017 | Option Exercise | $7.25 | 1,500 | 10,875 | 4,562 | Apr 27, 2017, 06:03 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 25, 2017 | Option Exercise | $7.25 | 15,000 | 108,750 | 53,014 | Apr 27, 2017, 06:03 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 25, 2017 | Sale | $47.81 | 1,500 | 71,715 | 3,062 | Apr 27, 2017, 06:03 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 25, 2017 | Sale | $47.81 | 15,000 | 717,150 | 38,014 | Apr 27, 2017, 06:03 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Apr 24, 2017 | Option Exercise | $10.82 | 500 | 5,410 | 10,875 | Apr 26, 2017, 05:58 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Apr 24, 2017 | Sale | $45.00 | 500 | 22,500 | 10,449 | Apr 26, 2017, 05:58 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 19, 2017 | Option Exercise | $7.25 | 500 | 3,625 | 3,562 | Apr 21, 2017, 05:42 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 19, 2017 | Option Exercise | $7.25 | 5,000 | 36,250 | 43,014 | Apr 21, 2017, 05:42 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 19, 2017 | Sale | $43.25 | 500 | 21,625 | 3,062 | Apr 21, 2017, 05:42 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 19, 2017 | Sale | $43.25 | 5,000 | 216,250 | 38,014 | Apr 21, 2017, 05:42 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Apr 12, 2017 | Sale | $40.07 | 1,000 | 40,070 | 10,449 | Apr 13, 2017, 07:25 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 13, 2017 | Option Exercise | $7.25 | 10,000 | 72,500 | 48,014 | Apr 13, 2017, 07:24 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 12, 2017 | Option Exercise | $10.29 | 1,000 | 10,290 | 4,062 | Apr 13, 2017, 07:24 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 12, 2017 | Option Exercise | $7.25 | 10,000 | 72,500 | 48,014 | Apr 13, 2017, 07:24 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 13, 2017 | Option Exercise | $8.77 | 1,000 | 8,770 | 3,562 | Apr 13, 2017, 07:24 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 13, 2017 | Sale | $41.30 | 10,000 | 413,000 | 38,014 | Apr 13, 2017, 07:24 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 12, 2017 | Sale | $40.07 | 1,000 | 40,070 | 3,062 | Apr 13, 2017, 07:24 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 12, 2017 | Sale | $40.07 | 10,000 | 400,700 | 38,014 | Apr 13, 2017, 07:24 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 13, 2017 | Sale | $41.30 | 1,000 | 41,300 | 3,062 | Apr 13, 2017, 07:24 PM |
BENNETT C FRANK | SVP, Antisense Research | Mar 03, 2017 | Option Exercise | $10.29 | 5,000 | 51,450 | 19,788 | Mar 06, 2017, 07:25 PM |
BENNETT C FRANK | SVP, Antisense Research | Mar 03, 2017 | Sale | $55.00 | 5,000 | 275,000 | 14,788 | Mar 06, 2017, 07:25 PM |
CROOKE STANLEY T | Chairman and CEO | Mar 02, 2017 | Option Exercise | $10.29 | 1,100 | 11,319 | 4,162 | Mar 06, 2017, 07:23 PM |
CROOKE STANLEY T | Chairman and CEO | Mar 02, 2017 | Option Exercise | $7.25 | 11,000 | 79,750 | 49,014 | Mar 06, 2017, 07:23 PM |
CROOKE STANLEY T | Chairman and CEO | Mar 02, 2017 | Sale | $51.05 | 1,100 | 56,155 | 3,062 | Mar 06, 2017, 07:23 PM |
CROOKE STANLEY T | Chairman and CEO | Mar 02, 2017 | Sale | $51.05 | 11,000 | 561,550 | 38,014 | Mar 06, 2017, 07:23 PM |
PARSHALL B LYNNE | COO | Mar 01, 2017 | Option Exercise | $14.69 | 4,625 | 67,941 | 30,276 | Mar 02, 2017, 07:12 PM |
PARSHALL B LYNNE | COO | Mar 01, 2017 | Sale | $49.26 | 4,625 | 227,827 | 25,651 | Mar 02, 2017, 07:12 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Mar 01, 2017 | Option Exercise | $10.82 | 500 | 5,410 | 12,949 | Mar 02, 2017, 07:11 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Mar 01, 2017 | Sale | $49.29 | 1,500 | 73,935 | 12,449 | Mar 02, 2017, 07:11 PM |
BERTHELSEN SPENCER R | Director | Feb 24, 2017 | Option Exercise | $9.77 | 12,500 | 122,125 | 88,958 | Feb 27, 2017, 07:15 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Feb 06, 2017 | Option Exercise | $10.68 | 500 | 5,342 | 12,930 | Feb 08, 2017, 06:32 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Feb 06, 2017 | Sale | $46.17 | 1,500 | 69,254 | 12,449 | Feb 08, 2017, 06:32 PM |
Boyce Sarah | Chief Business Officer | Jan 17, 2017 | Sale | $46.29 | 1,361 | 63,001 | 5,252 | Jan 18, 2017, 06:48 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jan 17, 2017 | Sale | $46.29 | 2,502 | 115,819 | 11,772 | Jan 18, 2017, 06:38 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jan 17, 2017 | Sale | $46.29 | 2,246 | 103,968 | 13,449 | Jan 18, 2017, 06:37 PM |
BENNETT C FRANK | SVP, Antisense Research | Jan 17, 2017 | Sale | $46.29 | 2,421 | 112,069 | 14,788 | Jan 18, 2017, 06:37 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 17, 2017 | Sale | $46.29 | 575 | 26,617 | 3,062 | Jan 18, 2017, 06:36 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 17, 2017 | Sale | $46.29 | 15,382 | 712,026 | 38,014 | Jan 18, 2017, 06:36 PM |
PARSHALL B LYNNE | COO | Jan 17, 2017 | Sale | $46.29 | 7,246 | 335,414 | 25,651 | Jan 18, 2017, 06:36 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Jan 17, 2017 | Sale | $46.29 | 2,273 | 105,218 | 10,288 | Jan 18, 2017, 06:35 PM |
Geary Richard S | SVP, Development | Jan 17, 2017 | Sale | $46.29 | 2,441 | 112,996 | 12,962 | Jan 18, 2017, 06:35 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 10, 2017 | Option Exercise | $10.29 | 1,200 | 12,348 | 3,370 | Jan 12, 2017, 06:18 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 10, 2017 | Option Exercise | $7.25 | 12,000 | 87,000 | 37,029 | Jan 12, 2017, 06:18 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 10, 2017 | Sale | $49.25 | 1,200 | 59,100 | 2,170 | Jan 12, 2017, 06:18 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 10, 2017 | Sale | $49.25 | 12,000 | 591,000 | 25,029 | Jan 12, 2017, 06:18 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 03, 2017 | Option Exercise | $7.25 | 10,000 | 72,500 | 30,029 | Jan 04, 2017, 06:35 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 04, 2017 | Option Exercise | $10.29 | 700 | 7,203 | 2,870 | Jan 04, 2017, 06:35 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 04, 2017 | Option Exercise | $7.25 | 7,000 | 50,750 | 32,029 | Jan 04, 2017, 06:35 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 03, 2017 | Option Exercise | $10.29 | 1,000 | 10,290 | 2,670 | Jan 04, 2017, 06:35 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 04, 2017 | Sale | $50.10 | 700 | 35,070 | 2,170 | Jan 04, 2017, 06:35 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 04, 2017 | Sale | $50.10 | 7,000 | 350,700 | 25,029 | Jan 04, 2017, 06:35 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 03, 2017 | Sale | $48.05 | 1,000 | 48,050 | 2,170 | Jan 04, 2017, 06:35 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 03, 2017 | Sale | $48.05 | 10,000 | 480,500 | 25,029 | Jan 04, 2017, 06:35 PM |
Boyce Sarah | Chief Business Officer | Jan 01, 2017 | Option Exercise | $20.76 | 992 | 20,591 | 3,130 | Jan 04, 2017, 06:35 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jan 01, 2017 | Option Exercise | $20.76 | 309 | 6,414 | 8,181 | Jan 04, 2017, 06:34 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jan 03, 2017 | Sale | $48.60 | 309 | 15,017 | 7,872 | Jan 04, 2017, 06:34 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jan 01, 2017 | Option Exercise | $20.76 | 424 | 8,801 | 9,950 | Jan 04, 2017, 06:34 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Jan 01, 2017 | Option Exercise | $20.76 | 199 | 4,131 | 6,747 | Jan 04, 2017, 06:33 PM |
BENNETT C FRANK | SVP, Antisense Research | Jan 01, 2017 | Option Exercise | $20.76 | 211 | 4,380 | 11,014 | Jan 04, 2017, 06:32 PM |
PARSHALL B LYNNE | COO | Jan 01, 2017 | Option Exercise | $20.76 | 171 | 3,549 | 16,864 | Jan 04, 2017, 06:31 PM |
Geary Richard S | SVP, Development | Jan 01, 2017 | Option Exercise | $20.76 | 640 | 13,284 | 9,157 | Jan 04, 2017, 06:30 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Dec 20, 2016 | Sale | $52.48 | 130 | 6,822 | 7,872 | Dec 20, 2016, 06:48 PM |
PARSHALL B LYNNE | COO | Dec 15, 2016 | Option Exercise | $7.25 | 1,000 | 7,250 | 1,000 | Dec 16, 2016, 07:21 PM |
PARSHALL B LYNNE | COO | Dec 15, 2016 | Option Exercise | $7.25 | 2,000 | 14,500 | 1,000 | Dec 16, 2016, 07:21 PM |
PARSHALL B LYNNE | COO | Dec 15, 2016 | Option Exercise | $7.25 | 1,000 | 7,250 | 1,000 | Dec 16, 2016, 07:21 PM |
PARSHALL B LYNNE | COO | Dec 15, 2016 | Sale | $50.00 | 2,000 | 100,000 | 0 | Dec 16, 2016, 07:21 PM |
PARSHALL B LYNNE | COO | Dec 15, 2016 | Sale | $50.00 | 1,000 | 50,000 | 0 | Dec 16, 2016, 07:21 PM |
PARSHALL B LYNNE | COO | Dec 15, 2016 | Sale | $50.00 | 1,000 | 50,000 | 0 | Dec 16, 2016, 07:21 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Dec 05, 2016 | Option Exercise | $11.27 | 2,500 | 28,175 | 9,048 | Dec 07, 2016, 07:51 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Dec 05, 2016 | Sale | $46.05 | 2,500 | 115,125 | 6,548 | Dec 07, 2016, 07:51 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Dec 05, 2016 | Option Exercise | $10.82 | 350 | 3,787 | 9,876 | Dec 07, 2016, 07:27 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Dec 05, 2016 | Sale | $45.00 | 350 | 15,750 | 9,526 | Dec 07, 2016, 07:27 PM |
PARSHALL B LYNNE | COO | Dec 01, 2016 | Option Exercise | $14.69 | 12,500 | 183,625 | 23,693 | Dec 02, 2016, 06:58 PM |
PARSHALL B LYNNE | COO | Dec 01, 2016 | Sale | $42.23 | 12,500 | 527,865 | 16,693 | Dec 02, 2016, 06:58 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Nov 14, 2016 | Option Exercise | $10.82 | 1,000 | 10,820 | 10,332 | Nov 14, 2016, 06:53 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Nov 14, 2016 | Sale | $45.00 | 1,000 | 45,000 | 9,526 | Nov 14, 2016, 06:53 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Nov 11, 2016 | Option Exercise | $11.27 | 2,500 | 28,175 | 9,048 | Nov 14, 2016, 06:52 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Nov 09, 2016 | Option Exercise | $11.27 | 2,500 | 28,175 | 9,048 | Nov 14, 2016, 06:52 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Nov 11, 2016 | Sale | $41.00 | 2,500 | 102,500 | 6,548 | Nov 14, 2016, 06:52 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Nov 09, 2016 | Sale | $38.49 | 2,500 | 96,225 | 6,548 | Nov 14, 2016, 06:52 PM |
CROOKE STANLEY T | Chairman and CEO | Nov 10, 2016 | Option Exercise | $7.25 | 10,000 | 72,500 | 35,029 | Nov 14, 2016, 06:51 PM |
CROOKE STANLEY T | Chairman and CEO | Nov 09, 2016 | Option Exercise | $10.29 | 2,000 | 20,580 | 3,170 | Nov 14, 2016, 06:51 PM |
CROOKE STANLEY T | Chairman and CEO | Nov 09, 2016 | Option Exercise | $9.72 | 20,000 | 194,427 | 35,029 | Nov 14, 2016, 06:51 PM |
CROOKE STANLEY T | Chairman and CEO | Nov 10, 2016 | Option Exercise | $10.29 | 1,000 | 10,290 | 3,170 | Nov 14, 2016, 06:51 PM |
CROOKE STANLEY T | Chairman and CEO | Nov 10, 2016 | Sale | $40.23 | 10,000 | 402,300 | 25,029 | Nov 14, 2016, 06:51 PM |
CROOKE STANLEY T | Chairman and CEO | Nov 09, 2016 | Sale | $36.17 | 2,000 | 72,350 | 2,170 | Nov 14, 2016, 06:51 PM |
CROOKE STANLEY T | Chairman and CEO | Nov 09, 2016 | Sale | $36.40 | 20,000 | 727,996 | 25,029 | Nov 14, 2016, 06:51 PM |
CROOKE STANLEY T | Chairman and CEO | Nov 10, 2016 | Sale | $42.22 | 1,000 | 42,220 | 2,170 | Nov 14, 2016, 06:51 PM |
BENNETT C FRANK | SVP, Antisense Research | Nov 09, 2016 | Option Exercise | $11.27 | 22,805 | 257,012 | 28,608 | Nov 14, 2016, 06:51 PM |
BENNETT C FRANK | SVP, Antisense Research | Nov 09, 2016 | Sale | $37.56 | 22,805 | 856,605 | 10,803 | Nov 14, 2016, 06:51 PM |
BENNETT C FRANK | SVP, Antisense Research | Nov 07, 2016 | Option Exercise | $11.27 | 5,000 | 56,350 | 15,803 | Nov 09, 2016, 06:22 PM |
BENNETT C FRANK | SVP, Antisense Research | Nov 07, 2016 | Sale | $34.00 | 5,000 | 170,000 | 10,803 | Nov 09, 2016, 06:22 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 05, 2016 | Option Exercise | $10.29 | 1,000 | 10,290 | 3,170 | Oct 07, 2016, 05:49 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 05, 2016 | Option Exercise | $10.29 | 10,000 | 102,900 | 35,029 | Oct 07, 2016, 05:49 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 05, 2016 | Sale | $36.61 | 1,000 | 36,610 | 2,170 | Oct 07, 2016, 05:49 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 05, 2016 | Sale | $36.61 | 10,000 | 366,100 | 25,029 | Oct 07, 2016, 05:49 PM |
CROOKE STANLEY T | Chairman and CEO | Sep 27, 2016 | Option Exercise | $10.29 | 2,000 | 20,580 | 4,170 | Sep 29, 2016, 05:05 PM |
CROOKE STANLEY T | Chairman and CEO | Sep 27, 2016 | Option Exercise | $10.29 | 20,000 | 205,800 | 45,029 | Sep 29, 2016, 05:05 PM |
CROOKE STANLEY T | Chairman and CEO | Sep 27, 2016 | Sale | $36.02 | 20,000 | 720,400 | 25,029 | Sep 29, 2016, 05:05 PM |
CROOKE STANLEY T | Chairman and CEO | Sep 27, 2016 | Sale | $36.05 | 2,000 | 72,100 | 2,170 | Sep 29, 2016, 05:05 PM |
CROOKE STANLEY T | Chairman and CEO | Sep 21, 2016 | Option Exercise | $10.29 | 20,000 | 205,800 | 45,029 | Sep 23, 2016, 06:31 PM |
CROOKE STANLEY T | Chairman and CEO | Sep 21, 2016 | Option Exercise | $10.29 | 2,000 | 20,580 | 4,170 | Sep 23, 2016, 06:31 PM |
CROOKE STANLEY T | Chairman and CEO | Sep 21, 2016 | Sale | $35.50 | 2,000 | 71,000 | 2,170 | Sep 23, 2016, 06:31 PM |
CROOKE STANLEY T | Chairman and CEO | Sep 21, 2016 | Sale | $35.50 | 20,000 | 710,000 | 25,029 | Sep 23, 2016, 06:31 PM |
PARSHALL B LYNNE | COO | Sep 01, 2016 | Option Exercise | $9.41 | 12,500 | 117,669 | 25,558 | Sep 06, 2016, 06:52 PM |
PARSHALL B LYNNE | COO | Sep 01, 2016 | Sale | $29.88 | 12,500 | 373,545 | 16,693 | Sep 06, 2016, 06:52 PM |
PARSHALL B LYNNE | COO | Jul 01, 2016 | Option Exercise | $20.76 | 403 | 8,365 | 16,693 | Jul 01, 2016, 08:22 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jul 01, 2016 | Option Exercise | $20.76 | 402 | 8,344 | 9,526 | Jul 01, 2016, 08:21 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jul 01, 2016 | Option Exercise | $20.76 | 309 | 6,414 | 8,002 | Jul 01, 2016, 08:20 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Jul 01, 2016 | Option Exercise | $20.76 | 217 | 4,504 | 6,548 | Jul 01, 2016, 08:20 PM |
Geary Richard S | SVP, Development | Jul 01, 2016 | Option Exercise | $20.76 | 163 | 3,383 | 8,517 | Jul 01, 2016, 08:19 PM |
Boyce Sarah | Chief Business Officer | Jul 01, 2016 | Option Exercise | $20.76 | 403 | 8,365 | 2,138 | Jul 01, 2016, 08:18 PM |
BENNETT C FRANK | SVP, Antisense Research | Jul 01, 2016 | Option Exercise | $20.76 | 213 | 4,421 | 10,803 | Jul 01, 2016, 08:18 PM |
MUTO FREDERICK T | Director | May 31, 2016 | Option Exercise | $5.93 | 12,500 | 74,125 | 15,043 | Jun 02, 2016, 06:25 PM |
MUTO FREDERICK T | Director | May 31, 2016 | Sale | $22.31 | 12,500 | 278,900 | 2,543 | Jun 02, 2016, 06:25 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Apr 06, 2016 | Option Exercise | $10.82 | 1,000 | 10,820 | 10,124 | Apr 07, 2016, 06:18 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Apr 06, 2016 | Sale | $45.00 | 1,000 | 45,000 | 9,124 | Apr 07, 2016, 06:18 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 06, 2016 | Option Exercise | $10.29 | 1,000 | 10,290 | 2,670 | Apr 07, 2016, 06:18 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 06, 2016 | Option Exercise | $10.29 | 10,000 | 102,900 | 30,029 | Apr 07, 2016, 06:18 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 06, 2016 | Sale | $46.13 | 10,000 | 461,250 | 25,029 | Apr 07, 2016, 06:18 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 06, 2016 | Sale | $46.13 | 1,000 | 46,125 | 2,170 | Apr 07, 2016, 06:18 PM |
CROOKE STANLEY T | Chairman and CEO | Mar 31, 2016 | Option Exercise | $10.29 | 10,000 | 102,900 | 30,029 | Apr 01, 2016, 06:18 PM |
CROOKE STANLEY T | Chairman and CEO | Mar 31, 2016 | Option Exercise | $9.76 | 1,000 | 9,755 | 2,670 | Apr 01, 2016, 06:18 PM |
CROOKE STANLEY T | Chairman and CEO | Mar 31, 2016 | Sale | $40.74 | 10,000 | 407,350 | 25,029 | Apr 01, 2016, 06:18 PM |
CROOKE STANLEY T | Chairman and CEO | Mar 31, 2016 | Sale | $40.74 | 1,000 | 40,735 | 2,170 | Apr 01, 2016, 06:18 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Mar 23, 2016 | Option Exercise | $10.82 | 1,000 | 10,820 | 10,124 | Mar 24, 2016, 07:13 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Mar 23, 2016 | Sale | $45.40 | 1,000 | 45,400 | 9,124 | Mar 24, 2016, 07:13 PM |
BERTHELSEN SPENCER R | Director | Feb 19, 2016 | Option Exercise | $5.93 | 12,500 | 74,125 | 74,343 | Feb 22, 2016, 04:10 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 19, 2016 | Sale | $41.46 | 576 | 23,882 | 2,170 | Jan 19, 2016, 08:27 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 19, 2016 | Sale | $41.46 | 12,825 | 531,716 | 25,029 | Jan 19, 2016, 08:27 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Jan 19, 2016 | Sale | $41.46 | 1,899 | 78,742 | 6,331 | Jan 19, 2016, 08:27 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jan 19, 2016 | Sale | $41.46 | 1,871 | 77,574 | 9,124 | Jan 19, 2016, 08:12 PM |
PARSHALL B LYNNE | COO & Secretary | Jan 19, 2016 | Sale | $41.46 | 5,192 | 215,257 | 16,290 | Jan 19, 2016, 08:11 PM |
Geary Richard S | SVP, Development | Jan 19, 2016 | Sale | $41.46 | 2,162 | 89,634 | 8,354 | Jan 19, 2016, 08:09 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jan 19, 2016 | Sale | $41.46 | 2,208 | 91,541 | 7,693 | Jan 19, 2016, 08:09 PM |
Boyce Sarah | Chief Business Officer | Jan 19, 2016 | Sale | $41.46 | 872 | 36,151 | 1,735 | Jan 19, 2016, 08:08 PM |
BENNETT C FRANK | SVP, Antisense Research | Jan 19, 2016 | Sale | $41.46 | 2,110 | 87,474 | 10,590 | Jan 19, 2016, 08:08 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 05, 2016 | Option Exercise | $9.22 | 500 | 4,610 | 1,797 | Jan 07, 2016, 06:52 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 05, 2016 | Option Exercise | $10.29 | 5,000 | 51,450 | 19,642 | Jan 07, 2016, 06:52 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 05, 2016 | Sale | $62.10 | 500 | 31,050 | 1,297 | Jan 07, 2016, 06:52 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 05, 2016 | Sale | $62.10 | 5,000 | 310,500 | 14,642 | Jan 07, 2016, 06:52 PM |
PARSHALL B LYNNE | COO & Secretary | Jan 01, 2016 | Option Exercise | $47.71 | 72 | 3,435 | 8,215 | Jan 04, 2016, 09:26 PM |
PARSHALL B LYNNE | COO & Secretary | Jan 04, 2016 | Option Exercise | $14.69 | 809 | 11,884 | 9,024 | Jan 04, 2016, 09:26 PM |
PARSHALL B LYNNE | COO & Secretary | Jan 04, 2016 | Sale | $61.05 | 809 | 49,389 | 8,215 | Jan 04, 2016, 09:26 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jan 01, 2016 | Option Exercise | $47.71 | 43 | 2,052 | 6,302 | Jan 04, 2016, 09:25 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jan 04, 2016 | Option Exercise | $7.79 | 1,000 | 7,793 | 7,150 | Jan 04, 2016, 09:25 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jan 04, 2016 | Sale | $61.10 | 1,000 | 61,100 | 6,302 | Jan 04, 2016, 09:25 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jan 01, 2016 | Option Exercise | $47.71 | 130 | 6,202 | 4,485 | Jan 04, 2016, 09:24 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jan 04, 2016 | Sale | $61.00 | 127 | 7,747 | 4,358 | Jan 04, 2016, 09:24 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Jan 01, 2016 | Option Exercise | $47.71 | 41 | 1,956 | 3,468 | Jan 04, 2016, 09:23 PM |
Geary Richard S | SVP, Development | Jan 01, 2016 | Option Exercise | $47.71 | 269 | 12,834 | 5,089 | Jan 04, 2016, 09:23 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 04, 2016 | Option Exercise | $10.29 | 10,000 | 102,900 | 24,642 | Jan 04, 2016, 09:22 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 04, 2016 | Option Exercise | $9.22 | 1,000 | 9,220 | 2,297 | Jan 04, 2016, 09:22 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 04, 2016 | Sale | $61.05 | 1,000 | 61,050 | 1,297 | Jan 04, 2016, 09:22 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 04, 2016 | Sale | $61.05 | 10,000 | 610,500 | 14,642 | Jan 04, 2016, 09:22 PM |
Boyce Sarah | Chief Business Officer | Jan 01, 2016 | Option Exercise | $47.71 | 419 | 19,991 | 419 | Jan 04, 2016, 09:21 PM |
BENNETT C FRANK | SVP, Antisense Research | Jan 01, 2016 | Option Exercise | $47.71 | 89 | 4,246 | 7,405 | Jan 04, 2016, 09:19 PM |
BENNETT C FRANK | SVP, Antisense Research | Dec 15, 2015 | Option Exercise | $14.47 | 4,000 | 57,880 | 11,316 | Dec 17, 2015, 07:23 PM |
BENNETT C FRANK | SVP, Antisense Research | Dec 16, 2015 | Option Exercise | $14.47 | 3,909 | 56,563 | 11,225 | Dec 17, 2015, 07:23 PM |
BENNETT C FRANK | SVP, Antisense Research | Dec 16, 2015 | Sale | $58.85 | 3,909 | 230,045 | 7,316 | Dec 17, 2015, 07:23 PM |
BENNETT C FRANK | SVP, Antisense Research | Dec 15, 2015 | Sale | $56.00 | 4,000 | 224,000 | 7,316 | Dec 17, 2015, 07:23 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Dec 01, 2015 | Option Exercise | $7.25 | 1,000 | 7,250 | 7,259 | Dec 02, 2015, 06:49 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Dec 01, 2015 | Sale | $61.50 | 1,000 | 61,500 | 6,259 | Dec 02, 2015, 06:49 PM |
BENNETT C FRANK | SVP, Antisense Research | Nov 10, 2015 | Option Exercise | $14.47 | 5,000 | 72,350 | 12,316 | Nov 12, 2015, 07:03 PM |
BENNETT C FRANK | SVP, Antisense Research | Nov 10, 2015 | Sale | $64.00 | 5,000 | 320,000 | 7,316 | Nov 12, 2015, 07:03 PM |
KLEIN JOSEPH III | Director | Nov 11, 2015 | Option Exercise | $10.95 | 6,875 | 75,312 | 9,293 | Nov 12, 2015, 07:02 PM |
KLEIN JOSEPH III | Director | Nov 11, 2015 | Sale | $64.18 | 6,875 | 441,234 | 5,543 | Nov 12, 2015, 07:02 PM |
BENNETT C FRANK | SVP, Antisense Research | Nov 06, 2015 | Option Exercise | $14.47 | 5,000 | 72,350 | 12,316 | Nov 09, 2015, 07:28 PM |
BENNETT C FRANK | SVP, Antisense Research | Nov 06, 2015 | Sale | $56.00 | 5,000 | 280,000 | 7,316 | Nov 09, 2015, 07:28 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Nov 03, 2015 | Option Exercise | $7.25 | 1,000 | 7,250 | 7,259 | Nov 04, 2015, 07:00 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Nov 03, 2015 | Sale | $51.95 | 1,000 | 51,950 | 6,259 | Nov 04, 2015, 07:00 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 21, 2015 | Option Exercise | $10.59 | 1,500 | 15,880 | 2,297 | Oct 23, 2015, 07:35 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 21, 2015 | Option Exercise | $11.27 | 15,000 | 169,050 | 29,642 | Oct 23, 2015, 07:35 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 23, 2015 | Option Exercise | $9.22 | 2,500 | 23,050 | 3,297 | Oct 23, 2015, 07:35 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 23, 2015 | Option Exercise | $10.45 | 25,000 | 261,330 | 30,479 | Oct 23, 2015, 07:35 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 21, 2015 | Sale | $43.00 | 15,000 | 645,000 | 14,642 | Oct 23, 2015, 07:35 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 23, 2015 | Sale | $44.40 | 2,500 | 111,000 | 1,297 | Oct 23, 2015, 07:35 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 23, 2015 | Sale | $44.35 | 25,000 | 1,108,855 | 14,642 | Oct 23, 2015, 07:35 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 21, 2015 | Sale | $43.00 | 1,500 | 64,500 | 1,297 | Oct 23, 2015, 07:35 PM |
PARSHALL B LYNNE | COO & Secretary | Oct 01, 2015 | Option Exercise | $10.27 | 7,000 | 71,865 | 12,305 | Oct 05, 2015, 07:14 PM |
PARSHALL B LYNNE | COO & Secretary | Oct 02, 2015 | Option Exercise | $14.69 | 5,436 | 79,855 | 11,579 | Oct 05, 2015, 07:14 PM |
PARSHALL B LYNNE | COO & Secretary | Oct 01, 2015 | Sale | $40.13 | 7,000 | 280,880 | 8,143 | Oct 05, 2015, 07:14 PM |
PARSHALL B LYNNE | COO & Secretary | Oct 02, 2015 | Sale | $41.55 | 5,436 | 225,867 | 8,143 | Oct 05, 2015, 07:14 PM |
PARSHALL B LYNNE | COO & Secretary | Jul 06, 2015 | Option Exercise | $7.92 | 6,218 | 49,260 | 12,986 | Jul 08, 2015, 05:55 PM |
PARSHALL B LYNNE | COO & Secretary | Jul 06, 2015 | Sale | $57.01 | 6,218 | 354,470 | 8,143 | Jul 08, 2015, 05:55 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 06, 2015 | Option Exercise | $11.27 | 5,000 | 56,350 | 19,642 | Jul 08, 2015, 05:54 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 06, 2015 | Option Exercise | $9.22 | 1,175 | 10,834 | 2,472 | Jul 08, 2015, 05:54 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 06, 2015 | Sale | $57.01 | 5,000 | 285,035 | 14,642 | Jul 08, 2015, 05:54 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 06, 2015 | Sale | $57.01 | 1,175 | 66,983 | 1,297 | Jul 08, 2015, 05:54 PM |
PARSHALL B LYNNE | COO & Secretary | Jul 01, 2015 | Option Exercise | $48.59 | 71 | 3,450 | 8,143 | Jul 02, 2015, 06:06 PM |
PARSHALL B LYNNE | COO & Secretary | Jul 01, 2015 | Option Exercise | $10.29 | 6,218 | 63,983 | 14,361 | Jul 02, 2015, 06:06 PM |
PARSHALL B LYNNE | COO & Secretary | Jul 01, 2015 | Sale | $57.56 | 6,218 | 357,914 | 8,143 | Jul 02, 2015, 06:06 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jul 01, 2015 | Option Exercise | $48.59 | 85 | 4,130 | 6,259 | Jul 02, 2015, 06:05 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jul 01, 2015 | Option Exercise | $48.59 | 127 | 6,170 | 4,553 | Jul 02, 2015, 06:05 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jul 02, 2015 | Sale | $56.30 | 198 | 11,147 | 4,355 | Jul 02, 2015, 06:05 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Jul 01, 2015 | Option Exercise | $48.59 | 40 | 1,943 | 3,427 | Jul 02, 2015, 06:04 PM |
Geary Richard S | SVP, Development | Jul 01, 2015 | Option Exercise | $48.59 | 265 | 12,875 | 4,820 | Jul 02, 2015, 06:03 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 01, 2015 | Option Exercise | $11.27 | 5,000 | 56,350 | 19,642 | Jul 02, 2015, 06:02 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 01, 2015 | Option Exercise | $9.22 | 1,175 | 10,834 | 2,472 | Jul 02, 2015, 06:02 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 01, 2015 | Sale | $57.56 | 1,175 | 67,634 | 1,297 | Jul 02, 2015, 06:02 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 01, 2015 | Sale | $57.56 | 5,000 | 287,805 | 14,642 | Jul 02, 2015, 06:02 PM |
BENNETT C FRANK | SVP, Antisense Research | Jul 01, 2015 | Option Exercise | $48.59 | 87 | 4,227 | 7,316 | Jul 02, 2015, 06:01 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jun 08, 2015 | Option Exercise | $10.29 | 7,600 | 78,204 | 12,026 | Jun 10, 2015, 06:36 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jun 08, 2015 | Sale | $66.22 | 7,600 | 503,280 | 4,426 | Jun 10, 2015, 06:36 PM |
MUTO FREDERICK T | Director | Jun 01, 2015 | Option Exercise | $3.95 | 10,000 | 39,500 | 11,095 | Jun 03, 2015, 05:29 PM |
MUTO FREDERICK T | Director | Jun 01, 2015 | Sale | $66.91 | 10,000 | 669,110 | 1,095 | Jun 03, 2015, 05:29 PM |
BERTHELSEN SPENCER R | Director | Apr 17, 2015 | Option Exercise | $3.95 | 10,000 | 39,500 | 60,395 | Apr 17, 2015, 06:13 PM |
PARSHALL B LYNNE | COO & Secretary | Apr 07, 2015 | Option Exercise | $14.69 | 5,565 | 81,750 | 13,637 | Apr 08, 2015, 05:12 PM |
PARSHALL B LYNNE | COO & Secretary | Apr 07, 2015 | Sale | $63.07 | 5,565 | 350,990 | 8,072 | Apr 08, 2015, 05:12 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 07, 2015 | Option Exercise | $9.22 | 2,034 | 18,753 | 3,331 | Apr 08, 2015, 05:11 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 07, 2015 | Option Exercise | $11.27 | 20,343 | 229,266 | 34,985 | Apr 08, 2015, 05:11 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 07, 2015 | Sale | $63.07 | 2,034 | 128,286 | 1,297 | Apr 08, 2015, 05:11 PM |
CROOKE STANLEY T | Chairman and CEO | Apr 07, 2015 | Sale | $63.07 | 20,343 | 1,283,053 | 14,642 | Apr 08, 2015, 05:11 PM |
PARSHALL B LYNNE | COO & Secretary | Apr 01, 2015 | Option Exercise | $14.69 | 5,377 | 78,988 | 13,449 | Apr 06, 2015, 11:51 AM |
PARSHALL B LYNNE | COO & Secretary | Apr 01, 2015 | Sale | $61.93 | 5,377 | 333,009 | 8,072 | Apr 06, 2015, 11:51 AM |
CROOKE STANLEY T | Chairman and CEO | Apr 01, 2015 | Option Exercise | $9.22 | 1,966 | 18,127 | 3,263 | Apr 06, 2015, 11:50 AM |
CROOKE STANLEY T | Chairman and CEO | Apr 01, 2015 | Option Exercise | $11.27 | 19,657 | 221,534 | 34,299 | Apr 06, 2015, 11:50 AM |
CROOKE STANLEY T | Chairman and CEO | Apr 01, 2015 | Sale | $61.93 | 1,966 | 121,759 | 1,297 | Apr 06, 2015, 11:50 AM |
CROOKE STANLEY T | Chairman and CEO | Apr 01, 2015 | Sale | $61.93 | 19,657 | 1,217,399 | 14,642 | Apr 06, 2015, 11:50 AM |
BENNETT C FRANK | SVP, Antisense Research | Mar 24, 2015 | Option Exercise | $14.47 | 9,000 | 130,230 | 16,229 | Mar 25, 2015, 04:23 PM |
BENNETT C FRANK | SVP, Antisense Research | Mar 23, 2015 | Option Exercise | $14.47 | 6,000 | 86,820 | 12,229 | Mar 25, 2015, 04:23 PM |
BENNETT C FRANK | SVP, Antisense Research | Mar 24, 2015 | Sale | $71.01 | 9,000 | 639,090 | 7,229 | Mar 25, 2015, 04:23 PM |
BENNETT C FRANK | SVP, Antisense Research | Mar 23, 2015 | Sale | $70.00 | 6,000 | 420,020 | 7,229 | Mar 25, 2015, 04:23 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Mar 19, 2015 | Option Exercise | $11.27 | 10,000 | 112,700 | 13,387 | Mar 20, 2015, 06:58 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Mar 19, 2015 | Sale | $73.33 | 10,000 | 733,260 | 3,387 | Mar 20, 2015, 06:58 PM |
WENDER JOSEPH H | Director | Mar 18, 2015 | Option Exercise | $5.93 | 12,500 | 74,125 | 36,617 | Mar 20, 2015, 06:57 PM |
WENDER JOSEPH H | Director | Mar 18, 2015 | Sale | $71.41 | 12,500 | 892,586 | 30,217 | Mar 20, 2015, 06:57 PM |
Geary Richard S | SVP, Development | Mar 19, 2015 | Option Exercise | $14.69 | 8,000 | 117,520 | 12,555 | Mar 20, 2015, 06:56 PM |
Geary Richard S | SVP, Development | Mar 19, 2015 | Sale | $75.00 | 8,000 | 600,032 | 4,555 | Mar 20, 2015, 06:56 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Mar 19, 2015 | Option Exercise | $22.62 | 30,525 | 690,416 | 16,699 | Mar 20, 2015, 06:55 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Mar 19, 2015 | Sale | $74.85 | 30,525 | 2,284,757 | 6,174 | Mar 20, 2015, 06:55 PM |
Geary Richard S | SVP, Development | Mar 05, 2015 | Option Exercise | $8.88 | 15,080 | 133,972 | 12,555 | Mar 09, 2015, 07:45 PM |
Geary Richard S | SVP, Development | Mar 05, 2015 | Sale | $71.15 | 18,095 | 1,287,382 | 4,555 | Mar 09, 2015, 07:45 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Mar 05, 2015 | Option Exercise | $10.50 | 28,094 | 295,065 | 16,044 | Mar 09, 2015, 07:27 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Mar 05, 2015 | Sale | $71.57 | 28,094 | 2,010,823 | 3,387 | Mar 09, 2015, 07:27 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Mar 05, 2015 | Option Exercise | $9.63 | 5,800 | 55,865 | 10,307 | Mar 09, 2015, 07:27 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Mar 05, 2015 | Sale | $71.67 | 5,800 | 415,674 | 6,174 | Mar 09, 2015, 07:27 PM |
WENDER JOSEPH H | Director | Mar 05, 2015 | Option Exercise | $9.77 | 12,500 | 122,125 | 42,717 | Mar 09, 2015, 07:26 PM |
WENDER JOSEPH H | Director | Mar 05, 2015 | Sale | $71.61 | 12,500 | 895,174 | 30,217 | Mar 09, 2015, 07:26 PM |
KLEIN JOSEPH III | Director | Mar 05, 2015 | Option Exercise | $10.18 | 10,000 | 101,800 | 11,095 | Mar 09, 2015, 07:25 PM |
KLEIN JOSEPH III | Director | Mar 05, 2015 | Sale | $70.95 | 7,000 | 496,681 | 4,095 | Mar 09, 2015, 07:25 PM |
WENDER JOSEPH H | Director | Mar 02, 2015 | Sale | $65.97 | 7,000 | 461,785 | 30,217 | Mar 04, 2015, 07:15 PM |
WENDER JOSEPH H | Director | Feb 12, 2015 | Option Exercise | $3.95 | 10,000 | 39,500 | 47,217 | Feb 17, 2015, 05:39 PM |
WENDER JOSEPH H | Director | Feb 12, 2015 | Sale | $62.15 | 10,000 | 621,460 | 37,217 | Feb 17, 2015, 05:39 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 27, 2015 | Option Exercise | $11.27 | 10,000 | 112,700 | 24,642 | Jan 29, 2015, 07:03 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 27, 2015 | Option Exercise | $9.22 | 1,000 | 9,220 | 2,297 | Jan 29, 2015, 07:03 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 27, 2015 | Sale | $72.93 | 10,000 | 729,260 | 14,642 | Jan 29, 2015, 07:03 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 27, 2015 | Sale | $72.93 | 1,000 | 72,926 | 1,297 | Jan 29, 2015, 07:03 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 16, 2015 | Sale | $67.96 | 417 | 28,341 | 1,297 | Jan 20, 2015, 08:00 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 16, 2015 | Sale | $67.96 | 8,637 | 587,007 | 14,642 | Jan 20, 2015, 08:00 PM |
PARSHALL B LYNNE | COO & Secretary | Jan 16, 2015 | Sale | $67.96 | 4,093 | 278,177 | 8,072 | Jan 20, 2015, 07:58 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jan 16, 2015 | Sale | $67.96 | 1,534 | 104,257 | 4,426 | Jan 20, 2015, 07:57 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Jan 16, 2015 | Sale | $67.96 | 1,291 | 87,742 | 3,387 | Jan 20, 2015, 07:57 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jan 16, 2015 | Sale | $67.96 | 1,291 | 87,742 | 6,174 | Jan 20, 2015, 07:56 PM |
BENNETT C FRANK | SVP, Antisense Research | Jan 16, 2015 | Sale | $67.96 | 1,518 | 103,169 | 7,229 | Jan 20, 2015, 07:55 PM |
Geary Richard S | SVP, Development | Jan 16, 2015 | Sale | $67.96 | 1,543 | 104,868 | 7,570 | Jan 20, 2015, 07:53 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 09, 2015 | Option Exercise | $9.22 | 1,000 | 9,220 | 1,627 | Jan 13, 2015, 06:51 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 09, 2015 | Option Exercise | $11.27 | 10,000 | 112,700 | 16,941 | Jan 13, 2015, 06:51 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 09, 2015 | Sale | $73.57 | 1,000 | 73,570 | 627 | Jan 13, 2015, 06:51 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 09, 2015 | Sale | $73.57 | 10,000 | 735,700 | 6,941 | Jan 13, 2015, 06:51 PM |
Geary Richard S | SVP, Development | Jan 12, 2015 | Sale | $73.10 | 597 | 43,641 | 5,064 | Jan 13, 2015, 06:49 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 06, 2015 | Option Exercise | $11.27 | 10,000 | 112,700 | 16,941 | Jan 08, 2015, 07:15 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 07, 2015 | Option Exercise | $9.22 | 1,000 | 9,220 | 1,627 | Jan 08, 2015, 07:15 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 07, 2015 | Option Exercise | $11.27 | 10,000 | 112,700 | 16,941 | Jan 08, 2015, 07:15 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 06, 2015 | Option Exercise | $9.22 | 1,000 | 9,220 | 1,627 | Jan 08, 2015, 07:15 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 06, 2015 | Sale | $66.04 | 10,000 | 660,380 | 6,941 | Jan 08, 2015, 07:15 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 07, 2015 | Sale | $68.05 | 1,000 | 68,048 | 627 | Jan 08, 2015, 07:15 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 07, 2015 | Sale | $68.05 | 10,000 | 680,480 | 6,941 | Jan 08, 2015, 07:15 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 06, 2015 | Sale | $66.04 | 1,000 | 66,038 | 627 | Jan 08, 2015, 07:15 PM |
PARSHALL B LYNNE | COO & Secretary | Jan 01, 2015 | Option Exercise | $30.05 | 111 | 3,335 | 4,417 | Jan 05, 2015, 08:04 PM |
PARSHALL B LYNNE | COO & Secretary | Jan 02, 2015 | Option Exercise | $14.69 | 11,200 | 164,528 | 15,617 | Jan 05, 2015, 08:04 PM |
PARSHALL B LYNNE | COO & Secretary | Jan 02, 2015 | Sale | $62.12 | 11,200 | 695,688 | 4,417 | Jan 05, 2015, 08:04 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jan 01, 2015 | Option Exercise | $30.05 | 329 | 9,886 | 4,082 | Jan 05, 2015, 08:03 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jan 02, 2015 | Option Exercise | $10.15 | 1,500 | 15,220 | 5,299 | Jan 05, 2015, 08:03 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jan 02, 2015 | Sale | $62.12 | 1,500 | 93,173 | 4,082 | Jan 05, 2015, 08:03 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Jan 01, 2015 | Option Exercise | $30.05 | 63 | 1,893 | 1,295 | Jan 05, 2015, 08:01 PM |
BENNETT C FRANK | SVP, Antisense Research | Jan 01, 2015 | Option Exercise | $30.05 | 136 | 4,086 | 4,763 | Jan 05, 2015, 07:59 PM |
Geary Richard S | SVP, Development | Jan 01, 2015 | Option Exercise | $30.05 | 273 | 8,203 | 5,661 | Jan 05, 2015, 07:57 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jan 01, 2015 | Option Exercise | $30.05 | 198 | 5,949 | 2,011 | Jan 05, 2015, 07:56 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jan 02, 2015 | Sale | $62.75 | 76 | 4,769 | 1,935 | Jan 05, 2015, 07:56 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Dec 01, 2014 | Option Exercise | $7.25 | 1,500 | 10,875 | 4,253 | Dec 03, 2014, 07:27 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Dec 01, 2014 | Sale | $51.21 | 1,500 | 76,815 | 3,753 | Dec 03, 2014, 07:27 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Nov 03, 2014 | Option Exercise | $7.25 | 1,500 | 10,875 | 5,253 | Nov 05, 2014, 06:07 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Nov 03, 2014 | Sale | $46.17 | 1,500 | 69,255 | 3,753 | Nov 05, 2014, 06:07 PM |
PARSHALL B LYNNE | COO & Secretary | Oct 30, 2014 | Option Exercise | $8.94 | 11,071 | 98,939 | 12,867 | Oct 31, 2014, 06:05 PM |
PARSHALL B LYNNE | COO & Secretary | Oct 30, 2014 | Sale | $45.12 | 11,071 | 499,535 | 4,306 | Oct 31, 2014, 06:05 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 23, 2014 | Option Exercise | $9.22 | 1,600 | 14,752 | 2,227 | Oct 24, 2014, 04:57 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 23, 2014 | Option Exercise | $12.01 | 13,000 | 156,110 | 16,941 | Oct 24, 2014, 04:57 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 23, 2014 | Sale | $42.22 | 13,000 | 548,860 | 6,941 | Oct 24, 2014, 04:57 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 23, 2014 | Sale | $42.22 | 1,600 | 67,552 | 627 | Oct 24, 2014, 04:57 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 03, 2014 | Option Exercise | $14.47 | 13,000 | 188,110 | 19,941 | Oct 03, 2014, 07:07 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 01, 2014 | Option Exercise | $10.45 | 2,000 | 20,900 | 1,827 | Oct 03, 2014, 07:07 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 01, 2014 | Option Exercise | $14.47 | 20,000 | 289,400 | 26,941 | Oct 03, 2014, 07:07 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 03, 2014 | Option Exercise | $9.22 | 1,000 | 9,220 | 1,627 | Oct 03, 2014, 07:07 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 01, 2014 | Sale | $37.91 | 2,000 | 75,822 | 627 | Oct 03, 2014, 07:07 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 01, 2014 | Sale | $37.91 | 20,000 | 758,220 | 6,941 | Oct 03, 2014, 07:07 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 03, 2014 | Sale | $39.49 | 1,000 | 39,487 | 627 | Oct 03, 2014, 07:07 PM |
CROOKE STANLEY T | Chairman and CEO | Oct 03, 2014 | Sale | $39.49 | 13,000 | 513,331 | 6,941 | Oct 03, 2014, 07:07 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Oct 01, 2014 | Option Exercise | $7.72 | 1,500 | 11,583 | 4,553 | Oct 03, 2014, 07:06 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Oct 01, 2014 | Sale | $38.04 | 1,500 | 57,060 | 3,753 | Oct 03, 2014, 07:06 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Sep 02, 2014 | Option Exercise | $10.29 | 1,500 | 15,435 | 4,553 | Sep 04, 2014, 07:13 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Sep 02, 2014 | Sale | $40.44 | 1,500 | 60,660 | 3,753 | Sep 04, 2014, 07:13 PM |
PARSHALL B LYNNE | COO | Sep 02, 2014 | Option Exercise | $10.17 | 11,071 | 112,574 | 14,934 | Sep 04, 2014, 07:13 PM |
PARSHALL B LYNNE | COO | Sep 02, 2014 | Sale | $40.24 | 11,071 | 445,507 | 4,306 | Sep 04, 2014, 07:13 PM |
BENNETT C FRANK | SVP, Antisense Research | Aug 27, 2014 | Option Exercise | $15.38 | 5,000 | 76,900 | 6,627 | Aug 28, 2014, 06:49 PM |
BENNETT C FRANK | SVP, Antisense Research | Aug 27, 2014 | Sale | $40.53 | 5,000 | 202,630 | 4,627 | Aug 28, 2014, 06:49 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Aug 26, 2014 | Option Exercise | $9.26 | 27,344 | 253,267 | 16,813 | Aug 28, 2014, 06:48 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Aug 26, 2014 | Sale | $38.14 | 27,344 | 1,043,010 | 1,813 | Aug 28, 2014, 06:48 PM |
CROOKE STANLEY T | Chairman, President and CEO | Aug 13, 2014 | Option Exercise | $11.27 | 1,600 | 18,032 | 2,227 | Aug 15, 2014, 06:39 PM |
CROOKE STANLEY T | Chairman, President and CEO | Aug 13, 2014 | Option Exercise | $14.47 | 15,500 | 224,285 | 22,441 | Aug 15, 2014, 06:39 PM |
CROOKE STANLEY T | Chairman, President and CEO | Aug 13, 2014 | Sale | $35.45 | 1,600 | 56,726 | 627 | Aug 15, 2014, 06:39 PM |
CROOKE STANLEY T | Chairman, President and CEO | Aug 13, 2014 | Sale | $35.45 | 15,500 | 549,537 | 6,941 | Aug 15, 2014, 06:39 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Aug 11, 2014 | Option Exercise | $10.29 | 700 | 7,203 | 4,453 | Aug 12, 2014, 06:51 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Aug 12, 2014 | Option Exercise | $10.29 | 800 | 8,232 | 4,553 | Aug 12, 2014, 06:51 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Aug 11, 2014 | Sale | $35.00 | 700 | 24,500 | 3,753 | Aug 12, 2014, 06:51 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Aug 12, 2014 | Sale | $35.00 | 800 | 28,000 | 3,753 | Aug 12, 2014, 06:51 PM |
CROOKE STANLEY T | Chairman, President and CEO | Aug 01, 2014 | Option Exercise | $11.27 | 1,000 | 11,270 | 1,627 | Aug 01, 2014, 07:44 PM |
CROOKE STANLEY T | Chairman, President and CEO | Aug 01, 2014 | Option Exercise | $14.47 | 15,000 | 217,050 | 21,941 | Aug 01, 2014, 07:44 PM |
CROOKE STANLEY T | Chairman, President and CEO | Aug 01, 2014 | Sale | $30.52 | 1,000 | 30,525 | 627 | Aug 01, 2014, 07:44 PM |
CROOKE STANLEY T | Chairman, President and CEO | Aug 01, 2014 | Sale | $30.52 | 15,000 | 457,875 | 6,941 | Aug 01, 2014, 07:44 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jul 31, 2014 | Sale | $31.50 | 79 | 2,489 | 1,813 | Aug 01, 2014, 07:16 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jul 01, 2014 | Option Exercise | $30.20 | 403 | 12,171 | 3,753 | Jul 02, 2014, 04:09 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jul 01, 2014 | Option Exercise | $10.29 | 1,500 | 15,435 | 5,253 | Jul 02, 2014, 04:09 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jul 01, 2014 | Sale | $35.33 | 1,500 | 53,000 | 3,753 | Jul 02, 2014, 04:09 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 01, 2014 | Option Exercise | $11.59 | 2,000 | 23,180 | 2,427 | Jul 02, 2014, 04:08 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 01, 2014 | Option Exercise | $14.47 | 15,500 | 224,285 | 22,441 | Jul 02, 2014, 04:08 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 01, 2014 | Sale | $35.55 | 2,000 | 71,100 | 627 | Jul 02, 2014, 04:08 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 01, 2014 | Sale | $35.58 | 15,500 | 551,459 | 6,941 | Jul 02, 2014, 04:08 PM |
Geary Richard S | SVP, Development | Jul 01, 2014 | Option Exercise | $30.20 | 597 | 18,030 | 5,552 | Jul 02, 2014, 04:08 PM |
Geary Richard S | SVP, Development | Jul 02, 2014 | Sale | $35.95 | 164 | 5,896 | 5,388 | Jul 02, 2014, 04:08 PM |
PARSHALL B LYNNE | COO & Secretary | Jul 01, 2014 | Option Exercise | $30.20 | 284 | 8,577 | 4,306 | Jul 01, 2014, 08:19 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jul 01, 2014 | Option Exercise | $30.20 | 76 | 2,295 | 1,892 | Jul 01, 2014, 08:18 PM |
BENNETT C FRANK | SVP, Antisense Research | Jul 01, 2014 | Option Exercise | $30.20 | 291 | 8,788 | 4,627 | Jul 01, 2014, 08:17 PM |
BENNETT C FRANK | SVP, Antisense Research | Jun 23, 2014 | Option Exercise | $15.38 | 11,200 | 172,256 | 10,536 | Jun 25, 2014, 07:47 PM |
BENNETT C FRANK | SVP, Antisense Research | Jun 23, 2014 | Sale | $36.78 | 11,200 | 411,910 | 4,336 | Jun 25, 2014, 07:47 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Jun 19, 2014 | Option Exercise | $10.18 | 700 | 7,127 | 3,650 | Jun 20, 2014, 04:15 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Jun 19, 2014 | Sale | $35.35 | 700 | 24,748 | 3,350 | Jun 20, 2014, 04:15 PM |
CROOKE STANLEY T | Chairman, President and CEO | Jun 19, 2014 | Option Exercise | $14.47 | 11,000 | 159,170 | 17,941 | Jun 20, 2014, 04:14 PM |
CROOKE STANLEY T | Chairman, President and CEO | Jun 19, 2014 | Sale | $35.10 | 11,000 | 386,111 | 6,941 | Jun 20, 2014, 04:14 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Jun 16, 2014 | Option Exercise | $8.00 | 800 | 6,400 | 3,750 | Jun 18, 2014, 07:06 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Jun 16, 2014 | Sale | $35.14 | 800 | 28,110 | 3,350 | Jun 18, 2014, 07:06 PM |
CROOKE STANLEY T | Chairman, President and CEO | Jun 10, 2014 | Option Exercise | $14.47 | 1,000 | 14,470 | 1,627 | Jun 12, 2014, 06:43 PM |
CROOKE STANLEY T | Chairman, President and CEO | Jun 10, 2014 | Option Exercise | $14.47 | 10,000 | 144,700 | 16,941 | Jun 12, 2014, 06:43 PM |
CROOKE STANLEY T | Chairman, President and CEO | Jun 10, 2014 | Sale | $33.46 | 1,000 | 33,455 | 627 | Jun 12, 2014, 06:43 PM |
CROOKE STANLEY T | Chairman, President and CEO | Jun 10, 2014 | Sale | $33.46 | 10,000 | 334,550 | 6,941 | Jun 12, 2014, 06:43 PM |
MUTO FREDERICK T | Director | Jun 02, 2014 | Option Exercise | $5.72 | 10,000 | 57,200 | 10,313 | Jun 03, 2014, 07:17 PM |
MUTO FREDERICK T | Director | Jun 02, 2014 | Sale | $28.59 | 10,000 | 285,900 | 313 | Jun 03, 2014, 07:17 PM |
BERTHELSEN SPENCER R | Director | Apr 17, 2014 | Option Exercise | $5.72 | 10,000 | 57,200 | 49,613 | Apr 17, 2014, 07:43 PM |
CROOKE STANLEY T | Chairman, President and CEO | Apr 02, 2014 | Option Exercise | $14.47 | 1,800 | 26,046 | 2,427 | Apr 04, 2014, 07:24 PM |
CROOKE STANLEY T | Chairman, President and CEO | Apr 02, 2014 | Option Exercise | $14.47 | 7,000 | 101,290 | 13,941 | Apr 04, 2014, 07:24 PM |
CROOKE STANLEY T | Chairman, President and CEO | Apr 02, 2014 | Sale | $43.65 | 1,800 | 78,566 | 627 | Apr 04, 2014, 07:24 PM |
CROOKE STANLEY T | Chairman, President and CEO | Apr 02, 2014 | Sale | $43.65 | 7,000 | 305,536 | 6,941 | Apr 04, 2014, 07:24 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Apr 01, 2014 | Option Exercise | $8.00 | 1,500 | 12,000 | 3,850 | Apr 03, 2014, 07:32 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Apr 01, 2014 | Sale | $44.40 | 1,500 | 66,600 | 3,350 | Apr 03, 2014, 07:32 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Mar 03, 2014 | Option Exercise | $10.93 | 1,500 | 16,396 | 4,150 | Mar 05, 2014, 06:55 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Mar 03, 2014 | Sale | $50.00 | 1,500 | 75,000 | 3,350 | Mar 05, 2014, 06:55 PM |
WENDER JOSEPH H | Director | Feb 06, 2014 | Option Exercise | $5.72 | 5,300 | 30,316 | 36,435 | Feb 07, 2014, 07:54 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Feb 03, 2014 | Option Exercise | $11.27 | 1,500 | 16,905 | 4,850 | Feb 05, 2014, 07:30 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Feb 03, 2014 | Sale | $50.45 | 1,500 | 75,677 | 3,350 | Feb 05, 2014, 07:30 PM |
WENDER JOSEPH H | Director | Feb 03, 2014 | Option Exercise | $5.72 | 4,700 | 26,884 | 35,835 | Feb 05, 2014, 07:29 PM |
WENDER JOSEPH H | Director | Feb 03, 2014 | Sale | $48.78 | 4,700 | 229,278 | 31,135 | Feb 05, 2014, 07:29 PM |
PARSHALL B LYNNE | COO | Jan 29, 2014 | Option Exercise | $7.25 | 10,000 | 72,500 | 5,000 | Jan 31, 2014, 07:34 PM |
PARSHALL B LYNNE | COO | Jan 29, 2014 | Option Exercise | $10.40 | 35,000 | 364,043 | 35,050 | Jan 31, 2014, 07:34 PM |
PARSHALL B LYNNE | COO | Jan 30, 2014 | Option Exercise | $9.07 | 39,510 | 358,298 | 27,657 | Jan 31, 2014, 07:34 PM |
PARSHALL B LYNNE | COO | Jan 29, 2014 | Option Exercise | $7.25 | 5,000 | 36,250 | 5,000 | Jan 31, 2014, 07:34 PM |
PARSHALL B LYNNE | COO | Jan 29, 2014 | Sale | $48.81 | 10,000 | 488,070 | 0 | Jan 31, 2014, 07:34 PM |
PARSHALL B LYNNE | COO | Jan 29, 2014 | Sale | $48.81 | 35,000 | 1,708,245 | 4,022 | Jan 31, 2014, 07:34 PM |
PARSHALL B LYNNE | COO | Jan 30, 2014 | Sale | $50.36 | 39,510 | 1,989,882 | 4,022 | Jan 31, 2014, 07:34 PM |
PARSHALL B LYNNE | COO | Jan 29, 2014 | Sale | $48.81 | 5,000 | 244,035 | 0 | Jan 31, 2014, 07:34 PM |
KLEIN JOSEPH III | Director | Jan 24, 2014 | Option Exercise | $15.40 | 10,313 | 158,800 | 9,813 | Jan 24, 2014, 08:26 PM |
KLEIN JOSEPH III | Director | Jan 24, 2014 | Sale | $48.66 | 10,313 | 501,838 | 2,313 | Jan 24, 2014, 08:26 PM |
Geary Richard S | SVP, Development | Jan 22, 2014 | Option Exercise | $10.03 | 22,200 | 222,702 | 18,855 | Jan 24, 2014, 08:07 PM |
Geary Richard S | SVP, Development | Jan 22, 2014 | Sale | $50.05 | 22,200 | 1,111,021 | 4,955 | Jan 24, 2014, 08:07 PM |
WENDER JOSEPH H | Director | Jan 22, 2014 | Sale | $50.98 | 10,000 | 509,803 | 31,135 | Jan 24, 2014, 08:06 PM |
BENNETT C FRANK | SVP, Antisense Research | Jan 16, 2014 | Sale | $47.08 | 804 | 37,853 | 4,336 | Jan 17, 2014, 07:41 PM |
Geary Richard S | SVP, Development | Jan 16, 2014 | Sale | $47.08 | 829 | 39,030 | 4,955 | Jan 17, 2014, 07:41 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Jan 16, 2014 | Sale | $47.08 | 577 | 27,165 | 1,232 | Jan 17, 2014, 07:40 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jan 16, 2014 | Sale | $47.08 | 821 | 38,653 | 1,816 | Jan 17, 2014, 07:39 PM |
PARSHALL B LYNNE | COO & Secretary | Jan 16, 2014 | Sale | $47.08 | 1,641 | 77,262 | 4,022 | Jan 17, 2014, 07:38 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 16, 2014 | Sale | $47.08 | 281 | 13,230 | 627 | Jan 17, 2014, 07:37 PM |
CROOKE STANLEY T | Chairman and CEO | Jan 16, 2014 | Sale | $47.08 | 3,246 | 152,825 | 6,941 | Jan 17, 2014, 07:37 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jan 16, 2014 | Sale | $47.08 | 577 | 27,166 | 3,350 | Jan 17, 2014, 07:36 PM |
CROOKE STANLEY T | Chairman, President and CEO | Jan 08, 2014 | Option Exercise | $14.47 | 1,500 | 21,705 | 1,674 | Jan 10, 2014, 07:24 PM |
CROOKE STANLEY T | Chairman, President and CEO | Jan 08, 2014 | Option Exercise | $14.47 | 11,000 | 159,170 | 12,661 | Jan 10, 2014, 07:24 PM |
CROOKE STANLEY T | Chairman, President and CEO | Jan 08, 2014 | Sale | $40.05 | 1,500 | 60,078 | 174 | Jan 10, 2014, 07:24 PM |
CROOKE STANLEY T | Chairman, President and CEO | Jan 08, 2014 | Sale | $40.05 | 11,000 | 440,572 | 1,661 | Jan 10, 2014, 07:24 PM |
Geary Richard S | SVP, Development | Jan 06, 2014 | Option Exercise | $11.27 | 7,400 | 83,398 | 11,010 | Jan 08, 2014, 07:40 PM |
Geary Richard S | SVP, Development | Jan 08, 2014 | Option Exercise | $10.29 | 7,600 | 78,204 | 11,210 | Jan 08, 2014, 07:40 PM |
Geary Richard S | SVP, Development | Jan 06, 2014 | Sale | $38.83 | 7,400 | 287,364 | 3,610 | Jan 08, 2014, 07:40 PM |
Geary Richard S | SVP, Development | Jan 08, 2014 | Sale | $42.02 | 7,600 | 319,352 | 3,610 | Jan 08, 2014, 07:40 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jan 01, 2014 | Option Exercise | $24.20 | 79 | 1,912 | 848 | Jan 03, 2014, 07:58 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jan 02, 2014 | Sale | $39.25 | 362 | 14,210 | 486 | Jan 03, 2014, 07:58 PM |
BENNETT C FRANK | SVP, Antisense Research | Jan 01, 2014 | Option Exercise | $24.20 | 164 | 3,969 | 3,030 | Jan 03, 2014, 07:50 PM |
CROOKE STANLEY T | Chairman, President and CEO | Jan 02, 2014 | Option Exercise | $14.47 | 2,500 | 36,175 | 2,674 | Jan 03, 2014, 07:46 PM |
CROOKE STANLEY T | Chairman, President and CEO | Jan 02, 2014 | Option Exercise | $14.47 | 29,000 | 419,630 | 26,661 | Jan 03, 2014, 07:46 PM |
CROOKE STANLEY T | Chairman, President and CEO | Jan 02, 2014 | Sale | $39.36 | 29,000 | 1,141,325 | 1,661 | Jan 03, 2014, 07:46 PM |
CROOKE STANLEY T | Chairman, President and CEO | Jan 02, 2014 | Sale | $39.25 | 2,500 | 98,132 | 174 | Jan 03, 2014, 07:46 PM |
Geary Richard S | SVP, Development | Jan 01, 2014 | Option Exercise | $24.20 | 164 | 3,969 | 3,610 | Jan 03, 2014, 07:46 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Jan 01, 2014 | Option Exercise | $24.20 | 395 | 9,559 | 2,418 | Jan 03, 2014, 07:45 PM |
PARSHALL B LYNNE | COO | Jan 01, 2014 | Option Exercise | $24.20 | 397 | 9,607 | 1,353 | Jan 03, 2014, 07:44 PM |
PARSHALL B LYNNE | COO | Dec 26, 2013 | Option Exercise | $11.27 | 37,811 | 426,130 | 38,767 | Dec 30, 2013, 06:29 PM |
PARSHALL B LYNNE | COO | Dec 26, 2013 | Sale | $40.91 | 37,811 | 1,546,772 | 956 | Dec 30, 2013, 06:29 PM |
PARSHALL B LYNNE | COO & Secretary | Dec 24, 2013 | Option Exercise | $11.27 | 20,000 | 225,400 | 20,956 | Dec 24, 2013, 03:21 PM |
PARSHALL B LYNNE | COO & Secretary | Dec 23, 2013 | Option Exercise | $14.36 | 50,000 | 717,833 | 49,185 | Dec 24, 2013, 03:21 PM |
PARSHALL B LYNNE | COO & Secretary | Dec 24, 2013 | Sale | $41.00 | 20,000 | 819,920 | 956 | Dec 24, 2013, 03:21 PM |
PARSHALL B LYNNE | COO & Secretary | Dec 23, 2013 | Sale | $41.68 | 50,000 | 2,084,050 | 956 | Dec 24, 2013, 03:21 PM |
WENDER JOSEPH H | Director | Dec 19, 2013 | Option Exercise | $16.32 | 15,000 | 244,800 | 60,866 | Dec 20, 2013, 09:27 PM |
WENDER JOSEPH H | Director | Dec 20, 2013 | Sale | $40.01 | 10,000 | 400,125 | 41,135 | Dec 20, 2013, 09:27 PM |
WENDER JOSEPH H | Director | Dec 19, 2013 | Sale | $39.13 | 9,731 | 380,813 | 51,135 | Dec 20, 2013, 09:27 PM |
BENNETT C FRANK | SVP, Antisense Research | Dec 05, 2013 | Option Exercise | $15.38 | 10,000 | 153,800 | 7,416 | Dec 06, 2013, 07:39 PM |
BENNETT C FRANK | SVP, Antisense Research | Dec 05, 2013 | Sale | $39.92 | 10,000 | 399,182 | 2,866 | Dec 06, 2013, 07:39 PM |
WENDER JOSEPH H | Director | Nov 26, 2013 | Sale | $36.63 | 10,000 | 366,336 | 45,866 | Nov 27, 2013, 04:41 PM |
KLEIN JOSEPH III | Director | Nov 25, 2013 | Sale | $36.86 | 6,000 | 221,156 | 2,313 | Nov 27, 2013, 04:40 PM |
CROOKE STANLEY T | Chairman and CEO | Sep 19, 2013 | Option Exercise | $11.12 | 50,000 | 556,000 | 31,661 | Sep 23, 2013, 07:39 PM |
CROOKE STANLEY T | Chairman and CEO | Sep 20, 2013 | Option Exercise | $11.12 | 8,740 | 97,189 | 10,401 | Sep 23, 2013, 07:39 PM |
CROOKE STANLEY T | Chairman and CEO | Sep 19, 2013 | Sale | $35.06 | 50,000 | 1,753,080 | 1,661 | Sep 23, 2013, 07:39 PM |
CROOKE STANLEY T | Chairman and CEO | Sep 20, 2013 | Sale | $35.90 | 8,740 | 313,749 | 1,661 | Sep 23, 2013, 07:39 PM |
PARSHALL B LYNNE | COO & Secretary | Sep 20, 2013 | Option Exercise | $14.70 | 40,000 | 587,900 | 30,956 | Sep 23, 2013, 07:38 PM |
PARSHALL B LYNNE | COO & Secretary | Sep 19, 2013 | Option Exercise | $16.02 | 50,000 | 801,100 | 30,956 | Sep 23, 2013, 07:38 PM |
PARSHALL B LYNNE | COO & Secretary | Sep 20, 2013 | Sale | $35.90 | 40,000 | 1,435,920 | 956 | Sep 23, 2013, 07:38 PM |
PARSHALL B LYNNE | COO & Secretary | Sep 19, 2013 | Sale | $35.06 | 50,000 | 1,753,080 | 956 | Sep 23, 2013, 07:38 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Sep 20, 2013 | Option Exercise | $11.27 | 18,281 | 206,027 | 19,050 | Sep 23, 2013, 07:37 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Sep 19, 2013 | Option Exercise | $14.75 | 50,000 | 737,400 | 23,269 | Sep 23, 2013, 07:37 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Sep 19, 2013 | Sale | $33.59 | 50,000 | 1,679,700 | 769 | Sep 23, 2013, 07:37 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Sep 20, 2013 | Sale | $35.89 | 18,281 | 656,105 | 769 | Sep 23, 2013, 07:37 PM |
BENNETT C FRANK | SVP, Antisense Research | Sep 19, 2013 | Option Exercise | $15.38 | 10,000 | 153,800 | 12,866 | Sep 23, 2013, 07:36 PM |
BENNETT C FRANK | SVP, Antisense Research | Sep 19, 2013 | Sale | $35.02 | 10,000 | 350,200 | 2,866 | Sep 23, 2013, 07:36 PM |
CROOKE STANLEY T | COO, President | Sep 09, 2013 | Option Exercise | $11.12 | 26,615 | 295,959 | 28,276 | Sep 11, 2013, 07:27 PM |
CROOKE STANLEY T | COO, President | Sep 10, 2013 | Sale | $31.65 | 30,000 | 949,440 | 745,391 | Sep 11, 2013, 07:27 PM |
CROOKE STANLEY T | COO, President | Sep 09, 2013 | Sale | $30.42 | 26,615 | 809,495 | 1,661 | Sep 11, 2013, 07:27 PM |
CROOKE STANLEY T | COO, President | Sep 11, 2013 | Sale | $31.18 | 20,000 | 623,620 | 725,391 | Sep 11, 2013, 07:27 PM |
BENNETT C FRANK | SVP, Antisense Research | Sep 09, 2013 | Option Exercise | $15.38 | 10,000 | 153,800 | 12,866 | Sep 11, 2013, 07:26 PM |
BENNETT C FRANK | SVP, Antisense Research | Sep 09, 2013 | Sale | $30.23 | 10,000 | 302,250 | 2,866 | Sep 11, 2013, 07:26 PM |
PARSHALL B LYNNE | COO | Sep 11, 2013 | Option Exercise | $15.38 | 1,520 | 23,378 | 4,461 | Sep 11, 2013, 07:26 PM |
PARSHALL B LYNNE | COO | Sep 10, 2013 | Option Exercise | $15.38 | 30,000 | 461,400 | 32,941 | Sep 11, 2013, 07:26 PM |
PARSHALL B LYNNE | COO | Sep 09, 2013 | Option Exercise | $15.38 | 30,000 | 461,400 | 32,941 | Sep 11, 2013, 07:26 PM |
PARSHALL B LYNNE | COO | Sep 10, 2013 | Sale | $31.65 | 30,000 | 949,440 | 2,941 | Sep 11, 2013, 07:26 PM |
PARSHALL B LYNNE | COO | Sep 09, 2013 | Sale | $30.42 | 30,000 | 912,450 | 2,941 | Sep 11, 2013, 07:26 PM |
PARSHALL B LYNNE | COO | Sep 11, 2013 | Sale | $31.18 | 3,505 | 109,289 | 2,941 | Sep 11, 2013, 07:26 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Sep 04, 2013 | Option Exercise | $11.29 | 2,500 | 28,236 | 3,340 | Sep 06, 2013, 07:03 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Sep 04, 2013 | Sale | $27.09 | 2,500 | 67,731 | 2,023 | Sep 06, 2013, 07:03 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Aug 26, 2013 | Sale | $25.58 | 2,909 | 74,403 | 769 | Aug 28, 2013, 07:19 PM |
KLEIN JOSEPH III | Director | Aug 09, 2013 | Option Exercise | $10.18 | 18,750 | 190,950 | 15,813 | Aug 13, 2013, 07:45 PM |
KLEIN JOSEPH III | Director | Aug 09, 2013 | Sale | $28.22 | 18,750 | 529,126 | 8,313 | Aug 13, 2013, 07:45 PM |
CROOKE STANLEY T | COO, President | Jul 23, 2013 | Option Exercise | $11.12 | 11,500 | 127,880 | 13,161 | Jul 25, 2013, 08:18 PM |
CROOKE STANLEY T | COO, President | Jul 23, 2013 | Sale | $30.00 | 11,500 | 345,000 | 1,661 | Jul 25, 2013, 08:18 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 22, 2013 | Option Exercise | $14.98 | 20,000 | 299,570 | 11,661 | Jul 22, 2013, 07:51 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 19, 2013 | Option Exercise | $15.38 | 22,200 | 341,436 | 11,661 | Jul 22, 2013, 07:51 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 18, 2013 | Option Exercise | $11.12 | 20,000 | 222,400 | 11,661 | Jul 22, 2013, 07:51 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 19, 2013 | Sale | $30.61 | 22,200 | 679,650 | 1,661 | Jul 22, 2013, 07:51 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 18, 2013 | Sale | $30.11 | 20,000 | 602,220 | 1,661 | Jul 22, 2013, 07:51 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 22, 2013 | Sale | $30.77 | 20,000 | 615,450 | 1,661 | Jul 22, 2013, 07:51 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 16, 2013 | Option Exercise | $11.12 | 18,000 | 200,160 | 7,661 | Jul 17, 2013, 07:41 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 15, 2013 | Option Exercise | $11.12 | 90,000 | 1,000,800 | 11,661 | Jul 17, 2013, 07:41 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 17, 2013 | Option Exercise | $13.33 | 39,900 | 531,762 | 8,430 | Jul 17, 2013, 07:41 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 16, 2013 | Sale | $33.31 | 18,000 | 599,526 | 1,661 | Jul 17, 2013, 07:41 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 15, 2013 | Sale | $33.81 | 90,000 | 3,042,540 | 1,661 | Jul 17, 2013, 07:41 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 17, 2013 | Sale | $31.50 | 39,900 | 1,256,876 | 174 | Jul 17, 2013, 07:41 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 11, 2013 | Option Exercise | $15.38 | 30,000 | 461,400 | 311,661 | Jul 12, 2013, 07:44 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 10, 2013 | Option Exercise | $15.38 | 30,000 | 461,400 | 31,661 | Jul 12, 2013, 07:44 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 12, 2013 | Option Exercise | $11.97 | 30,000 | 359,160 | 13,661 | Jul 12, 2013, 07:44 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 11, 2013 | Sale | $32.00 | 30,000 | 960,090 | 1,661 | Jul 12, 2013, 07:44 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 10, 2013 | Sale | $30.05 | 30,000 | 901,440 | 1,661 | Jul 12, 2013, 07:44 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 12, 2013 | Sale | $33.20 | 30,000 | 995,998 | 1,661 | Jul 12, 2013, 07:44 PM |
Geary Richard S | SVP, Development | Jul 11, 2013 | Option Exercise | $11.12 | 9,000 | 100,080 | 12,446 | Jul 12, 2013, 07:43 PM |
Geary Richard S | SVP, Development | Jul 11, 2013 | Sale | $31.90 | 9,000 | 287,100 | 3,446 | Jul 12, 2013, 07:43 PM |
Geary Richard S | SVP, Development | Jul 09, 2013 | Option Exercise | $10.29 | 10,358 | 106,584 | 13,804 | Jul 09, 2013, 08:35 PM |
Geary Richard S | SVP, Development | Jul 08, 2013 | Option Exercise | $11.04 | 30,000 | 331,181 | 21,379 | Jul 09, 2013, 08:35 PM |
Geary Richard S | SVP, Development | Jul 05, 2013 | Option Exercise | $15.13 | 24,180 | 365,831 | 20,406 | Jul 09, 2013, 08:35 PM |
Geary Richard S | SVP, Development | Jul 09, 2013 | Sale | $30.04 | 10,358 | 311,185 | 3,446 | Jul 09, 2013, 08:35 PM |
Geary Richard S | SVP, Development | Jul 08, 2013 | Sale | $30.08 | 30,000 | 902,380 | 3,446 | Jul 09, 2013, 08:35 PM |
Geary Richard S | SVP, Development | Jul 05, 2013 | Sale | $29.97 | 25,805 | 773,294 | 3,446 | Jul 09, 2013, 08:35 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 09, 2013 | Option Exercise | $15.38 | 30,000 | 461,400 | 31,661 | Jul 09, 2013, 07:38 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 08, 2013 | Option Exercise | $15.38 | 5,008 | 77,023 | 6,669 | Jul 09, 2013, 07:38 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 05, 2013 | Option Exercise | $15.38 | 24,180 | 371,888 | 25,841 | Jul 09, 2013, 07:38 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 08, 2013 | Sale | $23.40 | 54,992 | 1,286,756 | 26,653 | Jul 09, 2013, 07:38 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 05, 2013 | Sale | $30.01 | 24,180 | 725,763 | 1,661 | Jul 09, 2013, 07:38 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 09, 2013 | Sale | $30.04 | 30,000 | 901,290 | 1,661 | Jul 09, 2013, 07:38 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jul 01, 2013 | Option Exercise | $9.20 | 976 | 8,976 | 2,300 | Jul 05, 2013, 06:01 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jul 05, 2013 | Sale | $29.25 | 277 | 8,102 | 2,023 | Jul 05, 2013, 06:01 PM |
Geary Richard S | SVP, Development | Jul 01, 2013 | Option Exercise | $9.20 | 817 | 7,514 | 5,071 | Jul 03, 2013, 05:16 PM |
Geary Richard S | SVP, Development | Jul 03, 2013 | Option Exercise | $19.08 | 5,000 | 95,400 | 10,071 | Jul 03, 2013, 05:16 PM |
Geary Richard S | SVP, Development | Jul 03, 2013 | Sale | $29.02 | 5,000 | 145,100 | 5,071 | Jul 03, 2013, 05:16 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jul 01, 2013 | Option Exercise | $9.20 | 362 | 3,329 | 6,057 | Jul 03, 2013, 05:15 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jul 02, 2013 | Sale | $28.69 | 215 | 6,169 | 5,842 | Jul 03, 2013, 05:15 PM |
BENNETT C FRANK | SVP, Antisense Research | Jul 01, 2013 | Option Exercise | $9.20 | 756 | 6,953 | 2,866 | Jul 03, 2013, 05:13 PM |
CROOKE STANLEY T | Chairman and CEO | Jun 28, 2013 | Option Exercise | $9.21 | 10,683 | 98,430 | 6,132 | Jul 01, 2013, 07:33 PM |
CROOKE STANLEY T | Chairman and CEO | Jun 28, 2013 | Option Exercise | $6.81 | 10,000 | 68,100 | 11,661 | Jul 01, 2013, 07:33 PM |
CROOKE STANLEY T | Chairman and CEO | Jun 27, 2013 | Option Exercise | $6.81 | 20,000 | 136,200 | 11,661 | Jul 01, 2013, 07:33 PM |
CROOKE STANLEY T | Chairman and CEO | Jun 28, 2013 | Sale | $27.07 | 10,000 | 270,700 | 1,661 | Jul 01, 2013, 07:33 PM |
CROOKE STANLEY T | Chairman and CEO | Jun 27, 2013 | Sale | $27.85 | 20,000 | 557,000 | 1,661 | Jul 01, 2013, 07:33 PM |
CROOKE STANLEY T | Chairman and CEO | Jul 01, 2013 | Sale | $28.17 | 10,000 | 281,700 | 775,391 | Jul 01, 2013, 07:33 PM |
CROOKE STANLEY T | Chairman and CEO | Jun 28, 2013 | Sale | $27.31 | 10,683 | 291,753 | 174 | Jul 01, 2013, 07:33 PM |
CROOKE STANLEY T | Chairman and CEO | Jun 26, 2013 | Option Exercise | $6.81 | 20,000 | 136,200 | 21,661 | Jun 26, 2013, 07:46 PM |
CROOKE STANLEY T | Chairman and CEO | Jun 25, 2013 | Option Exercise | $6.81 | 30,000 | 204,300 | 21,226 | Jun 26, 2013, 07:46 PM |
CROOKE STANLEY T | Chairman and CEO | Jun 25, 2013 | Sale | $28.02 | 30,000 | 840,698 | 1,661 | Jun 26, 2013, 07:46 PM |
CROOKE STANLEY T | Chairman and CEO | Jun 24, 2013 | Sale | $25.19 | 30,000 | 755,624 | 809,121 | Jun 26, 2013, 07:46 PM |
CROOKE STANLEY T | Chairman and CEO | Jun 26, 2013 | Sale | $26.70 | 10,000 | 267,000 | 785,391 | Jun 26, 2013, 07:46 PM |
CROOKE STANLEY T | Chairman and CEO | Jun 26, 2013 | Sale | $27.10 | 20,000 | 542,020 | 1,661 | Jun 26, 2013, 07:46 PM |
Geary Richard S | SVP, Development | Jun 24, 2013 | Option Exercise | $15.50 | 30,000 | 465,100 | 17,984 | Jun 26, 2013, 07:45 PM |
Geary Richard S | SVP, Development | Jun 25, 2013 | Option Exercise | $14.21 | 17,049 | 242,304 | 14,689 | Jun 26, 2013, 07:45 PM |
Geary Richard S | SVP, Development | Jun 24, 2013 | Sale | $25.19 | 30,000 | 755,624 | 4,254 | Jun 26, 2013, 07:45 PM |
Geary Richard S | SVP, Development | Jun 25, 2013 | Sale | $27.99 | 17,049 | 477,283 | 4,254 | Jun 26, 2013, 07:45 PM |
WENDER JOSEPH H | Director | Jun 20, 2013 | Option Exercise | $5.17 | 10,000 | 51,700 | 61,000 | Jun 24, 2013, 08:33 PM |
WENDER JOSEPH H | Director | Jun 20, 2013 | Sale | $20.93 | 5,447 | 114,006 | 55,553 | Jun 24, 2013, 08:33 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jun 11, 2013 | Option Exercise | $15.75 | 9,375 | 147,656 | 15,070 | Jun 13, 2013, 07:58 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jun 11, 2013 | Sale | $23.76 | 9,375 | 222,750 | 5,695 | Jun 13, 2013, 07:58 PM |
MUTO FREDERICK T | Director | May 30, 2013 | Option Exercise | $5.17 | 10,000 | 51,700 | 10,000 | May 31, 2013, 07:15 PM |
MUTO FREDERICK T | Director | May 30, 2013 | Sale | $21.96 | 10,000 | 219,600 | 0 | May 31, 2013, 07:15 PM |
BENNETT C FRANK | SVP, Antisense Research | May 01, 2013 | Option Exercise | $7.69 | 29,945 | 230,410 | 25,910 | May 02, 2013, 07:48 PM |
BENNETT C FRANK | SVP, Antisense Research | Apr 30, 2013 | Option Exercise | $11.12 | 30,000 | 333,600 | 32,110 | May 02, 2013, 07:48 PM |
BENNETT C FRANK | SVP, Antisense Research | Apr 30, 2013 | Sale | $22.51 | 30,000 | 675,153 | 2,110 | May 02, 2013, 07:48 PM |
BENNETT C FRANK | SVP, Antisense Research | May 01, 2013 | Sale | $22.26 | 29,945 | 666,606 | 2,110 | May 02, 2013, 07:48 PM |
PARSHALL B LYNNE | COO, Secretary | Apr 24, 2013 | Option Exercise | $11.12 | 30,000 | 333,600 | 32,941 | Apr 26, 2013, 07:06 PM |
PARSHALL B LYNNE | COO, Secretary | Apr 25, 2013 | Option Exercise | $8.05 | 25,854 | 208,192 | 21,341 | Apr 26, 2013, 07:06 PM |
PARSHALL B LYNNE | COO, Secretary | Apr 25, 2013 | Sale | $22.50 | 25,854 | 581,586 | 2,941 | Apr 26, 2013, 07:06 PM |
PARSHALL B LYNNE | COO, Secretary | Apr 24, 2013 | Sale | $22.12 | 30,000 | 663,600 | 2,941 | Apr 26, 2013, 07:06 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Apr 24, 2013 | Option Exercise | $15.38 | 10,417 | 160,213 | 10,717 | Apr 26, 2013, 07:02 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Apr 24, 2013 | Sale | $22.38 | 10,417 | 233,132 | 300 | Apr 26, 2013, 07:02 PM |
CROOKE STANLEY T | Chairman, CEO and President | Apr 24, 2013 | Sale | $22.12 | 10,000 | 221,200 | 825,391 | Apr 26, 2013, 07:01 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Apr 19, 2013 | Option Exercise | $14.94 | 15,000 | 224,040 | 7,324 | Apr 23, 2013, 09:04 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Apr 23, 2013 | Option Exercise | $13.22 | 27,320 | 361,101 | 11,984 | Apr 23, 2013, 09:04 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Apr 19, 2013 | Sale | $20.36 | 15,000 | 305,436 | 1,324 | Apr 23, 2013, 09:04 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Apr 23, 2013 | Sale | $22.13 | 27,320 | 604,592 | 1,324 | Apr 23, 2013, 09:04 PM |
PARSHALL B LYNNE | COO, Secretary | Apr 22, 2013 | Option Exercise | $11.12 | 30,000 | 333,600 | 32,941 | Apr 23, 2013, 08:48 PM |
PARSHALL B LYNNE | COO, Secretary | Apr 19, 2013 | Option Exercise | $7.26 | 30,000 | 217,800 | 32,941 | Apr 23, 2013, 08:48 PM |
PARSHALL B LYNNE | COO, Secretary | Apr 23, 2013 | Option Exercise | $6.81 | 20,000 | 136,200 | 10,000 | Apr 23, 2013, 08:48 PM |
PARSHALL B LYNNE | COO, Secretary | Apr 23, 2013 | Option Exercise | $11.12 | 10,000 | 111,200 | 12,941 | Apr 23, 2013, 08:48 PM |
PARSHALL B LYNNE | COO, Secretary | Apr 19, 2013 | Sale | $20.01 | 30,000 | 600,180 | 2,941 | Apr 23, 2013, 08:48 PM |
PARSHALL B LYNNE | COO, Secretary | Apr 23, 2013 | Sale | $22.10 | 20,000 | 441,934 | 0 | Apr 23, 2013, 08:48 PM |
PARSHALL B LYNNE | COO, Secretary | Apr 23, 2013 | Sale | $22.10 | 10,000 | 220,967 | 2,941 | Apr 23, 2013, 08:48 PM |
PARSHALL B LYNNE | COO, Secretary | Apr 22, 2013 | Sale | $20.99 | 30,000 | 629,700 | 2,941 | Apr 23, 2013, 08:48 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Apr 19, 2013 | Option Exercise | $11.12 | 2,500 | 27,800 | 8,195 | Apr 23, 2013, 08:47 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Apr 22, 2013 | Option Exercise | $11.12 | 17,000 | 189,040 | 22,695 | Apr 23, 2013, 08:47 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Apr 22, 2013 | Sale | $21.26 | 17,000 | 361,420 | 5,695 | Apr 23, 2013, 08:47 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Apr 19, 2013 | Sale | $21.25 | 2,500 | 53,125 | 5,695 | Apr 23, 2013, 08:47 PM |
CROOKE STANLEY T | Chairman, CEO and President | Apr 22, 2013 | Option Exercise | $7.26 | 20,000 | 145,200 | 21,661 | Apr 23, 2013, 08:46 PM |
CROOKE STANLEY T | Chairman, CEO and President | Apr 19, 2013 | Option Exercise | $7.26 | 30,000 | 217,800 | 31,661 | Apr 23, 2013, 08:46 PM |
CROOKE STANLEY T | Chairman, CEO and President | Apr 23, 2013 | Sale | $22.10 | 30,000 | 662,901 | 835,391 | Apr 23, 2013, 08:46 PM |
CROOKE STANLEY T | Chairman, CEO and President | Apr 22, 2013 | Sale | $20.99 | 10,000 | 209,900 | 865,391 | Apr 23, 2013, 08:46 PM |
CROOKE STANLEY T | Chairman, CEO and President | Apr 22, 2013 | Sale | $20.99 | 20,000 | 419,800 | 1,661 | Apr 23, 2013, 08:46 PM |
CROOKE STANLEY T | Chairman, CEO and President | Apr 19, 2013 | Sale | $20.01 | 30,000 | 600,180 | 1,661 | Apr 23, 2013, 08:46 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Apr 22, 2013 | Option Exercise | $14.87 | 17,656 | 262,592 | 10,143 | Apr 23, 2013, 08:45 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Apr 22, 2013 | Sale | $21.46 | 17,656 | 378,814 | 300 | Apr 23, 2013, 08:45 PM |
Geary Richard S | SVP, Development | Apr 19, 2013 | Option Exercise | $11.12 | 2,042 | 22,707 | 6,296 | Apr 23, 2013, 08:44 PM |
Geary Richard S | SVP, Development | Apr 19, 2013 | Sale | $20.80 | 2,042 | 42,474 | 4,254 | Apr 23, 2013, 08:44 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Apr 12, 2013 | Option Exercise | $14.24 | 5,460 | 77,751 | 5,654 | Apr 15, 2013, 07:09 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Apr 12, 2013 | Sale | $19.61 | 5,460 | 107,096 | 1,324 | Apr 15, 2013, 07:09 PM |
Geary Richard S | Sr VP, Development | Apr 11, 2013 | Option Exercise | $11.12 | 7,000 | 77,840 | 11,254 | Apr 15, 2013, 07:07 PM |
Geary Richard S | Sr VP, Development | Apr 11, 2013 | Sale | $19.52 | 7,000 | 136,640 | 4,254 | Apr 15, 2013, 07:07 PM |
Geary Richard S | Sr VP, Development | Mar 21, 2013 | Option Exercise | $11.12 | 1,000 | 11,120 | 5,254 | Mar 22, 2013, 07:57 PM |
Geary Richard S | Sr VP, Development | Mar 21, 2013 | Sale | $19.50 | 1,000 | 19,500 | 4,254 | Mar 22, 2013, 07:57 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Mar 21, 2013 | Option Exercise | $14.18 | 9,000 | 127,620 | 10,324 | Mar 22, 2013, 07:56 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Mar 21, 2013 | Sale | $19.26 | 9,000 | 173,340 | 1,324 | Mar 22, 2013, 07:56 PM |
HOUGEN ELIZABETH L | SVP, Finance and CFO | Mar 20, 2013 | Option Exercise | $11.12 | 14,376 | 159,861 | 9,884 | Mar 21, 2013, 08:25 PM |
HOUGEN ELIZABETH L | SVP, Finance and CFO | Mar 20, 2013 | Sale | $18.13 | 14,376 | 260,637 | 300 | Mar 21, 2013, 08:25 PM |
KLEIN JOSEPH III | Director | Mar 20, 2013 | Option Exercise | $13.60 | 3,924 | 53,357 | 2,500 | Mar 21, 2013, 08:25 PM |
KLEIN JOSEPH III | Director | Mar 20, 2013 | Sale | $18.00 | 3,924 | 70,632 | 0 | Mar 21, 2013, 08:25 PM |
KLEIN JOSEPH III | Director | Mar 19, 2013 | Option Exercise | $5.93 | 7,453 | 44,196 | 3,826 | Mar 21, 2013, 08:24 PM |
KLEIN JOSEPH III | Director | Mar 20, 2013 | Option Exercise | $12.34 | 11,841 | 146,118 | 4,167 | Mar 21, 2013, 08:24 PM |
KLEIN JOSEPH III | Director | Mar 20, 2013 | Option Exercise | $12.09 | 19,756 | 238,864 | 4,266 | Mar 21, 2013, 08:24 PM |
KLEIN JOSEPH III | Director | Mar 19, 2013 | Option Exercise | $5.93 | 3,726 | 22,095 | 3,726 | Mar 21, 2013, 08:24 PM |
KLEIN JOSEPH III | Director | Mar 19, 2013 | Sale | $18.00 | 7,453 | 134,154 | 100 | Mar 21, 2013, 08:24 PM |
KLEIN JOSEPH III | Director | Mar 20, 2013 | Sale | $18.00 | 11,841 | 213,138 | 0 | Mar 21, 2013, 08:24 PM |
KLEIN JOSEPH III | Director | Mar 20, 2013 | Sale | $18.00 | 19,756 | 355,608 | 100 | Mar 21, 2013, 08:24 PM |
KLEIN JOSEPH III | Director | Mar 19, 2013 | Sale | $18.00 | 3,726 | 67,068 | 0 | Mar 21, 2013, 08:24 PM |
KLEIN JOSEPH III | Director | Mar 13, 2013 | Option Exercise | $5.20 | 6,933 | 36,046 | 6,667 | Mar 14, 2013, 09:00 PM |
KLEIN JOSEPH III | Director | Mar 13, 2013 | Option Exercise | $5.20 | 13,867 | 72,098 | 6,766 | Mar 14, 2013, 09:00 PM |
KLEIN JOSEPH III | Director | Mar 13, 2013 | Sale | $18.01 | 6,933 | 124,842 | 0 | Mar 14, 2013, 09:00 PM |
KLEIN JOSEPH III | Director | Mar 13, 2013 | Sale | $18.01 | 13,867 | 249,702 | 100 | Mar 14, 2013, 09:00 PM |
HOUGEN ELIZABETH L | SVP, Finance and CFO | Mar 05, 2013 | Option Exercise | $6.81 | 5,040 | 34,322 | 5,340 | Mar 07, 2013, 08:16 PM |
HOUGEN ELIZABETH L | SVP, Finance and CFO | Mar 05, 2013 | Sale | $16.86 | 5,040 | 84,960 | 300 | Mar 07, 2013, 08:16 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Mar 05, 2013 | Option Exercise | $6.81 | 18,240 | 124,214 | 23,935 | Mar 07, 2013, 08:16 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Mar 05, 2013 | Sale | $16.86 | 18,240 | 307,599 | 5,695 | Mar 07, 2013, 08:16 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Mar 04, 2013 | Option Exercise | $11.25 | 11,700 | 131,657 | 11,674 | Mar 04, 2013, 08:05 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Mar 04, 2013 | Sale | $15.82 | 11,700 | 185,059 | 1,324 | Mar 04, 2013, 08:05 PM |
BERTHELSEN SPENCER R | Director | Feb 21, 2013 | Option Exercise | $5.17 | 10,000 | 51,700 | 39,300 | Feb 22, 2013, 07:17 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Feb 19, 2013 | Option Exercise | $10.29 | 1,600 | 16,464 | 2,924 | Feb 20, 2013, 07:03 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Feb 15, 2013 | Option Exercise | $10.29 | 350 | 3,601 | 1,574 | Feb 20, 2013, 07:03 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Feb 15, 2013 | Sale | $14.81 | 350 | 5,185 | 1,324 | Feb 20, 2013, 07:03 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Feb 19, 2013 | Sale | $14.80 | 1,600 | 23,680 | 1,324 | Feb 20, 2013, 07:03 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Feb 13, 2013 | Option Exercise | $7.36 | 6,100 | 44,900 | 6,663 | Feb 14, 2013, 08:35 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Feb 13, 2013 | Sale | $14.17 | 6,239 | 88,407 | 1,463 | Feb 14, 2013, 08:35 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Jan 30, 2013 | Option Exercise | $10.29 | 2,000 | 20,580 | 3,463 | Jan 31, 2013, 07:57 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Jan 29, 2013 | Sale | $13.40 | 300 | 4,020 | 1,463 | Jan 31, 2013, 07:57 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Jan 30, 2013 | Sale | $14.82 | 2,000 | 29,640 | 1,463 | Jan 31, 2013, 07:57 PM |
BENNETT C FRANK | SVP, Antisense Research | Jan 16, 2013 | Sale | $14.00 | 309 | 4,326 | 2,110 | Jan 17, 2013, 08:40 PM |
Geary Richard S | SVP, Development | Jan 16, 2013 | Sale | $14.00 | 345 | 4,830 | 4,254 | Jan 17, 2013, 08:40 PM |
CROOKE STANLEY T | Chairman, CEO and President | Jan 16, 2013 | Sale | $14.00 | 143 | 2,002 | 174 | Jan 17, 2013, 08:39 PM |
CROOKE STANLEY T | Chairman, CEO and President | Jan 16, 2013 | Sale | $14.00 | 1,317 | 18,438 | 1,661 | Jan 17, 2013, 08:39 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jan 16, 2013 | Sale | $14.00 | 330 | 4,620 | 5,695 | Jan 17, 2013, 08:38 PM |
HOUGEN ELIZABETH L | SVP, Finance & CFO | Jan 16, 2013 | Sale | $14.00 | 242 | 3,388 | 300 | Jan 17, 2013, 08:37 PM |
PARSHALL B LYNNE | COO, Secretary | Jan 16, 2013 | Sale | $14.00 | 759 | 10,626 | 2,941 | Jan 17, 2013, 08:36 PM |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | Jan 17, 2013 | Sale | $14.16 | 242 | 3,427 | 1,763 | Jan 17, 2013, 08:35 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Jan 04, 2013 | Sale | $10.76 | 1,296 | 13,945 | 1,463 | Jan 04, 2013, 08:00 PM |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | Jan 01, 2013 | Option Exercise | $8.87 | 431 | 3,825 | 2,759 | Jan 03, 2013, 08:52 PM |
Monia Brett P | VP, Antisense Drug Discovery | Jan 01, 2013 | Option Exercise | $8.87 | 215 | 1,908 | 5,599 | Jan 03, 2013, 07:46 PM |
Monia Brett P | VP, Antisense Drug Discovery | Jan 03, 2013 | Sale | $10.84 | 311 | 3,371 | 5,288 | Jan 03, 2013, 07:46 PM |
BENNETT C FRANK | SVP, Antisense Research | Jan 01, 2013 | Option Exercise | $8.87 | 447 | 3,967 | 1,724 | Jan 03, 2013, 07:45 PM |
Geary Richard S | Sr VP, Development | Jan 01, 2013 | Option Exercise | $8.87 | 898 | 7,969 | 4,088 | Jan 03, 2013, 07:44 PM |
Geary Richard S | Sr VP, Development | Jan 03, 2013 | Sale | $10.84 | 265 | 2,873 | 3,823 | Jan 03, 2013, 07:44 PM |
Geary Richard S | Sr VP, Development | Dec 13, 2012 | Option Exercise | $5.25 | 6,000 | 31,500 | 9,190 | Dec 17, 2012, 08:03 PM |
Geary Richard S | Sr VP, Development | Dec 13, 2012 | Sale | $9.63 | 6,000 | 57,751 | 3,190 | Dec 17, 2012, 08:03 PM |
CROOKE STANLEY T | Chairman, CEO and President | Sep 20, 2012 | Option Exercise | $6.34 | 30,000 | 190,155 | 20,538 | Sep 21, 2012, 07:20 PM |
CROOKE STANLEY T | Chairman, CEO and President | Sep 19, 2012 | Option Exercise | $5.25 | 30,000 | 157,500 | 30,000 | Sep 21, 2012, 07:20 PM |
CROOKE STANLEY T | Chairman, CEO and President | Sep 21, 2012 | Option Exercise | $6.84 | 29,462 | 201,520 | 29,462 | Sep 21, 2012, 07:20 PM |
CROOKE STANLEY T | Chairman, CEO and President | Sep 20, 2012 | Sale | $15.01 | 30,000 | 450,240 | 0 | Sep 21, 2012, 07:20 PM |
CROOKE STANLEY T | Chairman, CEO and President | Sep 19, 2012 | Sale | $14.81 | 30,000 | 444,450 | 0 | Sep 21, 2012, 07:20 PM |
CROOKE STANLEY T | Chairman, CEO and President | Sep 21, 2012 | Sale | $14.06 | 29,462 | 414,236 | 0 | Sep 21, 2012, 07:20 PM |
CROOKE STANLEY T | Chairman, CEO and President | Sep 13, 2012 | Option Exercise | $5.25 | 27,074 | 142,139 | 27,074 | Sep 17, 2012, 06:36 PM |
CROOKE STANLEY T | Chairman, CEO and President | Sep 13, 2012 | Sale | $14.55 | 27,074 | 393,927 | 0 | Sep 17, 2012, 06:36 PM |
PARSHALL B LYNNE | COO, Secretary | Sep 07, 2012 | Option Exercise | $6.84 | 2,506 | 17,141 | 4,491 | Sep 11, 2012, 06:31 PM |
PARSHALL B LYNNE | COO, Secretary | Sep 07, 2012 | Option Exercise | $6.84 | 10,000 | 68,400 | 5,000 | Sep 11, 2012, 06:31 PM |
PARSHALL B LYNNE | COO, Secretary | Sep 07, 2012 | Sale | $15.12 | 10,000 | 151,200 | 0 | Sep 11, 2012, 06:31 PM |
PARSHALL B LYNNE | COO, Secretary | Sep 07, 2012 | Sale | $15.12 | 2,506 | 37,891 | 1,985 | Sep 11, 2012, 06:31 PM |
PARSHALL B LYNNE | COO, Secretary | Sep 04, 2012 | Option Exercise | $5.25 | 20,000 | 105,000 | 10,000 | Sep 06, 2012, 09:49 PM |
PARSHALL B LYNNE | COO, Secretary | Sep 06, 2012 | Option Exercise | $5.78 | 15,000 | 86,700 | 5,000 | Sep 06, 2012, 09:49 PM |
PARSHALL B LYNNE | COO, Secretary | Sep 04, 2012 | Option Exercise | $5.25 | 10,000 | 52,500 | 11,985 | Sep 06, 2012, 09:49 PM |
PARSHALL B LYNNE | COO, Secretary | Sep 06, 2012 | Option Exercise | $5.65 | 10,000 | 56,465 | 6,985 | Sep 06, 2012, 09:49 PM |
PARSHALL B LYNNE | COO, Secretary | Sep 05, 2012 | Option Exercise | $5.25 | 2,000 | 10,500 | 3,985 | Sep 06, 2012, 09:49 PM |
PARSHALL B LYNNE | COO, Secretary | Sep 06, 2012 | Option Exercise | $6.84 | 5,000 | 34,200 | 5,000 | Sep 06, 2012, 09:49 PM |
PARSHALL B LYNNE | COO, Secretary | Sep 06, 2012 | Sale | $15.02 | 20,000 | 300,370 | 0 | Sep 06, 2012, 09:49 PM |
PARSHALL B LYNNE | COO, Secretary | Sep 04, 2012 | Sale | $15.00 | 10,000 | 150,010 | 1,985 | Sep 06, 2012, 09:49 PM |
PARSHALL B LYNNE | COO, Secretary | Sep 06, 2012 | Sale | $15.02 | 10,000 | 150,185 | 1,985 | Sep 06, 2012, 09:49 PM |
PARSHALL B LYNNE | COO, Secretary | Sep 05, 2012 | Sale | $15.00 | 2,000 | 30,000 | 1,985 | Sep 06, 2012, 09:49 PM |
PARSHALL B LYNNE | COO, Secretary | Sep 04, 2012 | Sale | $15.00 | 20,000 | 300,020 | 0 | Sep 06, 2012, 09:49 PM |
REED JOHN C | Director | Sep 04, 2012 | Option Exercise | $5.17 | 5,100 | 26,367 | 5,100 | Sep 06, 2012, 09:39 PM |
REED JOHN C | Director | Sep 06, 2012 | Option Exercise | $5.17 | 4,900 | 25,333 | 4,900 | Sep 06, 2012, 09:39 PM |
REED JOHN C | Director | Sep 06, 2012 | Sale | $15.18 | 4,900 | 74,358 | 0 | Sep 06, 2012, 09:39 PM |
REED JOHN C | Director | Sep 04, 2012 | Sale | $15.17 | 5,100 | 77,367 | 0 | Sep 06, 2012, 09:39 PM |
Monia Brett P | VP, Antisense Drug Discovery | Sep 06, 2012 | Option Exercise | $5.25 | 12,031 | 63,163 | 17,415 | Sep 06, 2012, 09:39 PM |
Monia Brett P | VP, Antisense Drug Discovery | Sep 06, 2012 | Sale | $15.25 | 12,031 | 183,473 | 5,384 | Sep 06, 2012, 09:39 PM |
CROOKE STANLEY T | Chairman, CEO and President | Sep 06, 2012 | Option Exercise | $5.25 | 17,388 | 91,287 | 8,694 | Sep 06, 2012, 09:38 PM |
CROOKE STANLEY T | Chairman, CEO and President | Sep 05, 2012 | Option Exercise | $5.25 | 15,000 | 78,750 | 15,000 | Sep 06, 2012, 09:38 PM |
CROOKE STANLEY T | Chairman, CEO and President | Sep 04, 2012 | Option Exercise | $5.25 | 30,000 | 157,500 | 30,000 | Sep 06, 2012, 09:38 PM |
CROOKE STANLEY T | Chairman, CEO and President | Sep 06, 2012 | Option Exercise | $5.49 | 12,612 | 69,274 | 6,000 | Sep 06, 2012, 09:38 PM |
CROOKE STANLEY T | Chairman, CEO and President | Sep 05, 2012 | Sale | $14.82 | 15,000 | 222,345 | 0 | Sep 06, 2012, 09:38 PM |
CROOKE STANLEY T | Chairman, CEO and President | Sep 04, 2012 | Sale | $14.11 | 30,000 | 423,255 | 0 | Sep 06, 2012, 09:38 PM |
CROOKE STANLEY T | Chairman, CEO and President | Sep 06, 2012 | Sale | $15.02 | 12,612 | 189,413 | 0 | Sep 06, 2012, 09:38 PM |
CROOKE STANLEY T | Chairman, CEO and President | Sep 06, 2012 | Sale | $15.02 | 17,388 | 261,142 | 0 | Sep 06, 2012, 09:38 PM |
BENNETT C FRANK | SVP, Antisense Research | Jul 09, 2012 | Option Exercise | $6.83 | 10,500 | 71,670 | 6,777 | Jul 11, 2012, 04:46 PM |
BENNETT C FRANK | SVP, Antisense Research | Jul 09, 2012 | Sale | $13.51 | 10,500 | 141,855 | 1,277 | Jul 11, 2012, 04:46 PM |
Geary Richard S | Sr VP, Development | Jul 09, 2012 | Option Exercise | $5.25 | 5,686 | 29,852 | 5,876 | Jul 11, 2012, 04:45 PM |
Geary Richard S | Sr VP, Development | Jul 09, 2012 | Sale | $13.47 | 5,686 | 76,610 | 3,190 | Jul 11, 2012, 04:45 PM |
REED JOHN C | Director | Jul 09, 2012 | Option Exercise | $3.95 | 10,000 | 39,500 | 10,000 | Jul 11, 2012, 04:43 PM |
REED JOHN C | Director | Jul 09, 2012 | Sale | $13.99 | 10,000 | 139,900 | 0 | Jul 11, 2012, 04:43 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jul 01, 2012 | Option Exercise | $6.13 | 311 | 1,906 | 5,971 | Jul 03, 2012, 07:06 PM |
Monia Brett P | SVP, Antisense Drug Discovery | Jul 03, 2012 | Sale | $12.92 | 587 | 7,584 | 5,384 | Jul 03, 2012, 07:06 PM |
BENNETT C FRANK | SVP, Antisense Research | Jul 01, 2012 | Option Exercise | $6.13 | 648 | 3,971 | 1,277 | Jul 03, 2012, 07:06 PM |
BENNETT C FRANK | SVP, Antisense Research | Jul 03, 2012 | Option Exercise | $6.84 | 6,000 | 41,040 | 7,277 | Jul 03, 2012, 07:06 PM |
BENNETT C FRANK | SVP, Antisense Research | Jul 03, 2012 | Sale | $12.91 | 6,000 | 77,460 | 1,277 | Jul 03, 2012, 07:06 PM |
Geary Richard S | Sr VP, Development | Jul 01, 2012 | Option Exercise | $6.13 | 1,300 | 7,967 | 5,624 | Jul 03, 2012, 07:05 PM |
Geary Richard S | Sr VP, Development | Jul 03, 2012 | Sale | $12.91 | 2,434 | 31,423 | 3,190 | Jul 03, 2012, 07:05 PM |
BERTHELSEN SPENCER R | Director | Jun 25, 2012 | Option Exercise | $8.15 | 10,000 | 81,500 | 32,800 | Jun 25, 2012, 08:56 PM |
BERTHELSEN SPENCER R | Director | Jun 25, 2012 | Sale | $11.57 | 10,000 | 115,669 | 29,300 | Jun 25, 2012, 08:56 PM |
REED JOHN C | Director | Jun 22, 2012 | Option Exercise | $8.15 | 10,000 | 81,500 | 10,000 | Jun 22, 2012, 07:46 PM |
REED JOHN C | Director | Jun 22, 2012 | Sale | $11.06 | 10,000 | 110,600 | 0 | Jun 22, 2012, 07:46 PM |
Geary Richard S | Sr VP, Development | Jun 14, 2012 | Sale | $10.86 | 1,579 | 17,148 | 4,324 | Jun 14, 2012, 08:16 PM |
WENDER JOSEPH H | Director | Jun 12, 2012 | Option Exercise | $8.15 | 10,000 | 81,500 | 51,000 | Jun 13, 2012, 08:02 PM |
BERTHELSEN SPENCER R | Director | May 21, 2012 | Option Exercise | $9.40 | 2,731 | 25,671 | 32,031 | May 22, 2012, 07:51 PM |
BERTHELSEN SPENCER R | Director | May 22, 2012 | Option Exercise | $9.40 | 17,269 | 162,329 | 46,569 | May 22, 2012, 07:51 PM |
BERTHELSEN SPENCER R | Director | May 21, 2012 | Sale | $9.42 | 2,731 | 25,726 | 29,300 | May 22, 2012, 07:51 PM |
BERTHELSEN SPENCER R | Director | May 22, 2012 | Sale | $9.56 | 17,269 | 165,092 | 29,300 | May 22, 2012, 07:51 PM |
BENNETT C FRANK | Senior Vice President | Jan 01, 2012 | Option Exercise | $6.13 | 324 | 1,986 | 629 | Mar 07, 2012, 03:04 PM |
Geary Richard S | Senior Vice President | Jan 01, 2012 | Option Exercise | $6.13 | 1,625 | 9,959 | 5,903 | Jan 03, 2012, 06:34 PM |
BENNETT C FRANK | Senior Vice President | Dec 01, 2011 | Option Exercise | $6.13 | 324 | 1,986 | 629 | Jan 03, 2012, 06:27 PM |
Monia Brett P | Senior Vice President | Jan 01, 2012 | Option Exercise | $6.13 | 587 | 3,597 | 5,660 | Jan 03, 2012, 05:49 PM |
Geary Richard S | Senior Vice President | Dec 21, 2011 | Option Exercise | $5.80 | 1,144 | 6,635 | 5,422 | Dec 22, 2011, 05:21 PM |
Geary Richard S | Senior Vice President | Dec 21, 2011 | Sale | $6.92 | 1,144 | 7,916 | 4,278 | Dec 22, 2011, 05:21 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 21, 2011 | Option Exercise | $5.80 | 1,080 | 6,264 | 1,080 | Dec 22, 2011, 05:21 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 21, 2011 | Option Exercise | $5.80 | 16,720 | 96,976 | 16,720 | Dec 22, 2011, 05:21 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 21, 2011 | Sale | $6.92 | 1,080 | 7,474 | 0 | Dec 22, 2011, 05:21 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 21, 2011 | Sale | $6.92 | 16,720 | 115,702 | 0 | Dec 22, 2011, 05:21 PM |
PARSHALL B LYNNE | Director, COO | Dec 21, 2011 | Option Exercise | $5.80 | 4,400 | 25,520 | 2,200 | Dec 22, 2011, 05:20 PM |
PARSHALL B LYNNE | Director, COO | Dec 21, 2011 | Option Exercise | $5.80 | 2,363 | 13,705 | 4,348 | Dec 22, 2011, 05:20 PM |
PARSHALL B LYNNE | Director, COO | Dec 21, 2011 | Sale | $6.92 | 2,363 | 16,352 | 1,985 | Dec 22, 2011, 05:20 PM |
PARSHALL B LYNNE | Director, COO | Dec 21, 2011 | Sale | $6.92 | 4,400 | 30,448 | 0 | Dec 22, 2011, 05:20 PM |
BENNETT C FRANK | Senior Vice President | Dec 21, 2011 | Option Exercise | $5.80 | 1,555 | 9,019 | 1,860 | Dec 22, 2011, 05:20 PM |
BENNETT C FRANK | Senior Vice President | Dec 21, 2011 | Sale | $6.92 | 1,555 | 10,761 | 305 | Dec 22, 2011, 05:20 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 16, 2011 | Option Exercise | $5.80 | 15,000 | 87,000 | 15,000 | Dec 20, 2011, 09:09 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 19, 2011 | Option Exercise | $5.80 | 1,100 | 6,380 | 982 | Dec 20, 2011, 09:09 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 19, 2011 | Option Exercise | $5.80 | 17,000 | 98,600 | 15,178 | Dec 20, 2011, 09:09 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 20, 2011 | Option Exercise | $5.80 | 1,700 | 9,860 | 1,400 | Dec 20, 2011, 09:09 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 16, 2011 | Option Exercise | $5.80 | 1,500 | 8,700 | 1,500 | Dec 20, 2011, 09:09 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 20, 2011 | Option Exercise | $5.80 | 27,000 | 156,600 | 22,000 | Dec 20, 2011, 09:09 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 19, 2011 | Sale | $6.83 | 1,100 | 7,511 | 0 | Dec 20, 2011, 09:09 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 19, 2011 | Sale | $6.83 | 17,000 | 116,086 | 0 | Dec 20, 2011, 09:09 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 20, 2011 | Sale | $6.84 | 1,700 | 11,624 | 0 | Dec 20, 2011, 09:09 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 16, 2011 | Sale | $6.79 | 1,500 | 10,185 | 0 | Dec 20, 2011, 09:09 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 20, 2011 | Sale | $6.84 | 27,000 | 184,640 | 0 | Dec 20, 2011, 09:09 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 16, 2011 | Sale | $6.79 | 15,000 | 101,850 | 0 | Dec 20, 2011, 09:09 PM |
BENNETT C FRANK | Senior Vice President | Dec 16, 2011 | Option Exercise | $5.80 | 1,500 | 8,700 | 1,805 | Dec 20, 2011, 09:08 PM |
BENNETT C FRANK | Senior Vice President | Dec 20, 2011 | Option Exercise | $5.80 | 2,500 | 14,500 | 2,305 | Dec 20, 2011, 09:08 PM |
BENNETT C FRANK | Senior Vice President | Dec 19, 2011 | Option Exercise | $5.80 | 1,500 | 8,700 | 1,645 | Dec 20, 2011, 09:08 PM |
BENNETT C FRANK | Senior Vice President | Dec 20, 2011 | Sale | $6.84 | 2,500 | 17,100 | 305 | Dec 20, 2011, 09:08 PM |
BENNETT C FRANK | Senior Vice President | Dec 19, 2011 | Sale | $6.83 | 1,500 | 10,243 | 305 | Dec 20, 2011, 09:08 PM |
BENNETT C FRANK | Senior Vice President | Dec 16, 2011 | Sale | $6.79 | 1,500 | 10,185 | 305 | Dec 20, 2011, 09:08 PM |
Geary Richard S | Senior Vice President | Dec 20, 2011 | Option Exercise | $5.80 | 1,800 | 10,440 | 5,778 | Dec 20, 2011, 09:06 PM |
Geary Richard S | Senior Vice President | Dec 19, 2011 | Option Exercise | $5.80 | 1,100 | 6,380 | 5,260 | Dec 20, 2011, 09:06 PM |
Geary Richard S | Senior Vice President | Dec 16, 2011 | Option Exercise | $5.80 | 1,000 | 5,800 | 5,278 | Dec 20, 2011, 09:06 PM |
Geary Richard S | Senior Vice President | Dec 20, 2011 | Sale | $6.84 | 1,800 | 12,306 | 4,278 | Dec 20, 2011, 09:06 PM |
Geary Richard S | Senior Vice President | Dec 19, 2011 | Sale | $6.83 | 1,100 | 7,511 | 4,278 | Dec 20, 2011, 09:06 PM |
Geary Richard S | Senior Vice President | Dec 16, 2011 | Sale | $6.79 | 1,000 | 6,790 | 4,278 | Dec 20, 2011, 09:06 PM |
PARSHALL B LYNNE | Director, COO | Dec 16, 2011 | Option Exercise | $5.80 | 2,000 | 11,600 | 3,985 | Dec 20, 2011, 09:05 PM |
PARSHALL B LYNNE | Director, COO | Dec 19, 2011 | Option Exercise | $5.80 | 2,300 | 13,340 | 4,039 | Dec 20, 2011, 09:05 PM |
PARSHALL B LYNNE | Director, COO | Dec 16, 2011 | Option Exercise | $5.80 | 2,000 | 11,600 | 2,000 | Dec 20, 2011, 09:05 PM |
PARSHALL B LYNNE | Director, COO | Dec 20, 2011 | Option Exercise | $5.80 | 7,000 | 40,600 | 2,800 | Dec 20, 2011, 09:05 PM |
PARSHALL B LYNNE | Director, COO | Dec 19, 2011 | Option Exercise | $184.50 | 6,600 | 1,217,687 | 2,054 | Dec 20, 2011, 09:05 PM |
PARSHALL B LYNNE | Director, COO | Dec 20, 2011 | Option Exercise | $5.80 | 3,600 | 20,880 | 4,885 | Dec 20, 2011, 09:05 PM |
PARSHALL B LYNNE | Director, COO | Dec 19, 2011 | Sale | $6.83 | 2,300 | 15,706 | 1,985 | Dec 20, 2011, 09:05 PM |
PARSHALL B LYNNE | Director, COO | Dec 20, 2011 | Sale | $6.83 | 6,300 | 43,036 | 0 | Dec 20, 2011, 09:05 PM |
PARSHALL B LYNNE | Director, COO | Dec 20, 2011 | Sale | $6.92 | 700 | 4,844 | 0 | Dec 20, 2011, 09:05 PM |
PARSHALL B LYNNE | Director, COO | Dec 16, 2011 | Sale | $6.79 | 4,000 | 27,160 | 0 | Dec 20, 2011, 09:05 PM |
PARSHALL B LYNNE | Director, COO | Dec 20, 2011 | Sale | $6.84 | 3,600 | 24,622 | 1,985 | Dec 20, 2011, 09:05 PM |
PARSHALL B LYNNE | Director, COO | Dec 16, 2011 | Sale | $6.79 | 2,000 | 13,580 | 1,985 | Dec 20, 2011, 09:05 PM |
PARSHALL B LYNNE | Director, COO | Dec 19, 2011 | Sale | $6.83 | 4,600 | 31,411 | 0 | Dec 20, 2011, 09:05 PM |
BENNETT C FRANK | Senior Vice President | Aug 04, 2011 | Option Exercise | $5.25 | 10,000 | 52,500 | 10,305 | Aug 05, 2011, 05:40 PM |
BENNETT C FRANK | Senior Vice President | Aug 04, 2011 | Sale | $7.62 | 10,000 | 76,206 | 305 | Aug 05, 2011, 05:40 PM |
BENNETT C FRANK | Senior Vice President | Jul 28, 2011 | Sale | $8.60 | 1,000 | 8,600 | 305 | Jul 29, 2011, 06:11 PM |
BENNETT C FRANK | Senior Vice President | Jul 01, 2011 | Option Exercise | $7.91 | 251 | 1,984 | 1,305 | Jul 01, 2011, 06:27 PM |
Geary Richard S | Senior Vice President | Jul 01, 2011 | Option Exercise | $7.91 | 265 | 2,095 | 4,278 | Jul 01, 2011, 06:26 PM |
BENNETT C FRANK | Senior Vice President | Jan 01, 2011 | Option Exercise | $7.79 | 493 | 3,843 | 1,054 | Jan 03, 2011, 05:44 PM |
Geary Richard S | Senior Vice President | Jan 01, 2011 | Option Exercise | $7.79 | 2,434 | 18,972 | 4,013 | Jan 03, 2011, 05:05 PM |
Geary Richard S | Senior Vice President | Dec 29, 2010 | Option Exercise | $9.63 | 1,980 | 19,058 | 3,559 | Dec 29, 2010, 08:15 PM |
Geary Richard S | Senior Vice President | Dec 27, 2010 | Option Exercise | $9.63 | 3,300 | 31,763 | 4,879 | Dec 29, 2010, 08:15 PM |
Geary Richard S | Senior Vice President | Dec 29, 2010 | Sale | $10.31 | 1,980 | 20,424 | 1,579 | Dec 29, 2010, 08:15 PM |
Geary Richard S | Senior Vice President | Dec 27, 2010 | Sale | $10.42 | 3,300 | 34,386 | 1,579 | Dec 29, 2010, 08:15 PM |
PARSHALL B LYNNE | Director, COO | Dec 29, 2010 | Option Exercise | $9.63 | 6,400 | 61,600 | 8,385 | Dec 29, 2010, 08:14 PM |
PARSHALL B LYNNE | Director, COO | Dec 27, 2010 | Option Exercise | $9.63 | 10,800 | 103,950 | 12,785 | Dec 29, 2010, 08:14 PM |
PARSHALL B LYNNE | Director, COO | Dec 27, 2010 | Sale | $10.42 | 10,800 | 112,536 | 1,985 | Dec 29, 2010, 08:14 PM |
PARSHALL B LYNNE | Director, COO | Dec 29, 2010 | Sale | $10.31 | 6,400 | 66,016 | 1,985 | Dec 29, 2010, 08:14 PM |
BENNETT C FRANK | Senior Vice President | Dec 29, 2010 | Option Exercise | $9.63 | 4,600 | 44,275 | 5,161 | Dec 29, 2010, 08:09 PM |
BENNETT C FRANK | Senior Vice President | Dec 27, 2010 | Option Exercise | $9.63 | 7,700 | 74,113 | 8,261 | Dec 29, 2010, 08:09 PM |
BENNETT C FRANK | Senior Vice President | Dec 29, 2010 | Sale | $10.31 | 4,600 | 47,449 | 561 | Dec 29, 2010, 08:09 PM |
BENNETT C FRANK | Senior Vice President | Dec 27, 2010 | Sale | $10.42 | 7,700 | 80,234 | 561 | Dec 29, 2010, 08:09 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 29, 2010 | Option Exercise | $9.63 | 2,000 | 19,250 | 2,000 | Dec 29, 2010, 07:22 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 29, 2010 | Option Exercise | $9.63 | 10,000 | 96,250 | 10,000 | Dec 29, 2010, 07:22 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 27, 2010 | Option Exercise | $9.63 | 20,000 | 192,500 | 20,000 | Dec 29, 2010, 07:22 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 29, 2010 | Sale | $10.31 | 2,000 | 20,630 | 0 | Dec 29, 2010, 07:22 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 29, 2010 | Sale | $10.31 | 10,000 | 103,150 | 0 | Dec 29, 2010, 07:22 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 27, 2010 | Sale | $10.42 | 20,000 | 208,400 | 0 | Dec 29, 2010, 07:22 PM |
Geary Richard S | Senior Vice President | Dec 23, 2010 | Option Exercise | $9.63 | 200 | 1,925 | 1,779 | Dec 28, 2010, 07:40 PM |
Geary Richard S | Senior Vice President | Dec 23, 2010 | Sale | $10.52 | 200 | 2,105 | 1,579 | Dec 28, 2010, 07:40 PM |
PARSHALL B LYNNE | COO | Dec 23, 2010 | Option Exercise | $9.63 | 800 | 7,700 | 2,785 | Dec 27, 2010, 04:10 PM |
PARSHALL B LYNNE | COO | Dec 23, 2010 | Option Exercise | $9.63 | 1,300 | 12,513 | 650 | Dec 27, 2010, 04:10 PM |
PARSHALL B LYNNE | COO | Dec 22, 2010 | Option Exercise | $9.92 | 13,050 | 129,500 | 4,350 | Dec 27, 2010, 04:10 PM |
PARSHALL B LYNNE | COO | Dec 23, 2010 | Sale | $10.52 | 800 | 8,420 | 1,985 | Dec 27, 2010, 04:10 PM |
PARSHALL B LYNNE | COO | Dec 23, 2010 | Sale | $10.52 | 1,300 | 13,682 | 0 | Dec 27, 2010, 04:10 PM |
PARSHALL B LYNNE | COO | Dec 22, 2010 | Sale | $10.52 | 4,350 | 45,762 | 0 | Dec 27, 2010, 04:10 PM |
Geary Richard S | Senior Vice President | Dec 22, 2010 | Option Exercise | $9.63 | 2,600 | 25,025 | 4,179 | Dec 27, 2010, 04:09 PM |
Geary Richard S | Senior Vice President | Dec 23, 2010 | Option Exercise | $9.63 | 400 | 3,850 | 1,979 | Dec 27, 2010, 04:09 PM |
Geary Richard S | Senior Vice President | Dec 22, 2010 | Sale | $10.52 | 2,600 | 27,352 | 1,579 | Dec 27, 2010, 04:09 PM |
Geary Richard S | Senior Vice President | Dec 23, 2010 | Sale | $10.52 | 400 | 4,210 | 1,579 | Dec 27, 2010, 04:09 PM |
BENNETT C FRANK | Senior Vice President | Dec 23, 2010 | Option Exercise | $9.63 | 1,500 | 14,438 | 2,061 | Dec 27, 2010, 04:09 PM |
BENNETT C FRANK | Senior Vice President | Dec 22, 2010 | Option Exercise | $9.63 | 6,200 | 59,675 | 6,761 | Dec 27, 2010, 04:09 PM |
BENNETT C FRANK | Senior Vice President | Dec 23, 2010 | Sale | $10.52 | 1,500 | 15,787 | 561 | Dec 27, 2010, 04:09 PM |
BENNETT C FRANK | Senior Vice President | Dec 22, 2010 | Sale | $10.52 | 6,200 | 65,224 | 561 | Dec 27, 2010, 04:09 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 23, 2010 | Option Exercise | $9.63 | 4,000 | 38,500 | 4,000 | Dec 27, 2010, 04:09 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 22, 2010 | Option Exercise | $9.63 | 16,000 | 154,000 | 16,000 | Dec 27, 2010, 04:09 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 23, 2010 | Sale | $10.52 | 4,000 | 42,100 | 0 | Dec 27, 2010, 04:09 PM |
CROOKE STANLEY T | Chairman, President, CEO | Dec 22, 2010 | Sale | $10.52 | 16,000 | 168,320 | 0 | Dec 27, 2010, 04:09 PM |
BENNETT C FRANK | Senior Vice President | Jul 23, 2010 | Sale | $9.60 | 1,100 | 10,560 | 561 | Jul 26, 2010, 04:35 PM |
Owner | Relationship | Date | Value($) |
Swayze Eric | Officer Level 14 | 02/29/2024 | 20,827 |
Monia Brett P | CEO Level 15 | 02/29/2024 | 18,521 |
Geary Richard S | Officer Level 14 | 02/29/2024 | 20,793 |
Birchler Brian | Vice President Level 14 | 02/29/2024 | 20,793 |
BENNETT C FRANK | Officer Level 14 | 02/29/2024 | 13,185 |
Monia Brett P | Chief Executive Officer | 02/16/2024 | 17,219 |
Swayze Eric | EVP Research | 02/02/2024 | 94,513 |
Swayze Eric | EVP Research | 01/31/2024 | 560,196 |
Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 02/02/2024 | 102,701 |
O'NEIL PATRICK R. | EVP CLO & General Counsel | 02/02/2024 | 97,410 |
Monia Brett P | Chief Executive Officer | 02/02/2024 | 1,160,303 |
HOUGEN ELIZABETH L | EVP, Finance & CFO | 02/02/2024 | 105,272 |
Geary Richard S | EVP, Chief Development Officer | 02/02/2024 | 98,135 |
Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str & Oper Ofc | 02/02/2024 | 105,404 |
BENNETT C FRANK | EVP, Chief Scientific Officer | 02/02/2024 | 91,752 |
Monia Brett P | Chief Executive Officer | 01/25/2024 | 118,249 |
O'NEIL PATRICK R. | EVP CLO & General Counsel | 01/25/2024 | 333,788 |
Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str & Oper Ofc | 01/17/2024 | 280,520 |
O'NEIL PATRICK R. | EVP CLO & General Counsel | 01/17/2024 | 390,429 |
Birchler Brian | EVP, Corp and Development Ops | 01/17/2024 | 226,725 |
Swayze Eric | EVP Research | 01/17/2024 | 317,425 |
Swayze Eric | EVP Research | 01/17/2024 | 454 |
Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 01/17/2024 | 276,386 |
Monia Brett P | Chief Executive Officer | 01/17/2024 | 1,616,319 |
HOUGEN ELIZABETH L | EVP, Finance & CFO | 01/17/2024 | 437,771 |
Geary Richard S | EVP, Chief Development Officer | 01/17/2024 | 369,960 |
BENNETT C FRANK | EVP, Chief Scientific Officer | 01/17/2024 | 340,063 |
Baroldi Joseph | EVP, Chief Business Officer | 01/17/2024 | 28,435 |
Baroldi Joseph | EVP, Chief Business Officer | 01/17/2024 | 73,609 |
Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 01/12/2024 | 260,800 |
Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 01/12/2024 | 427,999 |
Swayze Eric | EVP Research | 12/28/2023 | 1,282,914 |
Swayze Eric | EVP Research | 12/28/2023 | 1,360,081 |
HOUGEN ELIZABETH L | EVP, Finance & CFO | 12/28/2023 | 2,211,799 |
HOUGEN ELIZABETH L | EVP, Finance & CFO | 12/28/2023 | 2,140,952 |
Birchler Brian | EVP, Corp and Development Ops | 12/28/2023 | 556,965 |
Birchler Brian | EVP, Corp and Development Ops | 12/28/2023 | 544,410 |
O'NEIL PATRICK R. | EVP CLO & General Counsel | 12/26/2023 | 985,856 |
O'NEIL PATRICK R. | EVP CLO & General Counsel | 12/26/2023 | 1,071,717 |
PARSHALL B LYNNE | Director | 12/28/2023 | 2,013,134 |
PARSHALL B LYNNE | Director | 12/27/2023 | 2,367,000 |
PARSHALL B LYNNE | Director | 12/26/2023 | 1,188,849 |
PARSHALL B LYNNE | Director | 12/27/2023 | 2,511,515 |
PARSHALL B LYNNE | Director | 12/26/2023 | 1,292,390 |
PARSHALL B LYNNE | Director | 12/28/2023 | 2,134,223 |
Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 12/26/2023 | 1,183,500 |
Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 12/26/2023 | 1,286,575 |
BENNETT C FRANK | EVP, Chief Scientific Officer | 12/20/2023 | 307,710 |
BENNETT C FRANK | EVP, Chief Scientific Officer | 12/21/2023 | 762,789 |
BENNETT C FRANK | EVP, Chief Scientific Officer | 12/20/2023 | 322,643 |
BENNETT C FRANK | EVP, Chief Scientific Officer | 12/21/2023 | 794,211 |
Geary Richard S | EVP, Chief Development Officer | 12/21/2023 | 194,662 |
Geary Richard S | EVP, Chief Development Officer | 12/20/2023 | 307,710 |
Geary Richard S | EVP, Chief Development Officer | 12/21/2023 | 202,681 |
Geary Richard S | EVP, Chief Development Officer | 12/20/2023 | 322,643 |
Monia Brett P | Chief Executive Officer | 12/21/2023 | 828,450 |
Monia Brett P | Chief Executive Officer | 12/20/2023 | 307,710 |
Monia Brett P | Chief Executive Officer | 12/21/2023 | 862,577 |
Monia Brett P | Chief Executive Officer | 12/20/2023 | 322,643 |
Monia Brett P | Chief Executive Officer | 12/14/2023 | 1,136,160 |
Monia Brett P | Chief Executive Officer | 12/14/2023 | 1,190,019 |
Geary Richard S | EVP, Chief Development Officer | 12/14/2023 | 502,419 |
Geary Richard S | EVP, Chief Development Officer | 12/14/2023 | 526,236 |
BENNETT C FRANK | EVP, Chief Scientific Officer | 12/14/2023 | 1,070,452 |
BENNETT C FRANK | EVP, Chief Scientific Officer | 12/14/2023 | 1,121,195 |
KLEIN JOSEPH III | Director | 11/15/2023 | 100,000 |
Swayze Eric | EVP Research | 10/17/2023 | 2,493 |
Monia Brett P | Chief Executive Officer | 10/12/2023 | 173,420 |
BENNETT C FRANK | EVP, Chief Scientific Officer | 09/28/2023 | 207,390 |
PARSHALL B LYNNE | Director | 09/26/2023 | 451,268 |
KLEIN JOSEPH III | Director | 09/26/2023 | 90,254 |
BENNETT C FRANK | Officer Level 14 | 08/31/2023 | 5,500 |
Geary Richard S | Officer Level 14 | 08/31/2023 | 31 |
Monia Brett P | CEO Level 15 | 08/31/2023 | 4,798 |
Diaz Allene M. | Director | 08/01/2023 | 26,970 |
KLEIN JOSEPH III | Director | 07/18/2023 | 149,310 |
Monia Brett P | Chief Executive Officer | 07/07/2023 | 787,953 |
BERTHELSEN SPENCER R | Director | 06/20/2023 | 320,287 |
O'NEIL PATRICK R. | EVP CLO & General Counsel | 05/24/2023 | 63,676 |
Monia Brett P | Chief Executive Officer | 05/22/2023 | 197,907 |
Birchler Brian | EVP, Corp and Development Ops | 04/18/2023 | 24,530 |
Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str & Oper Ofc | 04/18/2023 | 94,250 |
Baroldi Joseph | EVP, Chief Business Officer | 04/18/2023 | 141,631 |
Swayze Eric | EVP Research | 02/28/2023 | 17,546 |
O'NEIL PATRICK R. | EVP CLO & General Counsel | 02/28/2023 | 9,185 |
Geary Richard S | EVP, Chief Development Officer | 02/28/2023 | 17,546 |
HOUGEN ELIZABETH L | EVP, Finance & CFO | 02/28/2023 | 4,974 |
BENNETT C FRANK | EVP, Chief Scientific Officer | 02/28/2023 | 11,687 |
Swayze Eric | EVP Research | 02/06/2023 | 74,031 |
Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 02/06/2023 | 57,464 |
O'NEIL PATRICK R. | EVP CLO & General Counsel | 02/06/2023 | 78,460 |
Monia Brett P | Chief Executive Officer | 02/06/2023 | 1,003,153 |
HOUGEN ELIZABETH L | EVP, Finance & CFO | 02/06/2023 | 84,392 |
Geary Richard S | EVP, Chief Development Officer | 02/06/2023 | 78,070 |
Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str & Oper Ofc | 02/06/2023 | 58,997 |
BENNETT C FRANK | EVP, Chief Scientific Officer | 02/06/2023 | 73,560 |
O'NEIL PATRICK R. | EVP CLO & General Counsel | 01/31/2023 | 178,700 |
O'NEIL PATRICK R. | EVP CLO & General Counsel | 01/30/2023 | 177,372 |
Swayze Eric | EVP Research | 01/18/2023 | 223,800 |
Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 01/18/2023 | 188,052 |
O'NEIL PATRICK R. | EVP CLO & General Counsel | 01/18/2023 | 309,480 |
Monia Brett P | Chief Executive Officer | 01/18/2023 | 989,947 |
HOUGEN ELIZABETH L | EVP, Finance & CFO | 01/18/2023 | 328,721 |
Geary Richard S | EVP, Chief Development Officer | 01/18/2023 | 311,525 |
Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str & Oper Ofc | 01/18/2023 | 148,223 |
BENNETT C FRANK | EVP, Chief Scientific Officer | 01/18/2023 | 271,356 |
Baroldi Joseph | EVP, Chief Business Officer | 01/18/2023 | 14,920 |
KLEIN JOSEPH III | Director | 01/17/2023 | 80,000 |
Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 10/17/2022 | 6,699 |
Swayze Eric | EVP Research | 09/08/2022 | 20,493 |
O'NEIL PATRICK R. | EVP CLO & General Counsel | 08/31/2022 | 3,129 |
HOUGEN ELIZABETH L | EVP, Finance & CFO | 08/31/2022 | 5,852 |
BENNETT C FRANK | EVP, Chief Scientific Officer | 08/31/2022 | 5,301 |
Swayze Eric | EVP Research | 08/05/2022 | 45 |
KLEIN JOSEPH III | Director | 07/15/2022 | 50,977 |
MUTO FREDERICK T | Director | 07/01/2022 | 145,575 |
BERTHELSEN SPENCER R | Director | 06/07/2022 | 145,575 |
Swayze Eric | EVP Research | 04/21/2022 | 16,689 |
Cadoret-Manier Onaiza | EVP, Chf Pdt Str & Oper Ofc | 04/18/2022 | 80,380 |
O'NEIL PATRICK R. | EVP CLO & General Counsel | 04/12/2022 | 272,057 |
Monia Brett P | Chief Executive Officer | 04/01/2022 | 13,309 |
Swayze Eric | EVP Research | 02/28/2022 | 17,620 |
O'NEIL PATRICK R. | EVP CLO & General Counsel | 02/28/2022 | 20,854 |
Monia Brett P | Chief Executive Officer | 02/28/2022 | 17,620 |
HOUGEN ELIZABETH L | EVP, Finance & CFO | 02/28/2022 | 10,895 |
BENNETT C FRANK | EVP, Chief Scientific Officer | 02/28/2022 | 9,817 |
Geary Richard S | EVP, Chief Development Officer | 02/28/2022 | 17,620 |
Monia Brett P | Chief Executive Officer | 01/26/2022 | 252,526 |
PARSHALL B LYNNE | Director | 01/18/2022 | 49,758 |
Cadoret-Manier Onaiza | EVP, Chf Corp Dev and Cml Offc | 01/18/2022 | 69,427 |
BENNETT C FRANK | EVP, Chief Scientific Officer | 01/18/2022 | 202,587 |
O'NEIL PATRICK R. | EVP CLO & General Counsel | 01/18/2022 | 225,930 |
HOUGEN ELIZABETH L | EVP, Finance & CFO | 01/18/2022 | 235,779 |
Monia Brett P | Chief Executive Officer | 01/18/2022 | 593,786 |
Geary Richard S | EVP, Chief Development Officer | 01/18/2022 | 229,063 |
Schneider Eugene | EVP, Chf Clinical Develop Offc | 01/18/2022 | 114,908 |
Swayze Eric | EVP Research | 01/18/2022 | 150,419 |
Schneider Eugene | EVP, Chf Clinical Develop Offc | 10/15/2021 | 5,089 |
Geary Richard S | EVP, Chief Development Offc | 08/31/2021 | 1,555 |
O'NEIL PATRICK R. | EVP Legal & General Counsel | 08/31/2021 | 10,443 |
Monia Brett P | Chief Executive Officer | 08/31/2021 | 11,998 |
HOUGEN ELIZABETH L | EVP, Finance & CFO | 08/31/2021 | 5,610 |
Cadoret-Manier Onaiza | Chief Corp Dev and Cml Officer | 08/31/2021 | 14,566 |
BENNETT C FRANK | EVP & Chief Scientific Officer | 08/31/2021 | 5,103 |
KLEIN JOSEPH III | Director | 07/15/2021 | 152,989 |
BERTHELSEN SPENCER R | Director | 06/23/2021 | 139,500 |
BERTHELSEN SPENCER R | Director | 06/23/2021 | 566,100 |
MUTO FREDERICK T | Director | 06/15/2021 | 139,500 |
MUTO FREDERICK T | Director | 06/15/2021 | 549,500 |
Cadoret-Manier Onaiza | Chief Corp Dev and Cml Officer | 04/15/2021 | 80,419 |
Swayze Eric | EVP, Research | 02/26/2021 | 20,488 |
O'NEIL PATRICK R. | EVP & General Counsel | 02/26/2021 | 8,774 |
HOUGEN ELIZABETH L | EVP, Finance & CFO | 02/26/2021 | 5,167 |
Geary Richard S | EVP, Chief Development Offc | 02/26/2021 | 18,440 |
Cadoret-Manier Onaiza | Chief Corp Dev and Cml Officer | 02/26/2021 | 21,914 |
BENNETT C FRANK | Chief Scientific Officer | 02/26/2021 | 4,988 |
Monia Brett P | Chief Executive Officer | 02/26/2021 | 11,001 |
Monia Brett P | Chief Executive Officer | 03/01/2021 | 12,809 |
Monia Brett P | Chief Executive Officer | 01/28/2021 | 79,261 |
CROOKE STANLEY T | Exec Chairman of the Board | 01/26/2021 | 1,805,812 |
O'NEIL PATRICK R. | EVP & General Counsel | 01/25/2021 | 338,074 |
CROOKE STANLEY T | Exec Chairman of the Board | 01/22/2021 | 2,467,000 |
CROOKE STANLEY T | Exec Chairman of the Board | 01/21/2021 | 2,142,117 |
CROOKE STANLEY T | Exec Chairman of the Board | 01/15/2021 | 87,876 |
CROOKE STANLEY T | Exec Chairman of the Board | 01/15/2021 | 1,159,663 |
BENNETT C FRANK | Chief Scientific Officer | 01/15/2021 | 336,305 |
Geary Richard S | EVP, Chief Development Offc | 01/15/2021 | 392,069 |
HOUGEN ELIZABETH L | EVP, Finance & CFO | 01/15/2021 | 378,404 |
Monia Brett P | Chief Executive Officer | 01/15/2021 | 914,727 |
O'NEIL PATRICK R. | EVP & General Counsel | 01/15/2021 | 358,856 |
PARSHALL B LYNNE | Director | 01/15/2021 | 167,968 |
Schneider Eugene | EVP, Chf Clinical Develop Offc | 01/15/2021 | 166,559 |
Swayze Eric | EVP, Research | 01/15/2021 | 197,076 |
Geary Richard S | EVP, Chief Development Offc | 01/13/2021 | 8,390 |
Swayze Eric | EVP, Research | 01/05/2021 | 10,918 |
PARSHALL B LYNNE | Director | 12/23/2020 | 600,000 |
CROOKE STANLEY T | Exec Chairman of the Board | 12/17/2020 | 71,054 |
CROOKE STANLEY T | Exec Chairman of the Board | 12/15/2020 | 1,941,225 |
CROOKE STANLEY T | Exec Chairman of the Board | 12/07/2020 | 568,350 |
Monia Brett P | Chief Executive Officer | 12/04/2020 | 950,501 |
Monia Brett P | Chief Executive Officer | 12/04/2020 | 1,216,794 |
BENNETT C FRANK | Chief Scientific Officer | 12/04/2020 | 316,847 |
BENNETT C FRANK | Chief Scientific Officer | 12/04/2020 | 405,615 |
BENNETT C FRANK | Chief Scientific Officer | 12/02/2020 | 281,203 |
BENNETT C FRANK | Chief Scientific Officer | 12/02/2020 | 361,960 |
Monia Brett P | Chief Executive Officer | 12/02/2020 | 843,649 |
Monia Brett P | Chief Executive Officer | 12/02/2020 | 1,085,931 |
HOUGEN ELIZABETH L | EVP, Finance & CFO | 11/25/2020 | 864,382 |
HOUGEN ELIZABETH L | EVP, Finance & CFO | 11/25/2020 | 1,085,084 |
CROOKE STANLEY T | Exec Chairman of the Board | 11/25/2020 | 517,911 |
CROOKE STANLEY T | Exec Chairman of the Board | 11/25/2020 | 650,149 |
Geary Richard S | EVP, Development | 11/25/2020 | 475,250 |
Geary Richard S | EVP, Development | 11/25/2020 | 596,596 |
PARSHALL B LYNNE | Director | 11/25/2020 | 143,133 |
PARSHALL B LYNNE | Director | 11/25/2020 | 179,679 |
CROOKE STANLEY T | Exec Chairman of the Board | 11/24/2020 | 103,263 |
CROOKE STANLEY T | Exec Chairman of the Board | 11/23/2020 | 462,492 |
CROOKE STANLEY T | Exec Chairman of the Board | 11/23/2020 | 19,935 |
CROOKE STANLEY T | Exec Chairman of the Board | 11/23/2020 | 581,276 |
CROOKE STANLEY T | Exec Chairman of the Board | 11/23/2020 | 25,000 |
CROOKE STANLEY T | Exec Chairman of the Board | 11/24/2020 | 131,650 |
HOUGEN ELIZABETH L | EVP, Finance & CFO | 11/24/2020 | 172,238 |
HOUGEN ELIZABETH L | EVP, Finance & CFO | 11/23/2020 | 757,530 |
HOUGEN ELIZABETH L | EVP, Finance & CFO | 11/24/2020 | 219,586 |
HOUGEN ELIZABETH L | EVP, Finance & CFO | 11/23/2020 | 952,090 |
Geary Richard S | EVP, Development | 11/24/2020 | 94,891 |
Geary Richard S | EVP, Development | 11/23/2020 | 426,609 |
Geary Richard S | EVP, Development | 11/24/2020 | 120,975 |
Geary Richard S | EVP, Development | 11/23/2020 | 536,177 |
PARSHALL B LYNNE | Director | 11/24/2020 | 28,308 |
PARSHALL B LYNNE | Director | 11/23/2020 | 127,584 |
PARSHALL B LYNNE | Director | 11/23/2020 | 160,384 |
PARSHALL B LYNNE | Director | 11/24/2020 | 36,082 |
BENNETT C FRANK | Chief Scientific Officer | 11/03/2020 | 598,050 |
BENNETT C FRANK | Chief Scientific Officer | 11/03/2020 | 701,600 |
KLEIN JOSEPH III | Director | 10/20/2020 | 135,386 |
CROOKE STANLEY T | Exec Chairman of the Board | 09/22/2020 | 2,520,460 |
CROOKE STANLEY T | Exec Chairman of the Board | 09/21/2020 | 100,360 |
WENDER JOSEPH H | Director | 09/16/2020 | 465,862 |
HOUGEN ELIZABETH L | EVP, Finance & CFO | 08/31/2020 | 5,379 |
O'NEIL PATRICK R. | EVP & General Counsel | 08/31/2020 | 7,513 |
Geary Richard S | EVP, Development | 08/31/2020 | 44 |
Monia Brett P | Chief Executive Officer | 08/31/2020 | 10,491 |
Monia Brett P | Chief Executive Officer | 09/01/2020 | 16,862 |
BENNETT C FRANK | Chief Scientific Officer | 08/31/2020 | 4,979 |
Swayze Eric | EVP, Research | 08/31/2020 | 44 |
MUTO FREDERICK T | Director | 06/30/2020 | 138,300 |
Castleman Breaux | Director | 06/25/2020 | 266,600 |
Castleman Breaux | Director | 06/25/2020 | 600,000 |
BENNETT C FRANK | EVP, Chief Scientific Officer | 06/25/2020 | 598,050 |
BENNETT C FRANK | EVP, Chief Scientific Officer | 06/25/2020 | 896,505 |
CROOKE STANLEY T | Exec Chairman of the Board | 06/25/2020 | 595,907 |
CROOKE STANLEY T | Exec Chairman of the Board | 06/24/2020 | 294,000 |
BERTHELSEN SPENCER R | Director | 06/23/2020 | 138,300 |
BERTHELSEN SPENCER R | Director | 06/23/2020 | 881,400 |
CROOKE STANLEY T | Exec Chairman of the Board | 06/19/2020 | 583,250 |
CROOKE STANLEY T | Exec Chairman of the Board | 06/17/2020 | 116,500 |
CROOKE STANLEY T | Exec Chairman of the Board | 06/17/2020 | 868,521 |
CROOKE STANLEY T | Exec Chairman of the Board | 03/25/2020 | 47,000 |
CROOKE STANLEY T | Exec Chairman of the Board | 03/25/2020 | 705,000 |
CROOKE STANLEY T | Exec Chairman of the Board | 03/17/2020 | 895,000 |
CROOKE STANLEY T | Exec Chairman of the Board | 03/19/2020 | 45,000 |
CROOKE STANLEY T | Exec Chairman of the Board | 03/19/2020 | 677,546 |
CROOKE STANLEY T | Exec Chairman of the Board | 03/17/2020 | 912,355 |
Swayze Eric | SVP, Research | 02/29/2020 | 16,316 |
O'NEIL PATRICK R. | SVP & General Counsel | 02/29/2020 | 12,474 |
Monia Brett P | Chief Executive Officer | 02/29/2020 | 13,553 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 02/29/2020 | 6,345 |
Geary Richard S | SVP, Development | 02/29/2020 | 16,316 |
BENNETT C FRANK | Chief Scientific Officer | 02/29/2020 | 7,295 |
O'NEIL PATRICK R. | SVP & General Counsel | 02/10/2020 | 231,367 |
Swayze Eric | SVP, Research | 01/15/2020 | 146,896 |
PARSHALL B LYNNE | Director | 01/15/2020 | 242,344 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 01/15/2020 | 265,431 |
Monia Brett P | Chief Executive Officer | 01/15/2020 | 469,360 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 01/15/2020 | 265,431 |
Geary Richard S | SVP, Development | 01/15/2020 | 288,827 |
CROOKE STANLEY T | Executive Chairman of Board | 01/15/2020 | 78,692 |
CROOKE STANLEY T | Executive Chairman of Board | 01/15/2020 | 1,076,245 |
BENNETT C FRANK | Chief Scientific Officer | 01/15/2020 | 258,294 |
Monia Brett P | Chief Executive Officer | 01/02/2020 | 10,423 |
KLEIN JOSEPH III | Director | 12/23/2019 | 35,530 |
KLEIN JOSEPH III | Director | 12/23/2019 | 61,874 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 12/20/2019 | 383,208 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 12/20/2019 | 115,060 |
KLEIN JOSEPH III | Director | 12/16/2019 | 35,530 |
KLEIN JOSEPH III | Director | 12/16/2019 | 65,447 |
KLEIN JOSEPH III | Director | 12/09/2019 | 35,530 |
KLEIN JOSEPH III | Director | 12/09/2019 | 63,745 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 12/04/2019 | 49,404 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 12/04/2019 | 296,790 |
Geary Richard S | SVP, Development | 12/04/2019 | 146,900 |
Geary Richard S | SVP, Development | 12/04/2019 | 650,000 |
KLEIN JOSEPH III | Director | 12/02/2019 | 35,530 |
KLEIN JOSEPH III | Director | 12/02/2019 | 64,083 |
Geary Richard S | SVP, Development | 12/02/2019 | 73,450 |
Geary Richard S | SVP, Development | 12/02/2019 | 325,287 |
KLEIN JOSEPH III | Director | 11/25/2019 | 51,075 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 11/25/2019 | 43,280 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 11/25/2019 | 250,000 |
KLEIN JOSEPH III | Director | 11/20/2019 | 120,000 |
Monia Brett P | COO & SVP, Translational Med | 11/20/2019 | 346,618 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 11/19/2019 | 43,280 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 11/19/2019 | 235,200 |
CROOKE STANLEY T | Chairman and CEO | 08/20/2019 | 79,740 |
CROOKE STANLEY T | Chairman and CEO | 08/20/2019 | 398,700 |
CROOKE STANLEY T | Chairman and CEO | 08/21/2019 | 398,700 |
CROOKE STANLEY T | Chairman and CEO | 08/20/2019 | 142,000 |
CROOKE STANLEY T | Chairman and CEO | 08/20/2019 | 710,000 |
CROOKE STANLEY T | Chairman and CEO | 08/21/2019 | 721,500 |
CROOKE STANLEY T | Chairman & CEO | 07/18/2019 | 398,700 |
CROOKE STANLEY T | Chairman & CEO | 07/18/2019 | 702,506 |
McDevitt Damien | Chief Business Officer | 07/15/2019 | 83,129 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 07/01/2019 | 7,358 |
Monia Brett P | Chief Operating Officer | 07/01/2019 | 7,907 |
Monia Brett P | Chief Operating Officer | 07/02/2019 | 13,944 |
HOUGEN ELIZABETH L | SVP Finance & CFO | 07/01/2019 | 4,799 |
Geary Richard S | SVP, Development | 07/01/2019 | 6,444 |
BENNETT C FRANK | SVP, Antisense Research | 07/01/2019 | 5,393 |
McDevitt Damien | Chief Business Officer | 07/01/2019 | 11,700 |
BERTHELSEN SPENCER R | Director | 06/24/2019 | 244,800 |
BERTHELSEN SPENCER R | Director | 06/24/2019 | 955,113 |
MUTO FREDERICK T | Director | 06/04/2019 | 244,800 |
MUTO FREDERICK T | Director | 06/04/2019 | 979,350 |
MUTO FREDERICK T | Director | 05/06/2019 | 195,360 |
MUTO FREDERICK T | Director | 05/06/2019 | 582,002 |
PARSHALL B LYNNE | Director | 04/29/2019 | 1,993,500 |
PARSHALL B LYNNE | Director | 04/29/2019 | 3,750,635 |
CROOKE STANLEY T | Chairman and CEO | 04/15/2019 | 10,820 |
CROOKE STANLEY T | Chairman and CEO | 04/15/2019 | 146,900 |
CROOKE STANLEY T | Chairman and CEO | 04/16/2019 | 31,155 |
CROOKE STANLEY T | Chairman and CEO | 04/16/2019 | 629,198 |
CROOKE STANLEY T | Chairman and CEO | 04/15/2019 | 85,250 |
CROOKE STANLEY T | Chairman and CEO | 04/15/2019 | 852,500 |
CROOKE STANLEY T | Chairman and CEO | 04/16/2019 | 84,750 |
CROOKE STANLEY T | Chairman and CEO | 04/16/2019 | 1,692,500 |
Geary Richard S | SVP, Development | 04/08/2019 | 1,966,466 |
Geary Richard S | SVP, Development | 04/08/2019 | 3,884,753 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 04/05/2019 | 138,903 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 04/04/2019 | 2,078,809 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 04/03/2019 | 472,099 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 04/05/2019 | 190,857 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 04/04/2019 | 3,319,929 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 04/03/2019 | 649,289 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 03/18/2019 | 1,773,216 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 03/18/2019 | 2,269,187 |
WENDER JOSEPH H | Director | 03/19/2019 | 796,258 |
PARSHALL B LYNNE | Director | 03/12/2019 | 332,277 |
PARSHALL B LYNNE | Director | 03/12/2019 | 625,050 |
PARSHALL B LYNNE | Director | 02/27/2019 | 332,237 |
PARSHALL B LYNNE | Director | 02/27/2019 | 583,310 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 02/27/2019 | 1,208,952 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 02/27/2019 | 1,822,580 |
CROOKE STANLEY T | Chairman and CEO | 02/26/2019 | 1,475,190 |
CROOKE STANLEY T | Chairman and CEO | 02/25/2019 | 1,594,800 |
CROOKE STANLEY T | Chairman and CEO | 02/26/2019 | 2,276,799 |
CROOKE STANLEY T | Chairman and CEO | 02/25/2019 | 2,402,700 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 02/12/2019 | 10,964 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 02/12/2019 | 16,363 |
CROOKE STANLEY T | Chairman and CEO | 02/13/2019 | 228,666 |
CROOKE STANLEY T | Chairman and CEO | 02/13/2019 | 1,594,800 |
CROOKE STANLEY T | Chairman and CEO | 02/13/2019 | 2,404,028 |
CROOKE STANLEY T | Chairman and CEO | 02/13/2019 | 414,240 |
Geary Richard S | SVP, Development | 02/13/2019 | 59,940 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 02/05/2019 | 621,972 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 02/01/2019 | 159,480 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 02/05/2019 | 928,200 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 02/01/2019 | 233,160 |
BENNETT C FRANK | SVP, Antisense Research | 02/01/2019 | 132,401 |
BENNETT C FRANK | SVP, Antisense Research | 02/01/2019 | 525,368 |
BENNETT C FRANK | SVP, Antisense Research | 01/15/2019 | 164,177 |
Geary Richard S | SVP, Development | 01/15/2019 | 169,420 |
HOUGEN ELIZABETH L | SVP Finance & CFO | 01/15/2019 | 165,575 |
Monia Brett P | Chief Operating Officer | 01/15/2019 | 208,105 |
CROOKE STANLEY T | Chairman and CEO | 01/15/2019 | 54,881 |
CROOKE STANLEY T | Chairman and CEO | 01/15/2019 | 739,086 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 01/15/2019 | 159,283 |
PARSHALL B LYNNE | Director | 01/15/2019 | 358,823 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 01/01/2019 | 2,406 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 01/03/2019 | 163,808 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 01/03/2019 | 241,120 |
HOUGEN ELIZABETH L | SVP Finance & CFO | 01/01/2019 | 4,629 |
Monia Brett P | Chief Operating Officer | 01/01/2019 | 7,654 |
Monia Brett P | Chief Operating Officer | 01/02/2019 | 11,449 |
Geary Richard S | SVP, Development | 01/01/2019 | 14,834 |
BENNETT C FRANK | SVP, Antisense Research | 01/01/2019 | 4,665 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 12/19/2018 | 14,957 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 12/18/2018 | 14,500 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 12/19/2018 | 107,379 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 12/18/2018 | 104,000 |
Monia Brett P | Chief Operating Officer | 11/23/2018 | 499,460 |
Monia Brett P | Chief Operating Officer | 11/23/2018 | 1,870,058 |
BENNETT C FRANK | SVP, Antisense Research | 11/01/2018 | 183,625 |
BENNETT C FRANK | SVP, Antisense Research | 11/01/2018 | 619,245 |
Monia Brett P | Chief Operating Officer | 08/27/2018 | 119,274 |
Monia Brett P | Chief Operating Officer | 08/27/2018 | 890,622 |
BENNETT C FRANK | SVP, Antisense Research | 08/08/2018 | 183,528 |
BENNETT C FRANK | SVP, Antisense Research | 08/08/2018 | 562,500 |
Monia Brett P | Chief Operating Officer | 07/24/2018 | 7,337 |
WENDER JOSEPH H | Director | 07/17/2018 | 277,800 |
BENNETT C FRANK | SVP, Antisense Research | 07/01/2018 | 9,988 |
Geary Richard S | SVP, Development | 07/01/2018 | 6,269 |
HOUGEN ELIZABETH L | SVP Finance & CFO | 07/01/2018 | 9,705 |
Monia Brett P | Chief Operating Officer | 07/01/2018 | 7,580 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 07/01/2018 | 2,338 |
BERTHELSEN SPENCER R | Director | 06/25/2018 | 208,200 |
BERTHELSEN SPENCER R | Director | 06/25/2018 | 634,542 |
MUTO FREDERICK T | Director | 05/31/2018 | 208,200 |
MUTO FREDERICK T | Director | 05/31/2018 | 696,750 |
BENNETT C FRANK | SVP, Antisense Research | 05/11/2018 | 90,625 |
BENNETT C FRANK | SVP, Antisense Research | 05/11/2018 | 562,500 |
WENDER JOSEPH H | Director | 05/11/2018 | 208,200 |
WENDER JOSEPH H | Director | 05/11/2018 | 679,614 |
CROOKE STANLEY T | Chairman and CEO | 04/17/2018 | 43,280 |
CROOKE STANLEY T | Chairman and CEO | 04/17/2018 | 146,342 |
CROOKE STANLEY T | Chairman and CEO | 04/17/2018 | 177,600 |
CROOKE STANLEY T | Chairman and CEO | 04/17/2018 | 442,313 |
KLEIN JOSEPH III | Director | 03/29/2018 | 48,840 |
KLEIN JOSEPH III | Director | 03/29/2018 | 92,300 |
KLEIN JOSEPH III | Director | 03/15/2018 | 48,840 |
KLEIN JOSEPH III | Director | 03/15/2018 | 102,258 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 03/12/2018 | 10,820 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 03/12/2018 | 55,000 |
KLEIN JOSEPH III | Director | 02/28/2018 | 106,590 |
KLEIN JOSEPH III | Director | 02/28/2018 | 155,727 |
KLEIN JOSEPH III | Director | 02/15/2018 | 106,590 |
KLEIN JOSEPH III | Director | 02/15/2018 | 146,984 |
BENNETT C FRANK | SVP, Antisense Research | 02/01/2018 | 90,625 |
BENNETT C FRANK | SVP, Antisense Research | 02/01/2018 | 656,260 |
KLEIN JOSEPH III | Director | 01/30/2018 | 106,590 |
KLEIN JOSEPH III | Director | 01/30/2018 | 158,580 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 01/29/2018 | 3,841 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 01/29/2018 | 19,525 |
CROOKE STANLEY T | Chairman and CEO | 01/29/2018 | 10,820 |
CROOKE STANLEY T | Chairman and CEO | 01/29/2018 | 146,900 |
CROOKE STANLEY T | Chairman and CEO | 01/29/2018 | 541,200 |
CROOKE STANLEY T | Chairman and CEO | 01/29/2018 | 54,120 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 01/25/2018 | 6,979 |
O'NEIL PATRICK R. | SVP Legal & General Counsel | 01/25/2018 | 35,475 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 01/16/2018 | 140,994 |
KLEIN JOSEPH III | Director | 01/16/2018 | 106,590 |
KLEIN JOSEPH III | Director | 01/16/2018 | 157,566 |
Geary Richard S | SVP, Development | 01/16/2018 | 140,942 |
PARSHALL B LYNNE | Director | 01/16/2018 | 309,835 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 01/16/2018 | 139,597 |
Boyce Sarah | Chief Business Officer | 01/16/2018 | 113,665 |
BENNETT C FRANK | SVP, Antisense Research | 01/16/2018 | 139,545 |
CROOKE STANLEY T | Chairman and CEO | 01/15/2018 | 33,955 |
CROOKE STANLEY T | Chairman and CEO | 01/15/2018 | 822,622 |
Monia Brett P | COO | 01/16/2018 | 146,015 |
CROOKE STANLEY T | Chairman and CEO | 01/08/2018 | 10,820 |
CROOKE STANLEY T | Chairman and CEO | 01/08/2018 | 146,900 |
CROOKE STANLEY T | Chairman and CEO | 01/08/2018 | 52,010 |
CROOKE STANLEY T | Chairman and CEO | 01/08/2018 | 520,100 |
CROOKE STANLEY T | Chairman and CEO | 01/03/2018 | 18,413 |
CROOKE STANLEY T | Chairman and CEO | 01/03/2018 | 293,800 |
CROOKE STANLEY T | Chairman and CEO | 01/03/2018 | 1,000,400 |
CROOKE STANLEY T | Chairman and CEO | 01/03/2018 | 99,760 |
PARSHALL B LYNNE | COO | 01/01/2018 | 3,677 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 01/01/2018 | 2,266 |
Monia Brett P | SVP, Antisense Drug Discovery | 01/01/2018 | 6,670 |
Monia Brett P | SVP, Antisense Drug Discovery | 01/02/2018 | 8,150 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 01/01/2018 | 4,276 |
Geary Richard S | SVP, Development | 01/01/2018 | 13,682 |
Boyce Sarah | Chief Business Officer | 01/01/2018 | 20,993 |
BENNETT C FRANK | SVP, Antisense Research | 01/01/2018 | 4,532 |
KLEIN JOSEPH III | Director | 12/29/2017 | 85,410 |
KLEIN JOSEPH III | Director | 12/29/2017 | 151,680 |
KLEIN JOSEPH III | Director | 12/15/2017 | 85,410 |
KLEIN JOSEPH III | Director | 12/15/2017 | 155,070 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 12/15/2017 | 51,450 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 12/15/2017 | 262,750 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 12/04/2017 | 41,160 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 12/04/2017 | 228,000 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 11/29/2017 | 61,740 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 11/29/2017 | 318,120 |
KLEIN JOSEPH III | Director | 11/30/2017 | 85,410 |
KLEIN JOSEPH III | Director | 11/30/2017 | 160,650 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 12/01/2017 | 10,820 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 12/01/2017 | 55,500 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 11/16/2017 | 72,030 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 11/16/2017 | 380,450 |
KLEIN JOSEPH III | Director | 11/16/2017 | 36,387 |
KLEIN JOSEPH III | Director | 11/15/2017 | 64,057 |
KLEIN JOSEPH III | Director | 11/15/2017 | 120,510 |
KLEIN JOSEPH III | Director | 11/13/2017 | 166,170 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 11/01/2017 | 10,820 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 11/01/2017 | 58,350 |
BENNETT C FRANK | SVP, Antisense Research | 10/18/2017 | 126,052 |
BENNETT C FRANK | SVP, Antisense Research | 10/18/2017 | 796,250 |
PARSHALL B LYNNE | COO | 10/18/2017 | 446,598 |
PARSHALL B LYNNE | COO | 10/18/2017 | 1,047,670 |
CROOKE STANLEY T | Chairman and CEO | 10/13/2017 | 220,350 |
CROOKE STANLEY T | Chairman and CEO | 10/13/2017 | 10,875 |
CROOKE STANLEY T | Chairman and CEO | 10/13/2017 | 891,900 |
CROOKE STANLEY T | Chairman and CEO | 10/13/2017 | 89,190 |
Geary Richard S | SVP, Development | 10/13/2017 | 55,387 |
Geary Richard S | SVP, Development | 10/13/2017 | 496,080 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 10/05/2017 | 10,106 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 10/05/2017 | 55,000 |
CROOKE STANLEY T | Chairman and CEO | 10/02/2017 | 220,350 |
CROOKE STANLEY T | Chairman and CEO | 10/04/2017 | 7,250 |
CROOKE STANLEY T | Chairman and CEO | 10/04/2017 | 146,900 |
CROOKE STANLEY T | Chairman and CEO | 10/02/2017 | 10,875 |
CROOKE STANLEY T | Chairman and CEO | 10/04/2017 | 542,250 |
CROOKE STANLEY T | Chairman and CEO | 10/02/2017 | 78,000 |
CROOKE STANLEY T | Chairman and CEO | 10/02/2017 | 780,000 |
CROOKE STANLEY T | Chairman and CEO | 10/04/2017 | 54,225 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 09/06/2017 | 5,800 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 09/05/2017 | 1,450 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 09/06/2017 | 44,000 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 09/05/2017 | 11,000 |
BENNETT C FRANK | SVP, Antisense Research | 07/24/2017 | 102,900 |
BENNETT C FRANK | SVP, Antisense Research | 07/24/2017 | 592,900 |
CROOKE STANLEY T | Chairman and CEO | 07/20/2017 | 7,250 |
CROOKE STANLEY T | Chairman and CEO | 07/20/2017 | 146,900 |
CROOKE STANLEY T | Chairman and CEO | 07/20/2017 | 55,350 |
CROOKE STANLEY T | Chairman and CEO | 07/20/2017 | 553,500 |
CROOKE STANLEY T | Chairman and CEO | 07/17/2017 | 220,350 |
CROOKE STANLEY T | Chairman and CEO | 07/17/2017 | 10,875 |
CROOKE STANLEY T | Chairman and CEO | 07/17/2017 | 786,750 |
CROOKE STANLEY T | Chairman and CEO | 07/17/2017 | 78,675 |
Monia Brett P | SVP, Antisense Drug Discovery | 07/01/2017 | 6,627 |
Monia Brett P | SVP, Antisense Drug Discovery | 07/03/2017 | 15,867 |
PARSHALL B LYNNE | COO | 07/01/2017 | 3,659 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 07/01/2017 | 5,448 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 07/01/2017 | 4,228 |
Geary Richard S | SVP, Development | 07/01/2017 | 7,968 |
Boyce Sarah | Chief Business Officer | 07/01/2017 | 691 |
BENNETT C FRANK | SVP, Antisense Research | 07/01/2017 | 10,286 |
CROOKE STANLEY T | Chairman and CEO | 07/03/2017 | 120,193 |
CROOKE STANLEY T | Chairman and CEO | 07/03/2017 | 10,875 |
CROOKE STANLEY T | Chairman and CEO | 07/03/2017 | 78,150 |
CROOKE STANLEY T | Chairman and CEO | 07/03/2017 | 781,538 |
MUTO FREDERICK T | Director | 05/31/2017 | 122,125 |
MUTO FREDERICK T | Director | 05/31/2017 | 565,250 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 06/01/2017 | 757 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 06/01/2017 | 3,360 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 05/01/2017 | 5,410 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 05/01/2017 | 31,688 |
CROOKE STANLEY T | Chairman and CEO | 04/25/2017 | 10,875 |
CROOKE STANLEY T | Chairman and CEO | 04/25/2017 | 108,750 |
CROOKE STANLEY T | Chairman and CEO | 04/25/2017 | 71,715 |
CROOKE STANLEY T | Chairman and CEO | 04/25/2017 | 717,150 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 04/24/2017 | 5,410 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 04/24/2017 | 22,500 |
CROOKE STANLEY T | Chairman and CEO | 04/19/2017 | 3,625 |
CROOKE STANLEY T | Chairman and CEO | 04/19/2017 | 36,250 |
CROOKE STANLEY T | Chairman and CEO | 04/19/2017 | 21,625 |
CROOKE STANLEY T | Chairman and CEO | 04/19/2017 | 216,250 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 04/12/2017 | 40,070 |
CROOKE STANLEY T | Chairman and CEO | 04/13/2017 | 72,500 |
CROOKE STANLEY T | Chairman and CEO | 04/12/2017 | 10,290 |
CROOKE STANLEY T | Chairman and CEO | 04/12/2017 | 72,500 |
CROOKE STANLEY T | Chairman and CEO | 04/13/2017 | 8,770 |
CROOKE STANLEY T | Chairman and CEO | 04/13/2017 | 413,000 |
CROOKE STANLEY T | Chairman and CEO | 04/12/2017 | 40,070 |
CROOKE STANLEY T | Chairman and CEO | 04/12/2017 | 400,700 |
CROOKE STANLEY T | Chairman and CEO | 04/13/2017 | 41,300 |
BENNETT C FRANK | SVP, Antisense Research | 03/03/2017 | 51,450 |
BENNETT C FRANK | SVP, Antisense Research | 03/03/2017 | 275,000 |
CROOKE STANLEY T | Chairman and CEO | 03/02/2017 | 11,319 |
CROOKE STANLEY T | Chairman and CEO | 03/02/2017 | 79,750 |
CROOKE STANLEY T | Chairman and CEO | 03/02/2017 | 56,155 |
CROOKE STANLEY T | Chairman and CEO | 03/02/2017 | 561,550 |
PARSHALL B LYNNE | COO | 03/01/2017 | 67,941 |
PARSHALL B LYNNE | COO | 03/01/2017 | 227,827 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 03/01/2017 | 5,410 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 03/01/2017 | 73,935 |
BERTHELSEN SPENCER R | Director | 02/24/2017 | 122,125 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 02/06/2017 | 5,342 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 02/06/2017 | 69,254 |
Boyce Sarah | Chief Business Officer | 01/17/2017 | 63,001 |
Monia Brett P | SVP, Antisense Drug Discovery | 01/17/2017 | 115,819 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 01/17/2017 | 103,968 |
BENNETT C FRANK | SVP, Antisense Research | 01/17/2017 | 112,069 |
CROOKE STANLEY T | Chairman and CEO | 01/17/2017 | 26,617 |
CROOKE STANLEY T | Chairman and CEO | 01/17/2017 | 712,026 |
PARSHALL B LYNNE | COO | 01/17/2017 | 335,414 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 01/17/2017 | 105,218 |
Geary Richard S | SVP, Development | 01/17/2017 | 112,996 |
CROOKE STANLEY T | Chairman and CEO | 01/10/2017 | 12,348 |
CROOKE STANLEY T | Chairman and CEO | 01/10/2017 | 87,000 |
CROOKE STANLEY T | Chairman and CEO | 01/10/2017 | 59,100 |
CROOKE STANLEY T | Chairman and CEO | 01/10/2017 | 591,000 |
CROOKE STANLEY T | Chairman and CEO | 01/03/2017 | 72,500 |
CROOKE STANLEY T | Chairman and CEO | 01/04/2017 | 7,203 |
CROOKE STANLEY T | Chairman and CEO | 01/04/2017 | 50,750 |
CROOKE STANLEY T | Chairman and CEO | 01/03/2017 | 10,290 |
CROOKE STANLEY T | Chairman and CEO | 01/04/2017 | 35,070 |
CROOKE STANLEY T | Chairman and CEO | 01/04/2017 | 350,700 |
CROOKE STANLEY T | Chairman and CEO | 01/03/2017 | 48,050 |
CROOKE STANLEY T | Chairman and CEO | 01/03/2017 | 480,500 |
Boyce Sarah | Chief Business Officer | 01/01/2017 | 20,591 |
Monia Brett P | SVP, Antisense Drug Discovery | 01/01/2017 | 6,414 |
Monia Brett P | SVP, Antisense Drug Discovery | 01/03/2017 | 15,017 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 01/01/2017 | 8,801 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 01/01/2017 | 4,131 |
BENNETT C FRANK | SVP, Antisense Research | 01/01/2017 | 4,380 |
PARSHALL B LYNNE | COO | 01/01/2017 | 3,549 |
Geary Richard S | SVP, Development | 01/01/2017 | 13,284 |
Monia Brett P | SVP, Antisense Drug Discovery | 12/20/2016 | 6,822 |
PARSHALL B LYNNE | COO | 12/15/2016 | 7,250 |
PARSHALL B LYNNE | COO | 12/15/2016 | 14,500 |
PARSHALL B LYNNE | COO | 12/15/2016 | 7,250 |
PARSHALL B LYNNE | COO | 12/15/2016 | 100,000 |
PARSHALL B LYNNE | COO | 12/15/2016 | 50,000 |
PARSHALL B LYNNE | COO | 12/15/2016 | 50,000 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 12/05/2016 | 28,175 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 12/05/2016 | 115,125 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 12/05/2016 | 3,787 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 12/05/2016 | 15,750 |
PARSHALL B LYNNE | COO | 12/01/2016 | 183,625 |
PARSHALL B LYNNE | COO | 12/01/2016 | 527,865 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 11/14/2016 | 10,820 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 11/14/2016 | 45,000 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 11/11/2016 | 28,175 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 11/09/2016 | 28,175 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 11/11/2016 | 102,500 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 11/09/2016 | 96,225 |
CROOKE STANLEY T | Chairman and CEO | 11/10/2016 | 72,500 |
CROOKE STANLEY T | Chairman and CEO | 11/09/2016 | 20,580 |
CROOKE STANLEY T | Chairman and CEO | 11/09/2016 | 194,427 |
CROOKE STANLEY T | Chairman and CEO | 11/10/2016 | 10,290 |
CROOKE STANLEY T | Chairman and CEO | 11/10/2016 | 402,300 |
CROOKE STANLEY T | Chairman and CEO | 11/09/2016 | 72,350 |
CROOKE STANLEY T | Chairman and CEO | 11/09/2016 | 727,996 |
CROOKE STANLEY T | Chairman and CEO | 11/10/2016 | 42,220 |
BENNETT C FRANK | SVP, Antisense Research | 11/09/2016 | 257,012 |
BENNETT C FRANK | SVP, Antisense Research | 11/09/2016 | 856,605 |
BENNETT C FRANK | SVP, Antisense Research | 11/07/2016 | 56,350 |
BENNETT C FRANK | SVP, Antisense Research | 11/07/2016 | 170,000 |
CROOKE STANLEY T | Chairman and CEO | 10/05/2016 | 10,290 |
CROOKE STANLEY T | Chairman and CEO | 10/05/2016 | 102,900 |
CROOKE STANLEY T | Chairman and CEO | 10/05/2016 | 36,610 |
CROOKE STANLEY T | Chairman and CEO | 10/05/2016 | 366,100 |
CROOKE STANLEY T | Chairman and CEO | 09/27/2016 | 20,580 |
CROOKE STANLEY T | Chairman and CEO | 09/27/2016 | 205,800 |
CROOKE STANLEY T | Chairman and CEO | 09/27/2016 | 720,400 |
CROOKE STANLEY T | Chairman and CEO | 09/27/2016 | 72,100 |
CROOKE STANLEY T | Chairman and CEO | 09/21/2016 | 205,800 |
CROOKE STANLEY T | Chairman and CEO | 09/21/2016 | 20,580 |
CROOKE STANLEY T | Chairman and CEO | 09/21/2016 | 71,000 |
CROOKE STANLEY T | Chairman and CEO | 09/21/2016 | 710,000 |
PARSHALL B LYNNE | COO | 09/01/2016 | 117,669 |
PARSHALL B LYNNE | COO | 09/01/2016 | 373,545 |
PARSHALL B LYNNE | COO | 07/01/2016 | 8,365 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 07/01/2016 | 8,344 |
Monia Brett P | SVP, Antisense Drug Discovery | 07/01/2016 | 6,414 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 07/01/2016 | 4,504 |
Geary Richard S | SVP, Development | 07/01/2016 | 3,383 |
Boyce Sarah | Chief Business Officer | 07/01/2016 | 8,365 |
BENNETT C FRANK | SVP, Antisense Research | 07/01/2016 | 4,421 |
MUTO FREDERICK T | Director | 05/31/2016 | 74,125 |
MUTO FREDERICK T | Director | 05/31/2016 | 278,900 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 04/06/2016 | 10,820 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 04/06/2016 | 45,000 |
CROOKE STANLEY T | Chairman and CEO | 04/06/2016 | 10,290 |
CROOKE STANLEY T | Chairman and CEO | 04/06/2016 | 102,900 |
CROOKE STANLEY T | Chairman and CEO | 04/06/2016 | 461,250 |
CROOKE STANLEY T | Chairman and CEO | 04/06/2016 | 46,125 |
CROOKE STANLEY T | Chairman and CEO | 03/31/2016 | 102,900 |
CROOKE STANLEY T | Chairman and CEO | 03/31/2016 | 9,755 |
CROOKE STANLEY T | Chairman and CEO | 03/31/2016 | 407,350 |
CROOKE STANLEY T | Chairman and CEO | 03/31/2016 | 40,735 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 03/23/2016 | 10,820 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 03/23/2016 | 45,400 |
BERTHELSEN SPENCER R | Director | 02/19/2016 | 74,125 |
CROOKE STANLEY T | Chairman and CEO | 01/19/2016 | 23,882 |
CROOKE STANLEY T | Chairman and CEO | 01/19/2016 | 531,716 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 01/19/2016 | 78,742 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 01/19/2016 | 77,574 |
PARSHALL B LYNNE | COO & Secretary | 01/19/2016 | 215,257 |
Geary Richard S | SVP, Development | 01/19/2016 | 89,634 |
Monia Brett P | SVP, Antisense Drug Discovery | 01/19/2016 | 91,541 |
Boyce Sarah | Chief Business Officer | 01/19/2016 | 36,151 |
BENNETT C FRANK | SVP, Antisense Research | 01/19/2016 | 87,474 |
CROOKE STANLEY T | Chairman and CEO | 01/05/2016 | 4,610 |
CROOKE STANLEY T | Chairman and CEO | 01/05/2016 | 51,450 |
CROOKE STANLEY T | Chairman and CEO | 01/05/2016 | 31,050 |
CROOKE STANLEY T | Chairman and CEO | 01/05/2016 | 310,500 |
PARSHALL B LYNNE | COO & Secretary | 01/01/2016 | 3,435 |
PARSHALL B LYNNE | COO & Secretary | 01/04/2016 | 11,884 |
PARSHALL B LYNNE | COO & Secretary | 01/04/2016 | 49,389 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 01/01/2016 | 2,052 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 01/04/2016 | 7,793 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 01/04/2016 | 61,100 |
Monia Brett P | SVP, Antisense Drug Discovery | 01/01/2016 | 6,202 |
Monia Brett P | SVP, Antisense Drug Discovery | 01/04/2016 | 7,747 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 01/01/2016 | 1,956 |
Geary Richard S | SVP, Development | 01/01/2016 | 12,834 |
CROOKE STANLEY T | Chairman and CEO | 01/04/2016 | 102,900 |
CROOKE STANLEY T | Chairman and CEO | 01/04/2016 | 9,220 |
CROOKE STANLEY T | Chairman and CEO | 01/04/2016 | 61,050 |
CROOKE STANLEY T | Chairman and CEO | 01/04/2016 | 610,500 |
Boyce Sarah | Chief Business Officer | 01/01/2016 | 19,991 |
BENNETT C FRANK | SVP, Antisense Research | 01/01/2016 | 4,246 |
BENNETT C FRANK | SVP, Antisense Research | 12/15/2015 | 57,880 |
BENNETT C FRANK | SVP, Antisense Research | 12/16/2015 | 56,563 |
BENNETT C FRANK | SVP, Antisense Research | 12/16/2015 | 230,045 |
BENNETT C FRANK | SVP, Antisense Research | 12/15/2015 | 224,000 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 12/01/2015 | 7,250 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 12/01/2015 | 61,500 |
BENNETT C FRANK | SVP, Antisense Research | 11/10/2015 | 72,350 |
BENNETT C FRANK | SVP, Antisense Research | 11/10/2015 | 320,000 |
KLEIN JOSEPH III | Director | 11/11/2015 | 75,312 |
KLEIN JOSEPH III | Director | 11/11/2015 | 441,234 |
BENNETT C FRANK | SVP, Antisense Research | 11/06/2015 | 72,350 |
BENNETT C FRANK | SVP, Antisense Research | 11/06/2015 | 280,000 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 11/03/2015 | 7,250 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 11/03/2015 | 51,950 |
CROOKE STANLEY T | Chairman and CEO | 10/21/2015 | 15,880 |
CROOKE STANLEY T | Chairman and CEO | 10/21/2015 | 169,050 |
CROOKE STANLEY T | Chairman and CEO | 10/23/2015 | 23,050 |
CROOKE STANLEY T | Chairman and CEO | 10/23/2015 | 261,330 |
CROOKE STANLEY T | Chairman and CEO | 10/21/2015 | 645,000 |
CROOKE STANLEY T | Chairman and CEO | 10/23/2015 | 111,000 |
CROOKE STANLEY T | Chairman and CEO | 10/23/2015 | 1,108,855 |
CROOKE STANLEY T | Chairman and CEO | 10/21/2015 | 64,500 |
PARSHALL B LYNNE | COO & Secretary | 10/01/2015 | 71,865 |
PARSHALL B LYNNE | COO & Secretary | 10/02/2015 | 79,855 |
PARSHALL B LYNNE | COO & Secretary | 10/01/2015 | 280,880 |
PARSHALL B LYNNE | COO & Secretary | 10/02/2015 | 225,867 |
PARSHALL B LYNNE | COO & Secretary | 07/06/2015 | 49,260 |
PARSHALL B LYNNE | COO & Secretary | 07/06/2015 | 354,470 |
CROOKE STANLEY T | Chairman and CEO | 07/06/2015 | 56,350 |
CROOKE STANLEY T | Chairman and CEO | 07/06/2015 | 10,834 |
CROOKE STANLEY T | Chairman and CEO | 07/06/2015 | 285,035 |
CROOKE STANLEY T | Chairman and CEO | 07/06/2015 | 66,983 |
PARSHALL B LYNNE | COO & Secretary | 07/01/2015 | 3,450 |
PARSHALL B LYNNE | COO & Secretary | 07/01/2015 | 63,983 |
PARSHALL B LYNNE | COO & Secretary | 07/01/2015 | 357,914 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 07/01/2015 | 4,130 |
Monia Brett P | SVP, Antisense Drug Discovery | 07/01/2015 | 6,170 |
Monia Brett P | SVP, Antisense Drug Discovery | 07/02/2015 | 11,147 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 07/01/2015 | 1,943 |
Geary Richard S | SVP, Development | 07/01/2015 | 12,875 |
CROOKE STANLEY T | Chairman and CEO | 07/01/2015 | 56,350 |
CROOKE STANLEY T | Chairman and CEO | 07/01/2015 | 10,834 |
CROOKE STANLEY T | Chairman and CEO | 07/01/2015 | 67,634 |
CROOKE STANLEY T | Chairman and CEO | 07/01/2015 | 287,805 |
BENNETT C FRANK | SVP, Antisense Research | 07/01/2015 | 4,227 |
Monia Brett P | SVP, Antisense Drug Discovery | 06/08/2015 | 78,204 |
Monia Brett P | SVP, Antisense Drug Discovery | 06/08/2015 | 503,280 |
MUTO FREDERICK T | Director | 06/01/2015 | 39,500 |
MUTO FREDERICK T | Director | 06/01/2015 | 669,110 |
BERTHELSEN SPENCER R | Director | 04/17/2015 | 39,500 |
PARSHALL B LYNNE | COO & Secretary | 04/07/2015 | 81,750 |
PARSHALL B LYNNE | COO & Secretary | 04/07/2015 | 350,990 |
CROOKE STANLEY T | Chairman and CEO | 04/07/2015 | 18,753 |
CROOKE STANLEY T | Chairman and CEO | 04/07/2015 | 229,266 |
CROOKE STANLEY T | Chairman and CEO | 04/07/2015 | 128,286 |
CROOKE STANLEY T | Chairman and CEO | 04/07/2015 | 1,283,053 |
PARSHALL B LYNNE | COO & Secretary | 04/01/2015 | 78,988 |
PARSHALL B LYNNE | COO & Secretary | 04/01/2015 | 333,009 |
CROOKE STANLEY T | Chairman and CEO | 04/01/2015 | 18,127 |
CROOKE STANLEY T | Chairman and CEO | 04/01/2015 | 221,534 |
CROOKE STANLEY T | Chairman and CEO | 04/01/2015 | 121,759 |
CROOKE STANLEY T | Chairman and CEO | 04/01/2015 | 1,217,399 |
BENNETT C FRANK | SVP, Antisense Research | 03/24/2015 | 130,230 |
BENNETT C FRANK | SVP, Antisense Research | 03/23/2015 | 86,820 |
BENNETT C FRANK | SVP, Antisense Research | 03/24/2015 | 639,090 |
BENNETT C FRANK | SVP, Antisense Research | 03/23/2015 | 420,020 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 03/19/2015 | 112,700 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 03/19/2015 | 733,260 |
WENDER JOSEPH H | Director | 03/18/2015 | 74,125 |
WENDER JOSEPH H | Director | 03/18/2015 | 892,586 |
Geary Richard S | SVP, Development | 03/19/2015 | 117,520 |
Geary Richard S | SVP, Development | 03/19/2015 | 600,032 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 03/19/2015 | 690,416 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 03/19/2015 | 2,284,757 |
Geary Richard S | SVP, Development | 03/05/2015 | 133,972 |
Geary Richard S | SVP, Development | 03/05/2015 | 1,287,382 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 03/05/2015 | 295,065 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 03/05/2015 | 2,010,823 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 03/05/2015 | 55,865 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 03/05/2015 | 415,674 |
WENDER JOSEPH H | Director | 03/05/2015 | 122,125 |
WENDER JOSEPH H | Director | 03/05/2015 | 895,174 |
KLEIN JOSEPH III | Director | 03/05/2015 | 101,800 |
KLEIN JOSEPH III | Director | 03/05/2015 | 496,681 |
WENDER JOSEPH H | Director | 03/02/2015 | 461,785 |
WENDER JOSEPH H | Director | 02/12/2015 | 39,500 |
WENDER JOSEPH H | Director | 02/12/2015 | 621,460 |
CROOKE STANLEY T | Chairman and CEO | 01/27/2015 | 112,700 |
CROOKE STANLEY T | Chairman and CEO | 01/27/2015 | 9,220 |
CROOKE STANLEY T | Chairman and CEO | 01/27/2015 | 729,260 |
CROOKE STANLEY T | Chairman and CEO | 01/27/2015 | 72,926 |
CROOKE STANLEY T | Chairman and CEO | 01/16/2015 | 28,341 |
CROOKE STANLEY T | Chairman and CEO | 01/16/2015 | 587,007 |
PARSHALL B LYNNE | COO & Secretary | 01/16/2015 | 278,177 |
Monia Brett P | SVP, Antisense Drug Discovery | 01/16/2015 | 104,257 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 01/16/2015 | 87,742 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 01/16/2015 | 87,742 |
BENNETT C FRANK | SVP, Antisense Research | 01/16/2015 | 103,169 |
Geary Richard S | SVP, Development | 01/16/2015 | 104,868 |
CROOKE STANLEY T | Chairman and CEO | 01/09/2015 | 9,220 |
CROOKE STANLEY T | Chairman and CEO | 01/09/2015 | 112,700 |
CROOKE STANLEY T | Chairman and CEO | 01/09/2015 | 73,570 |
CROOKE STANLEY T | Chairman and CEO | 01/09/2015 | 735,700 |
Geary Richard S | SVP, Development | 01/12/2015 | 43,641 |
CROOKE STANLEY T | Chairman and CEO | 01/06/2015 | 112,700 |
CROOKE STANLEY T | Chairman and CEO | 01/07/2015 | 9,220 |
CROOKE STANLEY T | Chairman and CEO | 01/07/2015 | 112,700 |
CROOKE STANLEY T | Chairman and CEO | 01/06/2015 | 9,220 |
CROOKE STANLEY T | Chairman and CEO | 01/06/2015 | 660,380 |
CROOKE STANLEY T | Chairman and CEO | 01/07/2015 | 68,048 |
CROOKE STANLEY T | Chairman and CEO | 01/07/2015 | 680,480 |
CROOKE STANLEY T | Chairman and CEO | 01/06/2015 | 66,038 |
PARSHALL B LYNNE | COO & Secretary | 01/01/2015 | 3,335 |
PARSHALL B LYNNE | COO & Secretary | 01/02/2015 | 164,528 |
PARSHALL B LYNNE | COO & Secretary | 01/02/2015 | 695,688 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 01/01/2015 | 9,886 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 01/02/2015 | 15,220 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 01/02/2015 | 93,173 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 01/01/2015 | 1,893 |
BENNETT C FRANK | SVP, Antisense Research | 01/01/2015 | 4,086 |
Geary Richard S | SVP, Development | 01/01/2015 | 8,203 |
Monia Brett P | SVP, Antisense Drug Discovery | 01/01/2015 | 5,949 |
Monia Brett P | SVP, Antisense Drug Discovery | 01/02/2015 | 4,769 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 12/01/2014 | 10,875 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 12/01/2014 | 76,815 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 11/03/2014 | 10,875 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 11/03/2014 | 69,255 |
PARSHALL B LYNNE | COO & Secretary | 10/30/2014 | 98,939 |
PARSHALL B LYNNE | COO & Secretary | 10/30/2014 | 499,535 |
CROOKE STANLEY T | Chairman and CEO | 10/23/2014 | 14,752 |
CROOKE STANLEY T | Chairman and CEO | 10/23/2014 | 156,110 |
CROOKE STANLEY T | Chairman and CEO | 10/23/2014 | 548,860 |
CROOKE STANLEY T | Chairman and CEO | 10/23/2014 | 67,552 |
CROOKE STANLEY T | Chairman and CEO | 10/03/2014 | 188,110 |
CROOKE STANLEY T | Chairman and CEO | 10/01/2014 | 20,900 |
CROOKE STANLEY T | Chairman and CEO | 10/01/2014 | 289,400 |
CROOKE STANLEY T | Chairman and CEO | 10/03/2014 | 9,220 |
CROOKE STANLEY T | Chairman and CEO | 10/01/2014 | 75,822 |
CROOKE STANLEY T | Chairman and CEO | 10/01/2014 | 758,220 |
CROOKE STANLEY T | Chairman and CEO | 10/03/2014 | 39,487 |
CROOKE STANLEY T | Chairman and CEO | 10/03/2014 | 513,331 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 10/01/2014 | 11,583 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 10/01/2014 | 57,060 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 09/02/2014 | 15,435 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 09/02/2014 | 60,660 |
PARSHALL B LYNNE | COO | 09/02/2014 | 112,574 |
PARSHALL B LYNNE | COO | 09/02/2014 | 445,507 |
BENNETT C FRANK | SVP, Antisense Research | 08/27/2014 | 76,900 |
BENNETT C FRANK | SVP, Antisense Research | 08/27/2014 | 202,630 |
Monia Brett P | SVP, Antisense Drug Discovery | 08/26/2014 | 253,267 |
Monia Brett P | SVP, Antisense Drug Discovery | 08/26/2014 | 1,043,010 |
CROOKE STANLEY T | Chairman, President and CEO | 08/13/2014 | 18,032 |
CROOKE STANLEY T | Chairman, President and CEO | 08/13/2014 | 224,285 |
CROOKE STANLEY T | Chairman, President and CEO | 08/13/2014 | 56,726 |
CROOKE STANLEY T | Chairman, President and CEO | 08/13/2014 | 549,537 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 08/11/2014 | 7,203 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 08/12/2014 | 8,232 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 08/11/2014 | 24,500 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 08/12/2014 | 28,000 |
CROOKE STANLEY T | Chairman, President and CEO | 08/01/2014 | 11,270 |
CROOKE STANLEY T | Chairman, President and CEO | 08/01/2014 | 217,050 |
CROOKE STANLEY T | Chairman, President and CEO | 08/01/2014 | 30,525 |
CROOKE STANLEY T | Chairman, President and CEO | 08/01/2014 | 457,875 |
Monia Brett P | SVP, Antisense Drug Discovery | 07/31/2014 | 2,489 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 07/01/2014 | 12,171 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 07/01/2014 | 15,435 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 07/01/2014 | 53,000 |
CROOKE STANLEY T | Chairman and CEO | 07/01/2014 | 23,180 |
CROOKE STANLEY T | Chairman and CEO | 07/01/2014 | 224,285 |
CROOKE STANLEY T | Chairman and CEO | 07/01/2014 | 71,100 |
CROOKE STANLEY T | Chairman and CEO | 07/01/2014 | 551,459 |
Geary Richard S | SVP, Development | 07/01/2014 | 18,030 |
Geary Richard S | SVP, Development | 07/02/2014 | 5,896 |
PARSHALL B LYNNE | COO & Secretary | 07/01/2014 | 8,577 |
Monia Brett P | SVP, Antisense Drug Discovery | 07/01/2014 | 2,295 |
BENNETT C FRANK | SVP, Antisense Research | 07/01/2014 | 8,788 |
BENNETT C FRANK | SVP, Antisense Research | 06/23/2014 | 172,256 |
BENNETT C FRANK | SVP, Antisense Research | 06/23/2014 | 411,910 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 06/19/2014 | 7,127 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 06/19/2014 | 24,748 |
CROOKE STANLEY T | Chairman, President and CEO | 06/19/2014 | 159,170 |
CROOKE STANLEY T | Chairman, President and CEO | 06/19/2014 | 386,111 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 06/16/2014 | 6,400 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 06/16/2014 | 28,110 |
CROOKE STANLEY T | Chairman, President and CEO | 06/10/2014 | 14,470 |
CROOKE STANLEY T | Chairman, President and CEO | 06/10/2014 | 144,700 |
CROOKE STANLEY T | Chairman, President and CEO | 06/10/2014 | 33,455 |
CROOKE STANLEY T | Chairman, President and CEO | 06/10/2014 | 334,550 |
MUTO FREDERICK T | Director | 06/02/2014 | 57,200 |
MUTO FREDERICK T | Director | 06/02/2014 | 285,900 |
BERTHELSEN SPENCER R | Director | 04/17/2014 | 57,200 |
CROOKE STANLEY T | Chairman, President and CEO | 04/02/2014 | 26,046 |
CROOKE STANLEY T | Chairman, President and CEO | 04/02/2014 | 101,290 |
CROOKE STANLEY T | Chairman, President and CEO | 04/02/2014 | 78,566 |
CROOKE STANLEY T | Chairman, President and CEO | 04/02/2014 | 305,536 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 04/01/2014 | 12,000 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 04/01/2014 | 66,600 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 03/03/2014 | 16,396 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 03/03/2014 | 75,000 |
WENDER JOSEPH H | Director | 02/06/2014 | 30,316 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 02/03/2014 | 16,905 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 02/03/2014 | 75,677 |
WENDER JOSEPH H | Director | 02/03/2014 | 26,884 |
WENDER JOSEPH H | Director | 02/03/2014 | 229,278 |
PARSHALL B LYNNE | COO | 01/29/2014 | 72,500 |
PARSHALL B LYNNE | COO | 01/29/2014 | 364,043 |
PARSHALL B LYNNE | COO | 01/30/2014 | 358,298 |
PARSHALL B LYNNE | COO | 01/29/2014 | 36,250 |
PARSHALL B LYNNE | COO | 01/29/2014 | 488,070 |
PARSHALL B LYNNE | COO | 01/29/2014 | 1,708,245 |
PARSHALL B LYNNE | COO | 01/30/2014 | 1,989,882 |
PARSHALL B LYNNE | COO | 01/29/2014 | 244,035 |
KLEIN JOSEPH III | Director | 01/24/2014 | 158,800 |
KLEIN JOSEPH III | Director | 01/24/2014 | 501,838 |
Geary Richard S | SVP, Development | 01/22/2014 | 222,702 |
Geary Richard S | SVP, Development | 01/22/2014 | 1,111,021 |
WENDER JOSEPH H | Director | 01/22/2014 | 509,803 |
BENNETT C FRANK | SVP, Antisense Research | 01/16/2014 | 37,853 |
Geary Richard S | SVP, Development | 01/16/2014 | 39,030 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 01/16/2014 | 27,165 |
Monia Brett P | SVP, Antisense Drug Discovery | 01/16/2014 | 38,653 |
PARSHALL B LYNNE | COO & Secretary | 01/16/2014 | 77,262 |
CROOKE STANLEY T | Chairman and CEO | 01/16/2014 | 13,230 |
CROOKE STANLEY T | Chairman and CEO | 01/16/2014 | 152,825 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 01/16/2014 | 27,166 |
CROOKE STANLEY T | Chairman, President and CEO | 01/08/2014 | 21,705 |
CROOKE STANLEY T | Chairman, President and CEO | 01/08/2014 | 159,170 |
CROOKE STANLEY T | Chairman, President and CEO | 01/08/2014 | 60,078 |
CROOKE STANLEY T | Chairman, President and CEO | 01/08/2014 | 440,572 |
Geary Richard S | SVP, Development | 01/06/2014 | 83,398 |
Geary Richard S | SVP, Development | 01/08/2014 | 78,204 |
Geary Richard S | SVP, Development | 01/06/2014 | 287,364 |
Geary Richard S | SVP, Development | 01/08/2014 | 319,352 |
Monia Brett P | SVP, Antisense Drug Discovery | 01/01/2014 | 1,912 |
Monia Brett P | SVP, Antisense Drug Discovery | 01/02/2014 | 14,210 |
BENNETT C FRANK | SVP, Antisense Research | 01/01/2014 | 3,969 |
CROOKE STANLEY T | Chairman, President and CEO | 01/02/2014 | 36,175 |
CROOKE STANLEY T | Chairman, President and CEO | 01/02/2014 | 419,630 |
CROOKE STANLEY T | Chairman, President and CEO | 01/02/2014 | 1,141,325 |
CROOKE STANLEY T | Chairman, President and CEO | 01/02/2014 | 98,132 |
Geary Richard S | SVP, Development | 01/01/2014 | 3,969 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 01/01/2014 | 9,559 |
PARSHALL B LYNNE | COO | 01/01/2014 | 9,607 |
PARSHALL B LYNNE | COO | 12/26/2013 | 426,130 |
PARSHALL B LYNNE | COO | 12/26/2013 | 1,546,772 |
PARSHALL B LYNNE | COO & Secretary | 12/24/2013 | 225,400 |
PARSHALL B LYNNE | COO & Secretary | 12/23/2013 | 717,833 |
PARSHALL B LYNNE | COO & Secretary | 12/24/2013 | 819,920 |
PARSHALL B LYNNE | COO & Secretary | 12/23/2013 | 2,084,050 |
WENDER JOSEPH H | Director | 12/19/2013 | 244,800 |
WENDER JOSEPH H | Director | 12/20/2013 | 400,125 |
WENDER JOSEPH H | Director | 12/19/2013 | 380,813 |
BENNETT C FRANK | SVP, Antisense Research | 12/05/2013 | 153,800 |
BENNETT C FRANK | SVP, Antisense Research | 12/05/2013 | 399,182 |
WENDER JOSEPH H | Director | 11/26/2013 | 366,336 |
KLEIN JOSEPH III | Director | 11/25/2013 | 221,156 |
CROOKE STANLEY T | Chairman and CEO | 09/19/2013 | 556,000 |
CROOKE STANLEY T | Chairman and CEO | 09/20/2013 | 97,189 |
CROOKE STANLEY T | Chairman and CEO | 09/19/2013 | 1,753,080 |
CROOKE STANLEY T | Chairman and CEO | 09/20/2013 | 313,749 |
PARSHALL B LYNNE | COO & Secretary | 09/20/2013 | 587,900 |
PARSHALL B LYNNE | COO & Secretary | 09/19/2013 | 801,100 |
PARSHALL B LYNNE | COO & Secretary | 09/20/2013 | 1,435,920 |
PARSHALL B LYNNE | COO & Secretary | 09/19/2013 | 1,753,080 |
Monia Brett P | SVP, Antisense Drug Discovery | 09/20/2013 | 206,027 |
Monia Brett P | SVP, Antisense Drug Discovery | 09/19/2013 | 737,400 |
Monia Brett P | SVP, Antisense Drug Discovery | 09/19/2013 | 1,679,700 |
Monia Brett P | SVP, Antisense Drug Discovery | 09/20/2013 | 656,105 |
BENNETT C FRANK | SVP, Antisense Research | 09/19/2013 | 153,800 |
BENNETT C FRANK | SVP, Antisense Research | 09/19/2013 | 350,200 |
CROOKE STANLEY T | COO, President | 09/09/2013 | 295,959 |
CROOKE STANLEY T | COO, President | 09/10/2013 | 949,440 |
CROOKE STANLEY T | COO, President | 09/09/2013 | 809,495 |
CROOKE STANLEY T | COO, President | 09/11/2013 | 623,620 |
BENNETT C FRANK | SVP, Antisense Research | 09/09/2013 | 153,800 |
BENNETT C FRANK | SVP, Antisense Research | 09/09/2013 | 302,250 |
PARSHALL B LYNNE | COO | 09/11/2013 | 23,378 |
PARSHALL B LYNNE | COO | 09/10/2013 | 461,400 |
PARSHALL B LYNNE | COO | 09/09/2013 | 461,400 |
PARSHALL B LYNNE | COO | 09/10/2013 | 949,440 |
PARSHALL B LYNNE | COO | 09/09/2013 | 912,450 |
PARSHALL B LYNNE | COO | 09/11/2013 | 109,289 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 09/04/2013 | 28,236 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 09/04/2013 | 67,731 |
Monia Brett P | SVP, Antisense Drug Discovery | 08/26/2013 | 74,403 |
KLEIN JOSEPH III | Director | 08/09/2013 | 190,950 |
KLEIN JOSEPH III | Director | 08/09/2013 | 529,126 |
CROOKE STANLEY T | COO, President | 07/23/2013 | 127,880 |
CROOKE STANLEY T | COO, President | 07/23/2013 | 345,000 |
CROOKE STANLEY T | Chairman and CEO | 07/22/2013 | 299,570 |
CROOKE STANLEY T | Chairman and CEO | 07/19/2013 | 341,436 |
CROOKE STANLEY T | Chairman and CEO | 07/18/2013 | 222,400 |
CROOKE STANLEY T | Chairman and CEO | 07/19/2013 | 679,650 |
CROOKE STANLEY T | Chairman and CEO | 07/18/2013 | 602,220 |
CROOKE STANLEY T | Chairman and CEO | 07/22/2013 | 615,450 |
CROOKE STANLEY T | Chairman and CEO | 07/16/2013 | 200,160 |
CROOKE STANLEY T | Chairman and CEO | 07/15/2013 | 1,000,800 |
CROOKE STANLEY T | Chairman and CEO | 07/17/2013 | 531,762 |
CROOKE STANLEY T | Chairman and CEO | 07/16/2013 | 599,526 |
CROOKE STANLEY T | Chairman and CEO | 07/15/2013 | 3,042,540 |
CROOKE STANLEY T | Chairman and CEO | 07/17/2013 | 1,256,876 |
CROOKE STANLEY T | Chairman and CEO | 07/11/2013 | 461,400 |
CROOKE STANLEY T | Chairman and CEO | 07/10/2013 | 461,400 |
CROOKE STANLEY T | Chairman and CEO | 07/12/2013 | 359,160 |
CROOKE STANLEY T | Chairman and CEO | 07/11/2013 | 960,090 |
CROOKE STANLEY T | Chairman and CEO | 07/10/2013 | 901,440 |
CROOKE STANLEY T | Chairman and CEO | 07/12/2013 | 995,998 |
Geary Richard S | SVP, Development | 07/11/2013 | 100,080 |
Geary Richard S | SVP, Development | 07/11/2013 | 287,100 |
Geary Richard S | SVP, Development | 07/09/2013 | 106,584 |
Geary Richard S | SVP, Development | 07/08/2013 | 331,181 |
Geary Richard S | SVP, Development | 07/05/2013 | 365,831 |
Geary Richard S | SVP, Development | 07/09/2013 | 311,185 |
Geary Richard S | SVP, Development | 07/08/2013 | 902,380 |
Geary Richard S | SVP, Development | 07/05/2013 | 773,294 |
CROOKE STANLEY T | Chairman and CEO | 07/09/2013 | 461,400 |
CROOKE STANLEY T | Chairman and CEO | 07/08/2013 | 77,023 |
CROOKE STANLEY T | Chairman and CEO | 07/05/2013 | 371,888 |
CROOKE STANLEY T | Chairman and CEO | 07/08/2013 | 1,286,756 |
CROOKE STANLEY T | Chairman and CEO | 07/05/2013 | 725,763 |
CROOKE STANLEY T | Chairman and CEO | 07/09/2013 | 901,290 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 07/01/2013 | 8,976 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 07/05/2013 | 8,102 |
Geary Richard S | SVP, Development | 07/01/2013 | 7,514 |
Geary Richard S | SVP, Development | 07/03/2013 | 95,400 |
Geary Richard S | SVP, Development | 07/03/2013 | 145,100 |
Monia Brett P | SVP, Antisense Drug Discovery | 07/01/2013 | 3,329 |
Monia Brett P | SVP, Antisense Drug Discovery | 07/02/2013 | 6,169 |
BENNETT C FRANK | SVP, Antisense Research | 07/01/2013 | 6,953 |
CROOKE STANLEY T | Chairman and CEO | 06/28/2013 | 98,430 |
CROOKE STANLEY T | Chairman and CEO | 06/28/2013 | 68,100 |
CROOKE STANLEY T | Chairman and CEO | 06/27/2013 | 136,200 |
CROOKE STANLEY T | Chairman and CEO | 06/28/2013 | 270,700 |
CROOKE STANLEY T | Chairman and CEO | 06/27/2013 | 557,000 |
CROOKE STANLEY T | Chairman and CEO | 07/01/2013 | 281,700 |
CROOKE STANLEY T | Chairman and CEO | 06/28/2013 | 291,753 |
CROOKE STANLEY T | Chairman and CEO | 06/26/2013 | 136,200 |
CROOKE STANLEY T | Chairman and CEO | 06/25/2013 | 204,300 |
CROOKE STANLEY T | Chairman and CEO | 06/25/2013 | 840,698 |
CROOKE STANLEY T | Chairman and CEO | 06/24/2013 | 755,624 |
CROOKE STANLEY T | Chairman and CEO | 06/26/2013 | 267,000 |
CROOKE STANLEY T | Chairman and CEO | 06/26/2013 | 542,020 |
Geary Richard S | SVP, Development | 06/24/2013 | 465,100 |
Geary Richard S | SVP, Development | 06/25/2013 | 242,304 |
Geary Richard S | SVP, Development | 06/24/2013 | 755,624 |
Geary Richard S | SVP, Development | 06/25/2013 | 477,283 |
WENDER JOSEPH H | Director | 06/20/2013 | 51,700 |
WENDER JOSEPH H | Director | 06/20/2013 | 114,006 |
Monia Brett P | SVP, Antisense Drug Discovery | 06/11/2013 | 147,656 |
Monia Brett P | SVP, Antisense Drug Discovery | 06/11/2013 | 222,750 |
MUTO FREDERICK T | Director | 05/30/2013 | 51,700 |
MUTO FREDERICK T | Director | 05/30/2013 | 219,600 |
BENNETT C FRANK | SVP, Antisense Research | 05/01/2013 | 230,410 |
BENNETT C FRANK | SVP, Antisense Research | 04/30/2013 | 333,600 |
BENNETT C FRANK | SVP, Antisense Research | 04/30/2013 | 675,153 |
BENNETT C FRANK | SVP, Antisense Research | 05/01/2013 | 666,606 |
PARSHALL B LYNNE | COO, Secretary | 04/24/2013 | 333,600 |
PARSHALL B LYNNE | COO, Secretary | 04/25/2013 | 208,192 |
PARSHALL B LYNNE | COO, Secretary | 04/25/2013 | 581,586 |
PARSHALL B LYNNE | COO, Secretary | 04/24/2013 | 663,600 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 04/24/2013 | 160,213 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 04/24/2013 | 233,132 |
CROOKE STANLEY T | Chairman, CEO and President | 04/24/2013 | 221,200 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 04/19/2013 | 224,040 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 04/23/2013 | 361,101 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 04/19/2013 | 305,436 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 04/23/2013 | 604,592 |
PARSHALL B LYNNE | COO, Secretary | 04/22/2013 | 333,600 |
PARSHALL B LYNNE | COO, Secretary | 04/19/2013 | 217,800 |
PARSHALL B LYNNE | COO, Secretary | 04/23/2013 | 136,200 |
PARSHALL B LYNNE | COO, Secretary | 04/23/2013 | 111,200 |
PARSHALL B LYNNE | COO, Secretary | 04/19/2013 | 600,180 |
PARSHALL B LYNNE | COO, Secretary | 04/23/2013 | 441,934 |
PARSHALL B LYNNE | COO, Secretary | 04/23/2013 | 220,967 |
PARSHALL B LYNNE | COO, Secretary | 04/22/2013 | 629,700 |
Monia Brett P | SVP, Antisense Drug Discovery | 04/19/2013 | 27,800 |
Monia Brett P | SVP, Antisense Drug Discovery | 04/22/2013 | 189,040 |
Monia Brett P | SVP, Antisense Drug Discovery | 04/22/2013 | 361,420 |
Monia Brett P | SVP, Antisense Drug Discovery | 04/19/2013 | 53,125 |
CROOKE STANLEY T | Chairman, CEO and President | 04/22/2013 | 145,200 |
CROOKE STANLEY T | Chairman, CEO and President | 04/19/2013 | 217,800 |
CROOKE STANLEY T | Chairman, CEO and President | 04/23/2013 | 662,901 |
CROOKE STANLEY T | Chairman, CEO and President | 04/22/2013 | 209,900 |
CROOKE STANLEY T | Chairman, CEO and President | 04/22/2013 | 419,800 |
CROOKE STANLEY T | Chairman, CEO and President | 04/19/2013 | 600,180 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 04/22/2013 | 262,592 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 04/22/2013 | 378,814 |
Geary Richard S | SVP, Development | 04/19/2013 | 22,707 |
Geary Richard S | SVP, Development | 04/19/2013 | 42,474 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 04/12/2013 | 77,751 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 04/12/2013 | 107,096 |
Geary Richard S | Sr VP, Development | 04/11/2013 | 77,840 |
Geary Richard S | Sr VP, Development | 04/11/2013 | 136,640 |
Geary Richard S | Sr VP, Development | 03/21/2013 | 11,120 |
Geary Richard S | Sr VP, Development | 03/21/2013 | 19,500 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 03/21/2013 | 127,620 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 03/21/2013 | 173,340 |
HOUGEN ELIZABETH L | SVP, Finance and CFO | 03/20/2013 | 159,861 |
HOUGEN ELIZABETH L | SVP, Finance and CFO | 03/20/2013 | 260,637 |
KLEIN JOSEPH III | Director | 03/20/2013 | 53,357 |
KLEIN JOSEPH III | Director | 03/20/2013 | 70,632 |
KLEIN JOSEPH III | Director | 03/19/2013 | 44,196 |
KLEIN JOSEPH III | Director | 03/20/2013 | 146,118 |
KLEIN JOSEPH III | Director | 03/20/2013 | 238,864 |
KLEIN JOSEPH III | Director | 03/19/2013 | 22,095 |
KLEIN JOSEPH III | Director | 03/19/2013 | 134,154 |
KLEIN JOSEPH III | Director | 03/20/2013 | 213,138 |
KLEIN JOSEPH III | Director | 03/20/2013 | 355,608 |
KLEIN JOSEPH III | Director | 03/19/2013 | 67,068 |
KLEIN JOSEPH III | Director | 03/13/2013 | 36,046 |
KLEIN JOSEPH III | Director | 03/13/2013 | 72,098 |
KLEIN JOSEPH III | Director | 03/13/2013 | 124,842 |
KLEIN JOSEPH III | Director | 03/13/2013 | 249,702 |
HOUGEN ELIZABETH L | SVP, Finance and CFO | 03/05/2013 | 34,322 |
HOUGEN ELIZABETH L | SVP, Finance and CFO | 03/05/2013 | 84,960 |
Monia Brett P | SVP, Antisense Drug Discovery | 03/05/2013 | 124,214 |
Monia Brett P | SVP, Antisense Drug Discovery | 03/05/2013 | 307,599 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 03/04/2013 | 131,657 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 03/04/2013 | 185,059 |
BERTHELSEN SPENCER R | Director | 02/21/2013 | 51,700 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 02/19/2013 | 16,464 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 02/15/2013 | 3,601 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 02/15/2013 | 5,185 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 02/19/2013 | 23,680 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 02/13/2013 | 44,900 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 02/13/2013 | 88,407 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 01/30/2013 | 20,580 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 01/29/2013 | 4,020 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 01/30/2013 | 29,640 |
BENNETT C FRANK | SVP, Antisense Research | 01/16/2013 | 4,326 |
Geary Richard S | SVP, Development | 01/16/2013 | 4,830 |
CROOKE STANLEY T | Chairman, CEO and President | 01/16/2013 | 2,002 |
CROOKE STANLEY T | Chairman, CEO and President | 01/16/2013 | 18,438 |
Monia Brett P | SVP, Antisense Drug Discovery | 01/16/2013 | 4,620 |
HOUGEN ELIZABETH L | SVP, Finance & CFO | 01/16/2013 | 3,388 |
PARSHALL B LYNNE | COO, Secretary | 01/16/2013 | 10,626 |
O'NEIL PATRICK R. | SVP, Legal & General Counsel | 01/17/2013 | 3,427 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 01/04/2013 | 13,945 |
O'NEIL PATRICK R. | SVP, Legal and General Counsel | 01/01/2013 | 3,825 |
Monia Brett P | VP, Antisense Drug Discovery | 01/01/2013 | 1,908 |
Monia Brett P | VP, Antisense Drug Discovery | 01/03/2013 | 3,371 |
BENNETT C FRANK | SVP, Antisense Research | 01/01/2013 | 3,967 |
Geary Richard S | Sr VP, Development | 01/01/2013 | 7,969 |
Geary Richard S | Sr VP, Development | 01/03/2013 | 2,873 |
Geary Richard S | Sr VP, Development | 12/13/2012 | 31,500 |
Geary Richard S | Sr VP, Development | 12/13/2012 | 57,751 |
CROOKE STANLEY T | Chairman, CEO and President | 09/20/2012 | 190,155 |
CROOKE STANLEY T | Chairman, CEO and President | 09/19/2012 | 157,500 |
CROOKE STANLEY T | Chairman, CEO and President | 09/21/2012 | 201,520 |
CROOKE STANLEY T | Chairman, CEO and President | 09/20/2012 | 450,240 |
CROOKE STANLEY T | Chairman, CEO and President | 09/19/2012 | 444,450 |
CROOKE STANLEY T | Chairman, CEO and President | 09/21/2012 | 414,236 |
CROOKE STANLEY T | Chairman, CEO and President | 09/13/2012 | 142,139 |
CROOKE STANLEY T | Chairman, CEO and President | 09/13/2012 | 393,927 |
PARSHALL B LYNNE | COO, Secretary | 09/07/2012 | 17,141 |
PARSHALL B LYNNE | COO, Secretary | 09/07/2012 | 68,400 |
PARSHALL B LYNNE | COO, Secretary | 09/07/2012 | 151,200 |
PARSHALL B LYNNE | COO, Secretary | 09/07/2012 | 37,891 |
PARSHALL B LYNNE | COO, Secretary | 09/04/2012 | 105,000 |
PARSHALL B LYNNE | COO, Secretary | 09/06/2012 | 86,700 |
PARSHALL B LYNNE | COO, Secretary | 09/04/2012 | 52,500 |
PARSHALL B LYNNE | COO, Secretary | 09/06/2012 | 56,465 |
PARSHALL B LYNNE | COO, Secretary | 09/05/2012 | 10,500 |
PARSHALL B LYNNE | COO, Secretary | 09/06/2012 | 34,200 |
PARSHALL B LYNNE | COO, Secretary | 09/06/2012 | 300,370 |
PARSHALL B LYNNE | COO, Secretary | 09/04/2012 | 150,010 |
PARSHALL B LYNNE | COO, Secretary | 09/06/2012 | 150,185 |
PARSHALL B LYNNE | COO, Secretary | 09/05/2012 | 30,000 |
PARSHALL B LYNNE | COO, Secretary | 09/04/2012 | 300,020 |
REED JOHN C | Director | 09/04/2012 | 26,367 |
REED JOHN C | Director | 09/06/2012 | 25,333 |
REED JOHN C | Director | 09/06/2012 | 74,358 |
REED JOHN C | Director | 09/04/2012 | 77,367 |
Monia Brett P | VP, Antisense Drug Discovery | 09/06/2012 | 63,163 |
Monia Brett P | VP, Antisense Drug Discovery | 09/06/2012 | 183,473 |
CROOKE STANLEY T | Chairman, CEO and President | 09/06/2012 | 91,287 |
CROOKE STANLEY T | Chairman, CEO and President | 09/05/2012 | 78,750 |
CROOKE STANLEY T | Chairman, CEO and President | 09/04/2012 | 157,500 |
CROOKE STANLEY T | Chairman, CEO and President | 09/06/2012 | 69,274 |
CROOKE STANLEY T | Chairman, CEO and President | 09/05/2012 | 222,345 |
CROOKE STANLEY T | Chairman, CEO and President | 09/04/2012 | 423,255 |
CROOKE STANLEY T | Chairman, CEO and President | 09/06/2012 | 189,413 |
CROOKE STANLEY T | Chairman, CEO and President | 09/06/2012 | 261,142 |
BENNETT C FRANK | SVP, Antisense Research | 07/09/2012 | 71,670 |
BENNETT C FRANK | SVP, Antisense Research | 07/09/2012 | 141,855 |
Geary Richard S | Sr VP, Development | 07/09/2012 | 29,852 |
Geary Richard S | Sr VP, Development | 07/09/2012 | 76,610 |
REED JOHN C | Director | 07/09/2012 | 39,500 |
REED JOHN C | Director | 07/09/2012 | 139,900 |
Monia Brett P | SVP, Antisense Drug Discovery | 07/01/2012 | 1,906 |
Monia Brett P | SVP, Antisense Drug Discovery | 07/03/2012 | 7,584 |
BENNETT C FRANK | SVP, Antisense Research | 07/01/2012 | 3,971 |
BENNETT C FRANK | SVP, Antisense Research | 07/03/2012 | 41,040 |
BENNETT C FRANK | SVP, Antisense Research | 07/03/2012 | 77,460 |
Geary Richard S | Sr VP, Development | 07/01/2012 | 7,967 |
Geary Richard S | Sr VP, Development | 07/03/2012 | 31,423 |
BERTHELSEN SPENCER R | Director | 06/25/2012 | 81,500 |
BERTHELSEN SPENCER R | Director | 06/25/2012 | 115,669 |
REED JOHN C | Director | 06/22/2012 | 81,500 |
REED JOHN C | Director | 06/22/2012 | 110,600 |
Geary Richard S | Sr VP, Development | 06/14/2012 | 17,148 |
WENDER JOSEPH H | Director | 06/12/2012 | 81,500 |
BERTHELSEN SPENCER R | Director | 05/21/2012 | 25,671 |
BERTHELSEN SPENCER R | Director | 05/22/2012 | 162,329 |
BERTHELSEN SPENCER R | Director | 05/21/2012 | 25,726 |
BERTHELSEN SPENCER R | Director | 05/22/2012 | 165,092 |
BENNETT C FRANK | Senior Vice President | 01/01/2012 | 1,986 |
Geary Richard S | Senior Vice President | 01/01/2012 | 9,959 |
BENNETT C FRANK | Senior Vice President | 12/01/2011 | 1,986 |
Monia Brett P | Senior Vice President | 01/01/2012 | 3,597 |
Geary Richard S | Senior Vice President | 12/21/2011 | 6,635 |
Geary Richard S | Senior Vice President | 12/21/2011 | 7,916 |
CROOKE STANLEY T | Chairman, President, CEO | 12/21/2011 | 6,264 |
CROOKE STANLEY T | Chairman, President, CEO | 12/21/2011 | 96,976 |
CROOKE STANLEY T | Chairman, President, CEO | 12/21/2011 | 7,474 |
CROOKE STANLEY T | Chairman, President, CEO | 12/21/2011 | 115,702 |
PARSHALL B LYNNE | Director, COO | 12/21/2011 | 25,520 |
PARSHALL B LYNNE | Director, COO | 12/21/2011 | 13,705 |
PARSHALL B LYNNE | Director, COO | 12/21/2011 | 16,352 |
PARSHALL B LYNNE | Director, COO | 12/21/2011 | 30,448 |
BENNETT C FRANK | Senior Vice President | 12/21/2011 | 9,019 |
BENNETT C FRANK | Senior Vice President | 12/21/2011 | 10,761 |
CROOKE STANLEY T | Chairman, President, CEO | 12/16/2011 | 87,000 |
CROOKE STANLEY T | Chairman, President, CEO | 12/19/2011 | 6,380 |
CROOKE STANLEY T | Chairman, President, CEO | 12/19/2011 | 98,600 |
CROOKE STANLEY T | Chairman, President, CEO | 12/20/2011 | 9,860 |
CROOKE STANLEY T | Chairman, President, CEO | 12/16/2011 | 8,700 |
CROOKE STANLEY T | Chairman, President, CEO | 12/20/2011 | 156,600 |
CROOKE STANLEY T | Chairman, President, CEO | 12/19/2011 | 7,511 |
CROOKE STANLEY T | Chairman, President, CEO | 12/19/2011 | 116,086 |
CROOKE STANLEY T | Chairman, President, CEO | 12/20/2011 | 11,624 |
CROOKE STANLEY T | Chairman, President, CEO | 12/16/2011 | 10,185 |
CROOKE STANLEY T | Chairman, President, CEO | 12/20/2011 | 184,640 |
CROOKE STANLEY T | Chairman, President, CEO | 12/16/2011 | 101,850 |
BENNETT C FRANK | Senior Vice President | 12/16/2011 | 8,700 |
BENNETT C FRANK | Senior Vice President | 12/20/2011 | 14,500 |
BENNETT C FRANK | Senior Vice President | 12/19/2011 | 8,700 |
BENNETT C FRANK | Senior Vice President | 12/20/2011 | 17,100 |
BENNETT C FRANK | Senior Vice President | 12/19/2011 | 10,243 |
BENNETT C FRANK | Senior Vice President | 12/16/2011 | 10,185 |
Geary Richard S | Senior Vice President | 12/20/2011 | 10,440 |
Geary Richard S | Senior Vice President | 12/19/2011 | 6,380 |
Geary Richard S | Senior Vice President | 12/16/2011 | 5,800 |
Geary Richard S | Senior Vice President | 12/20/2011 | 12,306 |
Geary Richard S | Senior Vice President | 12/19/2011 | 7,511 |
Geary Richard S | Senior Vice President | 12/16/2011 | 6,790 |
PARSHALL B LYNNE | Director, COO | 12/16/2011 | 11,600 |
PARSHALL B LYNNE | Director, COO | 12/19/2011 | 13,340 |
PARSHALL B LYNNE | Director, COO | 12/16/2011 | 11,600 |
PARSHALL B LYNNE | Director, COO | 12/20/2011 | 40,600 |
PARSHALL B LYNNE | Director, COO | 12/19/2011 | 1,217,687 |
PARSHALL B LYNNE | Director, COO | 12/20/2011 | 20,880 |
PARSHALL B LYNNE | Director, COO | 12/19/2011 | 15,706 |
PARSHALL B LYNNE | Director, COO | 12/20/2011 | 43,036 |
PARSHALL B LYNNE | Director, COO | 12/20/2011 | 4,844 |
PARSHALL B LYNNE | Director, COO | 12/16/2011 | 27,160 |
PARSHALL B LYNNE | Director, COO | 12/20/2011 | 24,622 |
PARSHALL B LYNNE | Director, COO | 12/16/2011 | 13,580 |
PARSHALL B LYNNE | Director, COO | 12/19/2011 | 31,411 |
BENNETT C FRANK | Senior Vice President | 08/04/2011 | 52,500 |
BENNETT C FRANK | Senior Vice President | 08/04/2011 | 76,206 |
BENNETT C FRANK | Senior Vice President | 07/28/2011 | 8,600 |
BENNETT C FRANK | Senior Vice President | 07/01/2011 | 1,984 |
Geary Richard S | Senior Vice President | 07/01/2011 | 2,095 |
BENNETT C FRANK | Senior Vice President | 01/01/2011 | 3,843 |
Geary Richard S | Senior Vice President | 01/01/2011 | 18,972 |
Geary Richard S | Senior Vice President | 12/29/2010 | 19,058 |
Geary Richard S | Senior Vice President | 12/27/2010 | 31,763 |
Geary Richard S | Senior Vice President | 12/29/2010 | 20,424 |
Geary Richard S | Senior Vice President | 12/27/2010 | 34,386 |
PARSHALL B LYNNE | Director, COO | 12/29/2010 | 61,600 |
PARSHALL B LYNNE | Director, COO | 12/27/2010 | 103,950 |
PARSHALL B LYNNE | Director, COO | 12/27/2010 | 112,536 |
PARSHALL B LYNNE | Director, COO | 12/29/2010 | 66,016 |
BENNETT C FRANK | Senior Vice President | 12/29/2010 | 44,275 |
BENNETT C FRANK | Senior Vice President | 12/27/2010 | 74,113 |
BENNETT C FRANK | Senior Vice President | 12/29/2010 | 47,449 |
BENNETT C FRANK | Senior Vice President | 12/27/2010 | 80,234 |
CROOKE STANLEY T | Chairman, President, CEO | 12/29/2010 | 19,250 |
CROOKE STANLEY T | Chairman, President, CEO | 12/29/2010 | 96,250 |
CROOKE STANLEY T | Chairman, President, CEO | 12/27/2010 | 192,500 |
CROOKE STANLEY T | Chairman, President, CEO | 12/29/2010 | 20,630 |
CROOKE STANLEY T | Chairman, President, CEO | 12/29/2010 | 103,150 |
CROOKE STANLEY T | Chairman, President, CEO | 12/27/2010 | 208,400 |
Geary Richard S | Senior Vice President | 12/23/2010 | 1,925 |
Geary Richard S | Senior Vice President | 12/23/2010 | 2,105 |
PARSHALL B LYNNE | COO | 12/23/2010 | 7,700 |
PARSHALL B LYNNE | COO | 12/23/2010 | 12,513 |
PARSHALL B LYNNE | COO | 12/22/2010 | 129,500 |
PARSHALL B LYNNE | COO | 12/23/2010 | 8,420 |
PARSHALL B LYNNE | COO | 12/23/2010 | 13,682 |
PARSHALL B LYNNE | COO | 12/22/2010 | 45,762 |
Geary Richard S | Senior Vice President | 12/22/2010 | 25,025 |
Geary Richard S | Senior Vice President | 12/23/2010 | 3,850 |
Geary Richard S | Senior Vice President | 12/22/2010 | 27,352 |
Geary Richard S | Senior Vice President | 12/23/2010 | 4,210 |
BENNETT C FRANK | Senior Vice President | 12/23/2010 | 14,438 |
BENNETT C FRANK | Senior Vice President | 12/22/2010 | 59,675 |
BENNETT C FRANK | Senior Vice President | 12/23/2010 | 15,787 |
BENNETT C FRANK | Senior Vice President | 12/22/2010 | 65,224 |
CROOKE STANLEY T | Chairman, President, CEO | 12/23/2010 | 38,500 |
CROOKE STANLEY T | Chairman, President, CEO | 12/22/2010 | 154,000 |
CROOKE STANLEY T | Chairman, President, CEO | 12/23/2010 | 42,100 |
CROOKE STANLEY T | Chairman, President, CEO | 12/22/2010 | 168,320 |
BENNETT C FRANK | Senior Vice President | 07/23/2010 | 10,560 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 9,057,530 | 0.01% | -0.63% | Other |
ARK INVESTMENT MANAGEMENT LLC | 1,905,056 | 0.57% | -19.49% | Growth |
GEODE CAPITAL MANAGEMENT, LLC | 2,275,931 | 0.01% | 3.7% | Other |
ORBIMED ADVISORS LLC | 2,064,797 | 2.09% | -4.83% | Other |
FARALLON CAPITAL MANAGEMENT LLC | 1,555,020 | 0.39% | 113.9% | Event Driven, Value |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,385,300 | 0.15% | 29.83% | Other |
CAPITAL WORLD INVESTORS | 839,463 | 0.00755% | No change | Growth At A Reasonable Price |
CANDRIAM S.C.A. | 629,067 | 0.22% | 14.57% | Other |
D. E. SHAW & CO., INC. | 119,158 | 0.00527% | -67.09% | Other |
RENAISSANCE TECHNOLOGIES LLC | 112,414 | 0.0088% | -58.33% | Other |
SENATOR INVESTMENT GROUP LP | 135,000 | 0.29% | New | Event Driven, Value |
UBS OCONNOR LLC | 28,624 | 0.1% | -53.88% | Value |
GOTHAM ASSET MANAGEMENT, LLC | 6,989 | 0.00656% | -13.59% | Other |
AQR CAPITAL MANAGEMENT LLC | 4,300 | 0.0004% | New | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View